
<html lang="en"     class="pb-page"  data-request-id="2deb2756-27c7-4dca-9cd3-6613847b294c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm301404a;issue:issue:10.1021/jmcmar.2012.55.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of 6,7-Dihydro-5H-pyrrolo[2,3-a]pyrimidines as Orally Available G Protein-Coupled Receptor 119 Agonists" /></meta><meta name="dc.Creator" content="Subba R.  Katamreddy" /></meta><meta name="dc.Creator" content="Andrew J.  Carpenter" /></meta><meta name="dc.Creator" content="Carina E.  Ammala" /></meta><meta name="dc.Creator" content="Eric E.  Boros" /></meta><meta name="dc.Creator" content="Ron L.  Brashear" /></meta><meta name="dc.Creator" content="Celia P.  Briscoe" /></meta><meta name="dc.Creator" content="Sarah R.  Bullard" /></meta><meta name="dc.Creator" content="Richard D.  Caldwell" /></meta><meta name="dc.Creator" content="Christopher R.  Conlee" /></meta><meta name="dc.Creator" content="Dallas K.  Croom" /></meta><meta name="dc.Creator" content="Shane M.  Hart" /></meta><meta name="dc.Creator" content="Dennis O.  Heyer" /></meta><meta name="dc.Creator" content="Paul R.  Johnson" /></meta><meta name="dc.Creator" content="Jennifer A.  Kashatus" /></meta><meta name="dc.Creator" content="Doug J.  Minick" /></meta><meta name="dc.Creator" content="Gregory E.  Peckham" /></meta><meta name="dc.Creator" content="Sean A.  Ross" /></meta><meta name="dc.Creator" content="Shane G.  Roller" /></meta><meta name="dc.Creator" content="Vicente A.  Samano" /></meta><meta name="dc.Creator" content="Howard R.  Sauls" /></meta><meta name="dc.Creator" content="Sarva M.  Tadepalli" /></meta><meta name="dc.Creator" content="James B.  Thompson" /></meta><meta name="dc.Creator" content="Yun  Xu" /></meta><meta name="dc.Creator" content="James M.  Way" /></meta><meta name="dc.Description" content="GPR119 is a 7-transmembrane receptor that is expressed in the enteroendocrine cells in the intestine and in the islets of Langerhans in the pancreas. Indolines and 6,7-dihydro-5H-pyrrolo[2,3-a]pyri..." /></meta><meta name="Description" content="GPR119 is a 7-transmembrane receptor that is expressed in the enteroendocrine cells in the intestine and in the islets of Langerhans in the pancreas. Indolines and 6,7-dihydro-5H-pyrrolo[2,3-a]pyri..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 12, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301404a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301404a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301404a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301404a" /></link>
        
    
    

<title>Discovery of 6,7-Dihydro-5H-pyrrolo[2,3-a]pyrimidines as Orally Available G Protein-Coupled Receptor 119 Agonists | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301404a" /></meta><meta property="og:title" content="Discovery of 6,7-Dihydro-5H-pyrrolo[2,3-a]pyrimidines as Orally Available G Protein-Coupled Receptor 119 Agonists" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0025.jpeg" /></meta><meta property="og:description" content="GPR119 is a 7-transmembrane receptor that is expressed in the enteroendocrine cells in the intestine and in the islets of Langerhans in the pancreas. Indolines and 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines were discovered as G protein-coupled receptor 119 (GPR119) agonists, and lead optimization efforts led to the identification of 1-methylethyl 4-({7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (GSK1104252A) (3), a potent and selective GPR119 agonist. Compound 3 showed excellent pharmacokinetic properties and sufficient selectivity with in vivo studies supporting a role for GPR119 in glucose homeostasis in the rodent. Thus, 3 appeared to modulate the enteroinsular axis, improve glycemic control, and strengthen previous suggestions that GPR119 agonists may have utility in the treatment of type 2 diabetes." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301404a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301404a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301404a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301404a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301404a&amp;href=/doi/10.1021/jm301404a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 10972-10994</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301389h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm301443r" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of 6,7-Dihydro-5<i>H</i>-pyrrolo[2,3-<i>a</i>]pyrimidines as Orally Available G Protein-Coupled Receptor 119 Agonists</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Subba+R.++Katamreddy">Subba R. Katamreddy</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+J.++Carpenter">Andrew J. Carpenter</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Carina+E.++Ammala">Carina E. Ammala</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+E.++Boros">Eric E. Boros</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ron+L.++Brashear">Ron L. Brashear</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Celia+P.++Briscoe">Celia P. Briscoe</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+R.++Bullard">Sarah R. Bullard</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard+D.++Caldwell">Richard D. Caldwell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Conlee">Christopher R. Conlee</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dallas+K.++Croom">Dallas K. Croom</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shane+M.++Hart">Shane M. Hart</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis+O.++Heyer">Dennis O. Heyer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+R.++Johnson">Paul R. Johnson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer+A.++Kashatus">Jennifer A. Kashatus</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Doug+J.++Minick">Doug J. Minick</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+E.++Peckham">Gregory E. Peckham</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean+A.++Ross">Sean A. Ross</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shane+G.++Roller">Shane G. Roller</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vicente+A.++Samano">Vicente A. Samano</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Howard+R.++Sauls">Howard R. Sauls</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarva+M.++Tadepalli">Sarva M. Tadepalli</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+B.++Thompson">James B. Thompson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Xu">Yun Xu</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James+M.++Way">James M. Way</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">GlaxoSmithKline Research & Development, Five Moore Drive, Research Triangle Park, North Carolina 27709, United States</span></div><div class="corresp-info"><strong>*</strong>For S.R.K.: phone, (919) 314-5528; fax, (919) 314-5529; E-mail, <a href="/cdn-cgi/l/email-protection#aad9c1cbdecbc7d8cfceced3eac4c984d8d884c9c5c7"><span class="__cf_email__" data-cfemail="dba8b0baafbab6a9bebfbfa29bb5b8f5a9a9f5b8b4b6">[email protected]</span></a>. For A.J.C.: phone, (919) 483-9868; fax, (919) 315-6923; E-mail, <a href="/cdn-cgi/l/email-protection#7c1d12180e190b5216521f1d0e0c191208190e3c1b0f17521f1311"><span class="__cf_email__" data-cfemail="a4c5cac0d6c1d38ace8ac7c5d6d4c1cad0c1d6e4c3d7cf8ac7cbc9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301404a&amp;href=/doi/10.1021%2Fjm301404a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 10972–10994</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 5, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 September 2012</li><li><span class="item_label"><b>Published</b> online</span>12 December 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 December 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301404a" title="DOI URL">https://doi.org/10.1021/jm301404a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10972%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DSubba%2BR.%2BKatamreddy%252C%2BAndrew%2BJ.%2BCarpenter%252C%2BCarina%2BE.%2BAmmala%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D24%26contentID%3Djm301404a%26title%3DDiscovery%2Bof%2B6%252C7-Dihydro-5H-pyrrolo%255B2%252C3-a%255Dpyrimidines%2Bas%2BOrally%2BAvailable%2BG%2BProtein-Coupled%2BReceptor%2B119%2BAgonists%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10994%26publicationDate%3DDecember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301404a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2562</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301404a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of 6,7-Dihydro-5H-pyrrolo[2,3-a]pyrimidines as Orally Available G Protein-Coupled Receptor 119 Agonists&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Subba&quot;,&quot;last_name&quot;:&quot;R. Katamreddy&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;J. Carpenter&quot;},{&quot;first_name&quot;:&quot;Carina&quot;,&quot;last_name&quot;:&quot;E. Ammala&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;E. Boros&quot;},{&quot;first_name&quot;:&quot;Ron&quot;,&quot;last_name&quot;:&quot;L. Brashear&quot;},{&quot;first_name&quot;:&quot;Celia&quot;,&quot;last_name&quot;:&quot;P. Briscoe&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;R. Bullard&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;D. Caldwell&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Conlee&quot;},{&quot;first_name&quot;:&quot;Dallas&quot;,&quot;last_name&quot;:&quot;K. Croom&quot;},{&quot;first_name&quot;:&quot;Shane&quot;,&quot;last_name&quot;:&quot;M. Hart&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;O. Heyer&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;R. Johnson&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;A. Kashatus&quot;},{&quot;first_name&quot;:&quot;Doug&quot;,&quot;last_name&quot;:&quot;J. Minick&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;E. Peckham&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;A. Ross&quot;},{&quot;first_name&quot;:&quot;Shane&quot;,&quot;last_name&quot;:&quot;G. Roller&quot;},{&quot;first_name&quot;:&quot;Vicente&quot;,&quot;last_name&quot;:&quot;A. Samano&quot;},{&quot;first_name&quot;:&quot;Howard&quot;,&quot;last_name&quot;:&quot;R. Sauls&quot;},{&quot;first_name&quot;:&quot;Sarva&quot;,&quot;last_name&quot;:&quot;M. Tadepalli&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;B. Thompson&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;M. Way&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;10972-10994&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301404a&quot;},&quot;abstract&quot;:&quot;GPR119 is a 7-transmembrane receptor that is expressed in the enteroendocrine cells in the intestine and in the islets of Langerhans in the pancreas. Indolines and 6,7-dihydro-5H-pyrrolo[2,3-a]pyrimidines were discovered as G protein-coupled receptor 119 (GPR119) agonists, and lead optimization efforts led to the identification of 1-methylethyl 4-({7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (GSK1104252A) (3), a potent and selective GPR119 agonist. Compound 3 showed excellent pharmacokinetic properties and sufficient selectivity with in vivo studies supporting a role for GPR119 in glucose homeostasis in the rodent. Thus, 3 appeared to modulate the enteroinsular axis, improve glycemic control, and strengthen previous suggestions that GPR119 agonists may have utility in the treatment of type 2 diabetes.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301404a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301404a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301404a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301404a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301404a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301404a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301404a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301404a&amp;href=/doi/10.1021/jm301404a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301404a" /></input><a href="/doi/pdf/10.1021/jm301404a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301404a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301404a%26sid%3Dliteratum%253Aachs%26pmid%3D23214471%26genre%3Darticle%26aulast%3DKatamreddy%26date%3D2012%26atitle%3DDiscovery%2Bof%2B6%252C7-Dihydro-5H-pyrrolo%255B2%252C3-a%255Dpyrimidines%2Bas%2BOrally%2BAvailable%2BG%2BProtein-Coupled%2BReceptor%2B119%2BAgonists%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D24%26spage%3D10972%26epage%3D10994%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jmcmar.2012.55.issue-24/production/jmcmar.2012.55.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">GPR119 is a 7-transmembrane receptor that is expressed in the enteroendocrine cells in the intestine and in the islets of Langerhans in the pancreas. Indolines and 6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>a</i>]pyrimidines were discovered as G protein-coupled receptor 119 (GPR119) agonists, and lead optimization efforts led to the identification of 1-methylethyl 4-({7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (GSK1104252A) (<b>3</b>), a potent and selective GPR119 agonist. Compound <b>3</b> showed excellent pharmacokinetic properties and sufficient selectivity with in vivo studies supporting a role for GPR119 in glucose homeostasis in the rodent. Thus, <b>3</b> appeared to modulate the enteroinsular axis, improve glycemic control, and strengthen previous suggestions that GPR119 agonists may have utility in the treatment of type 2 diabetes.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>†</span> Author Present Address</h4><p class="last">Vijaya Pharmaceuticals, 104 T. W. Alexander Drive, Building #5, Research Triangle Park, North Carolina 27709, United States.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65157" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65157" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Type 2 diabetes (T2D) is a chronic disease characterized by insulin resistance, insufficient insulin secretion from pancreatic β-cells, and hyperglycemia. Glycemic control is the key for metabolic homeostasis, and the uncontrolled hyperglycemia leads to long-term complications including organ failure and amputation.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Recent estimates suggest that the incidence of diabetes in the U.S. may double over the next 20 years.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Presently, less than one-third of T2D patients will achieve the targeted plasma glucose levels with the currently available antidiabetic agents.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Furthermore, the currently available treatments either as monotherapies or combination therapies have their own limitations and potential risks.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This has prompted the scientific community to search for novel agents for the treatment and prevention of diabetes with novel mechanisms of action.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">G Protein-coupled receptor 119 (GPR119) is a class A (rhodopsin-like) 7-transmembrane, G protein-coupled receptor (GPCR) with little homology to other receptors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The human GPR119 receptor consists of 335 amino acids and is highly conserved in mouse and rat.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> GPR119 is expressed in human insulin-secreting pancreatic islets and incretin (GIP and GLP-1) secreting K- and L-cells of the gastrointestinal (GI) tract.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> There are some contradictory reports on its cellular subtype localization in islets;<a onclick="showRef(event, 'cit8a cit8b'); return false;" href="javascript:void(0);" class="ref cit8a cit8b">(8a, 8b)</a> however, there seems to be some consensus that the receptor is expressed in the β-cells.<a onclick="showRef(event, 'cit8b ref9'); return false;" href="javascript:void(0);" class="ref cit8b ref9">(8b, 9)</a></div><div class="NLM_p">The physiological role of GPR119 remains unknown. Elucidating the role of GPR119 signaling has been hampered by the lack of endogenous ligands that signal solely through GPR119. Lysophosphatidylcholine<a onclick="showRef(event, 'cit6a'); return false;" href="javascript:void(0);" class="ref cit6a">(6a)</a> (LPC), oleoylethanolamide<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> (OEA), <i>N</i>-acylated ethanolamine phospholipids<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> (NAPEs) and <i>N</i>-oleoyldopamine<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> (OLDA), and, most recently, 5-hydroxyeicosapentaenoic acid (5-HEPE)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> have all been suggested as endogenous ligands. However, given that the potency is relatively low or there are selectivity issues, it is difficult to conclusively identify any one of these as the only or true endogenous ligand.</div><div class="NLM_p">Evidence that activation of GPR119 may play a role in glucose homeostasis mainly comes from selective, small-molecule agonists. Specifically, GPR119 agonists have been shown to elicit nutrient-independent incretin and GI hormone release as well as nutrient-stimulated insulin secretion,<a onclick="showRef(event, 'cit8b cit8c ref14'); return false;" href="javascript:void(0);" class="ref cit8b cit8c ref14">(8b, 8c, 14)</a> thereby lowering plasma glucose levels during an oral glucose tolerance test.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> Interestingly, there is some evidence to support a role for GPR119 agonists in reducing food intake and promoting weight loss, possibly through the release of GLP-1, which is known to delay gastric emptying.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> However, Arena Pharmaceuticals have reported that anorectic effects of their GPR119 agonists are still observed in knockout mice.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> While the details of the mechanism of action of this receptor are not yet fully understood, GPR119 agonists may have the potential to deliver superior glycemic control versus current gold standard oral therapies given that no current antidiabetic medication triggers the incretin and GI hormone release as well as having direct actions on nutrient-stimulated insulin secretion mechanisms for glucose control.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">The disclosure by Arena Pharmaceuticals that pyrazolopyrimidines,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> represented by example <b>1</b>, were potent GPR119 agonists<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> led us to surmise that alternative bicyclic structures might be equally active (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>). In this article, we disclose our initial discoveries<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> of indolines, such as <b>2</b>, and 6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines (DHPPs), such as <b>3</b> (GSK1104252A), as GPR119 agonists.<a onclick="showRef(event, 'cit14a'); return false;" href="javascript:void(0);" class="ref cit14a">(14a)</a> The structure–activity relationships (SAR) of the DHPP chemotype, in addition to in vitro and in vivo activities of the lead molecule <b>3</b>, will be highlighted.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative GPR119 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Indoline-based agonists were prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. A Mitsunobu reaction between substituted 4-hydroxyindole (<b>4</b>) and <i>N</i>-Boc-4-hydroxypiperidine afforded the intermediate <b>5</b>. Compound <b>5</b>, upon <i>N</i>-arylation with 1,4-diiodobenzene using Buchwald conditions,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> yielded indole derivative <b>6</b>. A copper-mediated sulfonylation<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> was used to install the methyl sulfone group to afford <b>7</b>, and then the indole was reduced with NaCNBH<sub>3</sub> in acetic acid<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> to afford indoline <b>9</b>. Alternatively, indole <b>6</b> could first be reduced to afford indoline <b>8</b>, then sulfonylated to give compound <b>9</b>. Either scheme could be used to provide good yields of the desired indoline. The <i>tert</i>-butylcarbamate of compound <b>9</b> was removed using 20% trifluoroacetic acid in dichloromethane and then converted to isopropylcarbamate derivative <b>2</b> using isopropyl chloroformate in good overall yield. Substituting 4-bromo-2-fluoro-1-iodobenzene in the <i>N</i>-arylation step and following the rest of the sequence afforded compound <b>10</b>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Indolines <b>2</b>, <b>9</b>, and <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P, DIAD, THF, RT, 77%; (b) CuI, K<sub>3</sub>PO<sub>4</sub>, <i>trans</i>-1,2-cyclohexanediamine, toluene, reflux, 8%; (c) CuI, <span class="smallcaps smallerCapital">l</span>-proline, NaOH, CH<sub>3</sub>SO<sub>2</sub>Na, DMSO, 110 °C, 98% for <b>6</b>→<b>7</b>; (d) NaCNBH<sub>3</sub>, HOAc, RT, 71% for <b>7</b>→<b>9</b>; (e) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT, (ii) <i>i</i>-PrOCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, RT, 54%.</p></p></figure><div class="NLM_p">Preparation of DHPP-based agonists was attempted as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Transition metal-mediated coupling of 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>11</b>) with 1-bromo-4-iodobenzene afforded <i>N</i>-aryl derivative <b>12</b>. Introduction of the piperidine moiety was accomplished with treatment of the chloro derivative <b>12</b> with the sodium alkoxide in THF at reflux to afford intermediate <b>13</b>. Conversion of the bromide to the sulfone using sodium methanesulfinate afforded the pyrrolo[2,3-<i>d</i>]pyrimidine intermediate necessary to try the reduction step. Unfortunately, attempts to reduce the pyrrolo[2,3-<i>d</i>]pyrimidine of <b>14</b> to the desired dihydro derivative <b>15</b> using a variety of conditions (NaCNBH<sub>3</sub>, HOAc; NaCNBH<sub>3</sub>, BF<sub>3</sub>·OEt<sub>2</sub>, MeOH; Pd/C, EtOH; NiCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH) were unsuccessful.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Attempted Preparation of DHPP Chemotype<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, K<sub>3</sub>PO<sub>4</sub>, toluene, reflux, 30%; (b) NaH, THF, reflux, 70%; (c) CuI, <span class="smallcaps smallerCapital">l</span>-proline, NaOH, CH<sub>3</sub>SO<sub>2</sub>Na, DMSO, 110 °C, 84%; (d) NaCNBH<sub>3</sub>, HOAc or NaCNBH<sub>3</sub>, BF<sub>3</sub>·OEt<sub>2</sub>, MeOH, reflux or NiCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH or 10% Pd/C, H<sub>2</sub>, MeOH.</p></p></figure><div class="NLM_p">Our first successful synthesis in the DHPP series is illustrated in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> 2-Allyldiethylmalonate (<b>16</b>) and formamidine hydrochloride, under basic conditions, gave the 4,6-dihydroxypyrimidine derivative that, upon POCl<sub>3</sub> treatment, afforded dichloro compound <b>17</b>. Nucleophilic displacement reaction between <b>17</b> and 2-fluoro-4-methylsulfonylaniline (<b>18</b>) using NaH in THF delivered the pyrimidine derivative <b>19</b>. The allyl group of <b>19</b> was oxidatively cleaved using ozone, then reduced in situ with NaBH<sub>4</sub> to afford alcohol <b>20</b>. Selective activation of the alcohol moiety as a mesylate was achieved with Ms<sub>2</sub>O and Et<sub>3</sub>N in CH<sub>2</sub>Cl<sub>2</sub> to afford an intermediate, which spontaneously cyclized to afford the desired key bicyclic core <b>21</b>. Introduction of the hydroxypiperidine portion was accomplished as before, under basic conditions (NaH, THF, reflux), to provide desired compound <b>3</b>.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the DHPP Chemotype, Exemplifying <b>3</b> and <b>23</b>.<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a (i) 0.5M NaOMe in MeOH, (ii) POCl<sub>3</sub>, 86% yield from <b>16</b>; (b) NaH, THF, reflux; (c) (i) O<sub>3</sub>, −78 °C, CH<sub>2</sub>Cl<sub>2</sub>, (ii) NaBH<sub>4</sub>, MeOH; (d) Ms<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT, 46% overall yield from <b>17</b>; (e) NaH, THF, reflux, 71%.</p></p></figure><div class="NLM_p">Compound <b>23</b> was prepared by reacting 4-bromoaniline with <b>17</b> and then converting the bromide to the methylsulfonyl (CuI, <span class="smallcaps smallerCapital">l</span>-proline, NaOH, CH<sub>3</sub>SO<sub>2</sub>Na, DMSO, 110 °C) in the final step in the synthesis. An improved synthesis of the DHPPs, particularly for key intermediate <b>21</b>, employing a reductive amination reaction as the key step, has recently been reported.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p">Exploration of the SAR of the phenyl region of the DHPPs was most easily accomplished with intermediate <b>24</b>, which provided an opportunity to examine the left-hand side of these molecules in a divergent manner (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Compound <b>24</b> was prepared from <b>17</b> and commercially available 4-bromo-2-fluoroaniline as described for the synthesis of <b>3</b> in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The bromide of <b>24</b> served as a handle to access a nitrile <b>25</b> via Rosenmund–von Braun conditions,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or heteroaromatic groups (compounds <b>26</b> and <b>27</b>) via Suzuki conditions.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenyl Ring Derivatives <b>25</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuCN, NMP, 150 °C, 85% for <b>25</b>, or PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, 2-(tributylstannanyl)-1,3-thiazole, THF, 78 °C, 61% for <b>26</b>, or PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, 1-methyl-2-(tributylstannanyl)-1<i>H</i>-pyrrole, THF, 78 °C, 12% for <b>27</b>.</p></p></figure><div class="NLM_p">On the other end of the molecules, the <i>N</i>-Boc protected piperidine <b>28</b> served as a convenient spot for analogue synthesis through deprotection, to afford the unprotected piperidine, which could be functionalized. Carbamates <b>29</b>–<b>36</b> were prepared from the corresponding chloroformates. The thiocarbamates <b>37</b>–<b>39</b> and dithiocarbamate <b>40</b> were prepared from <i>S</i>-alkyl chloridothiocarbonates<a onclick="showRef(event, 'cit27a'); return false;" href="javascript:void(0);" class="ref cit27a">(27a)</a> or carbamoylimidazolium salts<a onclick="showRef(event, 'cit27b'); return false;" href="javascript:void(0);" class="ref cit27b">(27b)</a> and alkyl chlorodithiocarbonates,<a onclick="showRef(event, 'cit27a'); return false;" href="javascript:void(0);" class="ref cit27a">(27a)</a> respectively (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Sulfonamides <b>41</b>–<b>43</b> were prepared from sulfonyl chlorides. 2-Aminoacetamide <b>44</b> was prepared from the corresponding 2-chloroacetamide.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Piperidine Derivatives <b>29</b>–<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, THF, reflux, 71%; (b) (i) 20% TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT, (ii) RCO<sub>2</sub>Cl, Et<sub>3</sub>N (<b>29</b>–<b>36</b>); or RC(═O)SCl, Et<sub>3</sub>N (<b>37</b>, <b>38</b>); or 1,1′-carbonyldiimidazole; then MeI in CH<sub>3</sub>CN, then <i>i</i>-PrSH, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> (<b>39</b>); RCS<sub>2</sub>Ph, Et<sub>3</sub>N (<b>40</b>); or RSO<sub>2</sub>Cl, Et<sub>3</sub>N (<b>41</b>–<b>43</b>); or ClCH<sub>2</sub>CONEt<sub>2</sub>, Et<sub>3</sub>N (<b>44</b>).</p></p></figure><div class="NLM_p">While additional substituents on the left- and right-hand side were evaluated, they were prepared by an alternative route: coupling with the appropriate aniline or adding in the appropriately functionalized piperidine, respectively. A prominent feature found on the piperidine ring of many GPR119 agonists<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> is the 1,2,4-oxadiazole. This could be prepared following Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> 4-Hydroxypiperidine (<b>45</b>) was treated with cyanogen bromide in the presence of NaHCO<sub>3</sub> to afford the intermediate carbonitrile <b>46</b>. Treatment of <b>46</b> with <i>N</i>-hydroxy-2-methylpropanimidamide in the presence of ZnCl<sub>2</sub> afforded the coupled intermediate. Cyclization-dehydration occurred when the intermediate was treated with acid (4N HCl) in EtOH at reflux for 1 h to provide <b>47</b>. 1-(5-Fluoropyrimidin-2-yl)piperidin-4-ol (<b>50</b>) and 1-(5-ethylpyrimidin-2-yl)piperidin-4-ol (<b>51</b>) were prepared from <b>45</b> and the corresponding chloropyrimidines <b>48</b> and <b>49</b>, respectively, in acetonitrile with diisopropylethylamine. 1-(Pyrimidin-2-yl)piperidin-4-ol (<b>52</b>) was prepared in a similar manner, and then the pyrimidine ring of <b>53</b> was partially reduced with hydrogen and Degussa-type palladium on carbon in a mixture of acetic acid and aqueous hydrochloric acid to afford <b>54</b>.</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Oxadiazole, Pyrimidine, and Guanidine Intermediates <b>47</b>, <b>50</b>, <b>51</b>, and <b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) CNBr, aqueous NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) (i) 1N ZnCl<sub>2</sub>, Et<sub>2</sub>O/EtOAc, (ii) 4N HCl, EtOH, ∼30% from <b>45</b>; (c) <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, reflux, 83% for <b>50</b>, 50% for <b>51</b>, and 51% for <b>53</b>; (d) H<sub>2</sub>, 10% Pd/C, HOAc/aqueous HCl, 84%.</p></p></figure><div class="NLM_p">Analogues <b>55</b>–<b>58</b> were prepared from the corresponding hydroxypiperidine intermediates with <b>21</b> and NaH in refluxing THF as shown in Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Oxadiazole, Pyrimidine, and Guanidine Derivatives <b>55</b>–<b>58</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, THF, reflux, 55% for <b>55</b>, 39% for <b>56</b>, 50% for <b>57</b>, and 6% for <b>58</b>.</p></p></figure><div class="NLM_p">Substitution at the C2 position of the pyrimidine ring was explored. Compounds (<b>60</b>–<b>62</b>) with a methyl substituent at the C2 position of the DHPPs could be prepared in a similar manner to that described for the unsubstituted analogues shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> but starting with ethanimidamide hydrochloride (<b>59</b>) and <b>16</b> (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>).</div><figure id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of C2-Methyl Analogues <b>60</b>–<b>62</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds bearing an amino substituent at the C2 position of the pyrimidine ring of the DHPPs were prepared as described in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>, which shows that the five-membered ring is built first, then construction of the pyrimidine follows. Reaction<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> of 6,6-dimethyl-5,7-dioxaspiro[2.5]octane-4,8-dione (<b>63</b>) with aniline <b>19</b> afforded the 2-oxo-1-aryl-3-pyrrolidinecarboxylic acid <b>64</b>, which could be esterified using Fischer protocol (acid, methanol) to provide <b>65</b>. Conversion of the carbonyl moiety to a thiocarbonyl using P<sub>2</sub>S<sub>5</sub> or Lawesson’s reagent afforded intermediate <b>66</b>, which can be reacted with guanidine derivatives (R = H, guanidine hydrochloride, (<b>67</b>) or R = Me, <i>N</i>-methylguanidine hydrochloride (<b>68</b>)) in the presence of sodium methoxide to afford bicyclic intermediates <b>69</b> (R = H) and <b>70</b> (R = Me). Chlorination with POCl<sub>3</sub> afforded intermediates <b>71</b> and <b>72</b>, which was followed by introduction of the hydroxypiperidine portion via the alkoxide to give the desired targets <b>73</b> and <b>74</b>.</div><figure id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Preparation of C2-Amino Analogues <b>73</b> and <b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CN, 60 °C; (b) catalytic amount of concentrated H<sub>2</sub>SO<sub>4</sub>, MeOH, 43% for 2 steps; (c) P<sub>2</sub>S<sub>5</sub>, THF, 70 °C, 50%; (d) guanidine hydrochloride or <i>N</i>-methyl guanidine hydrochloride, 1M NaOMe, MeOH, 60 → 90 °C; (e) POCl<sub>3</sub>, Et<sub>3</sub>N, 70 °C; (f) NaH, THF, 60 °C, 2% from <b>61</b> and 15% from <b>62</b>.</p></p></figure><div class="NLM_p">Changes to the linker between the bicyclic core and the piperidine were investigated. The nitrogen-linked analogue <b>77</b> was prepared by treating the chloro intermediate <b>21</b> with 1-methylethyl 4-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-1-piperidinecarboxylate (<b>75</b>) and heating in a microwave in the presence of potassium carbonate, as shown in Scheme <a class="ref internalNav" href="#sch10" aria-label="10">10</a>. The <i>N</i>-methyl derivative <b>78</b> was prepared using 1-methylethyl 4-[{[(1,1-dimethylethyl)oxy]carbonyl}(methyl)amino]-1-piperidinecarboxylate (<b>76</b>) under conditions described above.</div><figure id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Preparation of Analogues <b>77</b> and <b>78</b> Bearing a Nitrogen-Atom Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, μw, 200 → 220 °C, 12% for <b>77</b> and 9% for <b>78</b>.</p></p></figure><div class="NLM_p">Thio- or sulfonyl-linked analogues were prepared by the following sequence (Scheme <a class="ref internalNav" href="#sch11" aria-label="11">11</a>), which employed 1-methylethyl 4-mercapto-1-piperidinecarboxylate (<b>79</b>)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as the nucleophile. Treatment of chloro intermediate <b>21</b> with mercaptan <b>79</b> in acetone in the presence of potassium carbonate at elevated temperature (60 °C) afforded desired compound <b>80</b> in good yield (71%). Oxidation of the sulfur to the sulfone oxidation state was accomplished with <i>m</i>-CPBA at 0 °C, which afforded compound <b>81</b>.</div><figure id="sch11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Preparation of Analogues <b>80</b> and <b>81</b> Bearing a Sulfur-Atom Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 71%; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 18%.</p></p></figure><div class="NLM_p">Introduction of a methyl group at the 2-position of the five-membered ring was accomplished by intercepting the <i>N</i>-Boc protected aldehyde <b>82</b>, prepared from allyl <b>19</b>, with methyl Grignard in THF at room temperature in 39% yield to afford racemic alcohol <b>83</b> (Scheme <a class="ref internalNav" href="#sch12" aria-label="12">12</a>). After <i>N</i>-Boc deprotection to afford intermediate <b>84</b>, activation of the secondary alcohol as its mesylate was achieved with methanesulfonyl anhydride in CH<sub>2</sub>Cl<sub>2</sub> with triethylamine. The presence of triethylamine likely facilitated cyclization as the isolated product was the pentultimate intermediate <b>85</b>. Introduction of the piperidine portion occurred as has been reported for other substrates. The resulting racemate was separated by chiral chromatography to afford individual enantiomers (+)-<b>86</b> and (−)-<b>87</b>. The assignment of <i>R</i>- or <i>S</i>-stereochemistry for this enantiomeric pair was not made.</div><figure id="sch12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Preparation of C6-Methyl Analogues <b>86</b> and <b>87</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) Boc<sub>2</sub>O, cat. DMAP, CH<sub>2</sub>Cl<sub>2</sub>, RT, (ii) K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O, 3:2 acetone/H<sub>2</sub>O, NaIO<sub>4</sub>, RT; (b) 1.4M MeMgBr, THF, 39% from <b>19</b>; (c) 20% TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT; (d) Ms<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, RT, 47% from <b>83</b>; (e) (i) NaH, THF, reflux; (ii) chiral separation, 82%.</p></p></figure><div class="NLM_p">Replacement of the <i>N</i>-phenyl group with pyridyl rings was accomplished using the sequence shown in Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>. Using the reductive amination strategy with the appropriate aminopyridine derivative (<b>90</b> and <b>91</b>) and aldehyde <b>88</b>, prepared from allyl <b>17</b>, the uncyclized intermediates <b>89</b> and <b>90</b> were prepared, respectively. Unlike the phenyl congeners, which cyclized under acidic conditions (TFA), the pyridyl analogues cyclized more smoothly in the presence of a base such as potassium <i>t</i>-butoxide or a trialkylamine (Hunig’s base). The resultant chloro intermediates <b>93</b> and <b>94</b> were then reacted with the alkoxide of the 4-hydroxypiperidine derivative to afford sulfides <b>95</b> and <b>96</b>. Oxidation of the sulfides to sulfones <b>97</b> and <b>98</b> was accomplished with Oxone or <i>m</i>-CPBA.</div><figure id="sch13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Preparation of Pyridyl Analogues <b>97</b> and <b>98</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaCNBH<sub>3</sub>, HOAc, MeOH, −15 °C → RT; (b) KO-<i>t</i>-Bu, MeOH, 11% for <b>93</b>; (c) NaH, THF, reflux, 88% for <b>95</b>; (d) Oxone, MeOH/acetone/H<sub>2</sub>O, RT, 81% for <b>97</b> and 7% overall yield for <b>98</b> from <b>17</b>.</p></p></figure><div class="NLM_p">Employing a similar strategy as shown in Scheme <a class="ref internalNav" href="#sch13" aria-label="13">13</a>, other pyridyl analogues (compounds <b>99</b>, <b>100</b>) and substituted phenyl derivatives (<b>102</b>–<b>105</b>) were prepared (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). For analogues <b>99</b> and <b>100</b>, the initial reductive amination step with <b>88</b> and commercially available 6-aminonicotinonitrile or 5-fluoropyridin-2-amine, respectively, employed Na(OAc)<sub>3</sub>BH and TFA in CH<sub>2</sub>Cl<sub>2</sub>. In addition, the acidic conditions in the reduction amination step facilitated the ring closure of the five-membered ring, so a separate cyclization step was not needed for each analogue. The synthesis of <b>99</b> and <b>100</b> were completed by introducing the functionalized hydroxypiperidine <b>22</b> as previously shown for other analogues. The synthesis of <b>101</b> began with a reduction amination reaction between <b>88</b> and commercially available 2-methyl-3-pyridinamine. The subsequent key five-membered ring closing step occurred using a Pd-mediated (PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, KO-<i>t</i>-Bu, toluene, reflux) cyclization reaction. Synthesis of <b>101</b> was completed by introducing the functionalized hydroxypiperidine <b>22</b> as previously shown for other analogues, in 55% overall yield. Intermediate bromide <b>102</b> was prepared from <b>88</b> and 4-bromo-3-fluoroaniline in a manner similar to that described for <b>99</b>. Bromide <b>102</b> was converted to nitrile <b>103</b> using CuCN in NMP at 150 °C (7% overall yield from <b>89</b>). Sulfone <b>104</b> was prepared from <b>102</b> using CH<sub>3</sub>SO<sub>2</sub>Na, CuI, <span class="smallcaps smallerCapital">l</span>-proline, and NaOH in DMSO at 110 °C (38% overall yield from <b>88</b>). Sulfonamide <b>105</b> was prepared from <b>88</b> and 4-amino-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide in a manner similar to that described for <b>99</b> in 17% overall yield. Sulfide <b>106</b> was prepared from <b>88</b> and 2-fluoro-4-(methylthio)aniline in 34% yield using the same strategy used in the synthesis of <b>99</b>. 2-Fluoro-4-(methylthio)aniline was prepared from the commercially available 2-fluoro-4-iodoaniline and NiBr<sub>2</sub> (Zn dust, 2,2′-dipyridyl, DMF, 75 °C) in 73% yield. Racemic sulfoxide was prepared from sulfide <b>106</b> via oxidation with hydrogen peroxide in hexafluoroisopropanol,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> to prevent overoxidation. The resultant racemate was separated by chiral chromatography to afford the individual sulfoxide enantiomers <b>107</b> (<i>R</i> enantiomer) and <b>108</b> (<i>S</i> enantiomer). The absolute stereochemistry was determined based on VCD spectroscopy.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pyridyl (<b>99</b>–<b>101</b>) and substituted phenyl (<b>102</b>–<b>108</b>) analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of sulfone <b>113</b> began by converting 4-fluoro-2-methyl-1-nitrobenzene (<b>109</b>) to the methylthio derivative <b>110</b> with sodium thiomethoxide. Reduction of the nitro group led to intermediate <b>111</b> that underwent the reduction amination/cyclization sequence with <b>88</b> to afford chloride <b>112</b>. The hydroxypiperidine portion was appended using NaH in THF, and the sulfide was oxidized with Oxone to complete the synthesis of <b>113</b>.</div><figure id="sch14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Preparation of Sulfone Analogue <b>113</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaSMe, DMF, 85 °C, 88%; (b) SnCl<sub>2</sub>, conc HCl, EtOH, 80 °C, 81%; (c) (i) NaCNBH<sub>3</sub>, HOAc, MeOH, −15 °C → RT, (ii) 4% TFA, 1,2-DCE, MeOH, RT, 31%; (d) (i) NaH, THF, reflux, 72%, (ii) Oxone, MeOH/acetone/H<sub>2</sub>O, RT, 29%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In relation to their bicyclic counterparts (represented by <b>1</b>), the indolines and DHPPs were initially designed to provide novel compounds with potentially better: (1) potency, (2) systemic exposure after oral administration, due to better solubility from the reduction of aromaticity, and (3) selectivity.</div><div class="NLM_p">The potency of the indolines and DHPPs were measured using a reporter assay with the human GPR119 receptor stably expressed in CHO-K1 6CRE-luciferase cells.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> All compounds are referenced to a small molecule GPR119 agonist<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> for evaluation of intrinsic efficacy (% max response) because this reporter assay is not sensitive enough to demonstrate robust activity with the putative endogenous ligands (OEA, LPC, etc.). The results are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Potency of Selected Analogues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">av pEC<sub>50</sub></th><th class="colsep0 rowsep0" align="center" char=".">StDev</th><th class="colsep0 rowsep0" align="center" char=".">av % max</th><th class="colsep0 rowsep0" align="center" char=".">StDev</th><th class="colsep0 rowsep0" align="center" char="."><i>n</i></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">91</td><td class="colsep0 rowsep0" align="char" char=".">15.9</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">5.6</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">154</td><td class="colsep0 rowsep0" align="char" char=".">26.4</td><td class="colsep0 rowsep0" align="char" char=".">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">134</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">0.16</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">10.8</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">7.7</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">139</td><td class="colsep0 rowsep0" align="char" char=".">18.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">119</td><td class="colsep0 rowsep0" align="char" char=".">34.1</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">135</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">111</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">131</td><td class="colsep0 rowsep0" align="char" char=".">22.4</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="char" char=".">7.6</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">5.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">10.2</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">135</td><td class="colsep0 rowsep0" align="char" char=".">25.9</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">13.9</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td><td class="colsep0 rowsep0" align="char" char=".">138</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="char" char=".">7.9</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="char" char=".">19.1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="char" char=".">5.8</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">10.8</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="char" char=".">5.9</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">7.4</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="char" char=".">4.1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="char" char=".">6.5</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">129</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">124</td><td class="colsep0 rowsep0" align="char" char=".">19.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">19.0</td><td class="colsep0 rowsep0" align="char" char=".">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">21.1</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">0.18</td><td class="colsep0 rowsep0" align="char" char=".">44</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>78</b></td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>80</b></td><td class="colsep0 rowsep0" align="char" char=".">7.1</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">12.2</td><td class="colsep0 rowsep0" align="char" char=".">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>81</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="char" char=".">6.9</td><td class="colsep0 rowsep0" align="char" char=".">0.10</td><td class="colsep0 rowsep0" align="char" char=".">111</td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="char" char=".">6.6</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">4.8</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99</b></td><td class="colsep0 rowsep0" align="char" char=".">6.1</td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">105</td><td class="colsep0 rowsep0" align="char" char=".">14.4</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>100</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="char" char="."><5</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>103</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>104</b></td><td class="colsep0 rowsep0" align="char" char=".">6.8</td><td class="colsep0 rowsep0" align="char" char=".">0.11</td><td class="colsep0 rowsep0" align="char" char=".">109</td><td class="colsep0 rowsep0" align="char" char=".">14.7</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>105</b></td><td class="colsep0 rowsep0" align="char" char=".">6.3</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">128</td><td class="colsep0 rowsep0" align="char" char=".">22.6</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>106</b></td><td class="colsep0 rowsep0" align="char" char=".">6.4</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">121</td><td class="colsep0 rowsep0" align="char" char=".">15.3</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>107</b></td><td class="colsep0 rowsep0" align="char" char=".">6.2</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td><td class="colsep0 rowsep0" align="char" char=".">155</td><td class="colsep0 rowsep0" align="char" char=".">45.1</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>108</b></td><td class="colsep0 rowsep0" align="char" char=".">7.3</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">122</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td><td class="colsep0 rowsep0" align="char" char=".">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>113</b></td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">0.24</td><td class="colsep0 rowsep0" align="char" char=".">80</td><td class="colsep0 rowsep0" align="char" char=".">26.8</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">av StDev = average standard deviation; av %max = average percent maximum response; <i>n</i> = number of runs.</p></div></div></div><div class="NLM_p">It was gratifying to observe that indoline <b>9</b> not only showed activity against human GPR119 with a pEC<sub>50</sub> = 6.8 (92%), it was markedly better than its indole counterpart <b>7</b> (pEC<sub>50</sub> = 6.2 (28%)). In addition, the intrinsic activity of the indoline was much improved over the indole, 92% versus 28%. This served as another impetus to continue to examine compounds with the DHPP scaffold. As anticipated, good activity was also observed with compounds <b>3</b> and <b>23</b> (pEC<sub>50</sub> = 7.3 (91%) and pEC<sub>50</sub> = 6.7 (154%), respectively), bearing the pyrimidine ring nitrogens of the DHPP scaffold.</div><div class="NLM_p">Substituents on the aryl or heteroaryl ring attached to the dihydropyrrole nitrogen were investigated. Substitution at the 4-position of the <i>N</i>-aryl ring was found to be critical for activity. For example, compounds that lacked a functional group that could act as a hydrogen bond acceptor were usually about a log unit less potent than methylsulfone or nitrile. Thiazole <b>26</b> and pyrrole <b>27</b>, with a heterocycle at the 4-position, were found to retain much of the potency, but not as much as the sulfone. Sulfide <b>106</b> also showed intermediate potency with a pEC<sub>50</sub> = 6.4, typical of a compound that lacked a hydrogen-bond acceptor. The oxidation state of the sulfur turned out to be less important than the stereochemistry. For example, (<i>R</i>)-sulfoxide <b>107</b> had similar potency to the sulfide and was a log less potent than the (<i>S</i>)-isomer <b>108</b>, which was equipotent with sulfone <b>3</b>.</div><div class="NLM_p">Substitution at the 2- and 3-positions of the phenyl ring was also examined. A substituent, such as fluoro or methyl, was found to increase potency over their unsubstituted versions, such as <b>23</b> (pEC<sub>50</sub> = 6.9). A very slight preference for a fluoro atom at the 2-position of <b>3</b> over the other possible iterations (3-F, <b>104</b>, and 2-Me, <b>113</b>) was observed.</div><div class="NLM_p">Similar findings with respect to optimal 4-substitution were observed in the analogues bearing a pyridyl ring in place of the phenyl ring. The methylsulfone in <b>97</b> (and <b>98</b>) was preferred over the nitrile from <b>99</b>, which was better than a fluoro atom found in <b>100</b>. The placement of the pyridyl nitrogen at the 2- or 3-position did not affect activity in <b>97</b> and <b>98</b>, respectively, as each had a pEC<sub>50</sub> ≥ 6.6.</div><div class="NLM_p">Structure–activity relationships of the bicyclic scaffold revealed that further substitution on the rings at the 2- and 6-positions did not produce compounds with greater potency. Quite the contrary, these changes produced compounds with diminished activity. Methyl-substituted analogues <b>60</b>–<b>62</b> were about a log unit less potent, as was amino <b>73</b>. The monomethylated analogue, <b>74</b>, did not agonize the receptor at measurable levels. The 6-substituted analogues, <b>86</b> and <b>87</b>, also showed diminished activity. In addition, compared to the oxygen-linked analogues, the nitrogen-linked analogues <b>77</b> and <b>78</b> were less active. The sulfur-linked analogue <b>80</b> was comparable to oxygen analogue <b>3</b>; however, the potency of sulfone derivative <b>81</b> was not.</div><div class="NLM_p">A general trend for the requirement of a lipophilic moiety was observed during exploration of the right-hand side. This is most easily seen in the carbamate series. As the size of the alkyl group grew, so did potency. Methyl carbamate <b>29</b> was the weakest of the group, while the larger <i>tert</i>-butyl carbamate <b>28</b>, <i>iso</i>-butyl carbamate <b>33</b>, and neopentyl carbamate <b>34</b> were more potent. When lipophilic portions were substituted with more hydrophilic groups, activity was lost. Replacing a methylene in the <i>n</i>-butyl derivative of <b>32</b> (pEC<sub>50</sub> = 7.3) with oxygen (3-methoxypropyl carbamate <b>36</b>, pEC<sub>50</sub> = 6.5) resulted in loss of potency. Similarly, the fluoroethyl derivative <b>35</b> was less potent than the corresponding <i>n</i>-propyl <b>31</b>.</div><div class="NLM_p"><i>S</i>-Thiocarbamates were also found to be potent. However, these analogues did not seem to offer any advantage over their oxygen congeners. For example, methyl <i>S</i>-thiocarbamate <b>37</b> had a pEC<sub>50</sub> = 6, which was about equipotent to methylcarbamate <b>29</b> (pEC<sub>50</sub> = 6.5). Briefly, dithiocarbamates were also investigated. Phenyldithiocarbamate <b>40</b> was potent, with a pEC<sub>50</sub> = 7.9. Unfortunately, these sulfur-containing compounds resulted in low plasma exposure (dose normalized area under the curve, DNAUC<sub>0–24h</sub> <0.03 μg·h/mL/dose), possibly due to extensive metabolism. In addition, there was the potential for reactive metabolites; thus, this class was deprioritized.</div><div class="NLM_p">Sulfonamides were also investigated. Alkyl sulfonamides <b>41</b> and <b>42</b> were active, but a direct comparison between the corresponding carbamate <b>30</b> to <b>41</b> demonstrates that carbamates are superior (<b>30</b>,pEC<sub>50</sub> = 7.1 versus <b>41</b>, pEC<sub>50</sub> = 5.8). The <i>N</i>,<i>N</i>-dimethylsulfonamide derivative <b>43</b> also showed activity but was still less potent than similar sized carbamates.</div><div class="NLM_p">Heterocyclic isosteres of the carbamates were examined. The two best replacements that were identified were the oxadiazoles and pyrimidines. For example, oxadiazole <b>55</b> and 4-ethylpyrimidine <b>57</b> were as potent as carbamate <b>3</b>.</div><div class="NLM_p">While other classes of functional groups (amides, ureas, substituted benzyls, alkyls; data not shown) were explored on the right-hand side, most of them did not show desirable potency (pEC<sub>50</sub> > 6). One example is acetamide <b>44</b>, in which a methylene has been inserted between the carbonyl and the piperidine nitrogen. Although it does preserve the lipophilic substitution with the <i>N</i>,<i>N</i>-diethyl moiety, this analogue did not agonize the receptor at concentrations lower than 10 μM. The SAR suggests that the more basic piperidine nitrogen is not well tolerated.</div><div class="NLM_p">In attempts to prepare analogues with increased solubility while preserving the lipophilic alkyl groups, and while not increasing molecular weight<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> significantly, guanidine-containing <b>58</b> was prepared. Unfortunately, this analogue was not very potent (pEC<sub>50</sub> = 5.7).</div><div class="NLM_p">Having established which arrangement of functional groups on the DHPP scaffold conferred reasonable potency, we turned our attention to identifying compounds possessing the proper combination of potency and plasma exposure. We had ruled out the <i>S</i>-thiocarbamates and dithiocarbamates due to putative extensive metabolism. As the size of the alkyl groups on the carbamates grew, potency went up; however, we were mindful to keep MW down in order to identify compounds with desirable developability parameters. Among the carbamates, the best balance of potency, MW, and exposure was the isopropylcarbamate. From a potency perspective, the isopropyloxadiazole and 4-ethylpyrimidine analogues were comparable and attractive. Unfortunately, the AUC<sub>0–24h</sub> for isopropyloxadiazole <b>55</b> in the rat<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> after a 10 mg/kg dose was 0.5 μg·h/mL. 4-Ethylpyrimidine <b>57</b> was equally poor in the mouse with a DNAUC<sub>0–24h</sub> = 0.04 μg·h/mL/dose. Nitrile <b>25</b>, however, did show good levels in rat plasma (DNAUC >1 μg·h/mL/dose). Ultimately, methylsulfone <b>3</b> emerged as possessing the best balance of potency and solubility. In fasted simulated intestinal fluid, the equilibrium solubility of <b>3</b> was 4 μg/mL. Importantly, sulfone <b>3</b> was found to have a DNAUC<sub>0–24h</sub> value of 2 μg·h/mL/dose. In addition, in the rat, it possessed a moderate half-life (<i>t</i><sub>1/2</sub> = 8.7 h) and good bioavailability (%<i>F</i> = 66). Additional pharmacokinetic properties of <b>3</b>, dosed 30 mg/kg in the rat and mouse, are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pharmacokinetic Properties of <b>3</b> in Rat and Mouse</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">Cl (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char=".">DNAUC<sub>0–24 h</sub> (μg·h/mL/dose)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub>(L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">brain:plasma</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">8.7</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">8.4</td><td class="colsep0 rowsep0" align="char" char=".">2035</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">7.2</td><td class="colsep0 rowsep0" align="char" char=".">1701</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">nd</td></tr></tbody></table></div></div><div class="NLM_p">The selectivity profile of <b>3</b> revealed few issues. In a panel against 50 aminergic receptors, <b>3</b> showed <20% binding at all receptors at a concentration of 1 μM. In a separate panel of 68 receptors, ion channels, and enzymes, the only activity that registered >50% inhibition or stimulation at 10 μM was monoamine oxidase-B (MAO-B) inhibition (54%). Sulfone <b>3</b> did inhibit the cytochrome P450 subtype 2C9 with an IC<sub>50</sub> = 3 μM. Overall, though, we concluded that the selectivity profile was sufficiently clean to carry forward into target validation studies.</div><div class="NLM_p">GPR119 agonist <b>3</b> was evaluated for its ability to increase incretin and insulin secretion in vitro and ex vivo. Compound <b>3</b> caused GLP-1 secretion in GluTag<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(36)</a> cells with a pEC<sub>50</sub> = 7.7, which closely approximates its receptor potency (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In primary colonic crypt cells harvested from mice, <b>3</b> stimulated GLP-1 release in a statistically significant manner over the vehicle treated group (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) (<i>p</i> < 0.001). The lack of a dose response in this study may be due to the inherent variability in an experiment working with primary cells or possibly that compound <b>3</b> had reached the upper plateau on the dose response curve at those doses. In isolated rat islets, <b>3</b>, at 0.3 μM, augmented insulin release in the presence of 12 mM glucose (<i>p</i> < 0.01). No insulin secretion was observed at 3 mM glucose for either the treated or untreated cells.</div><figure id="fig3" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GLP-1 release in GluTag cells with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GLP-1 secretion in primary colonic crypt (PCC) cells with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To determine if the effects observed in vitro were GPR119-mediated, <b>3</b> (30 mg/kg) was administered to wild-type and knockout mice that had been fasted overnight (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). A near 4-fold increase in GLP-1 and 2-fold increase in GIP, when compared to vehicle (<i>n</i> = 10, <i>p</i> < 0.01 and <i>p</i> < 0.01, respectively), was observed in the WT mice, whereas no increase was observed in GPR119 KO mice. This suggests that the effects on incretin hormone secretion are mediated through GPR119.</div><figure id="fig5" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Incretin secretion in WT and KO mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, there was also a 3-fold increase in PYY levels and a 2-fold increase in glucagon in WT mice, compared to vehicle (<i>n</i> = 8–10, <i>p</i> < 0.01 and <i>p</i> < 0.01, respectively; data not shown). Like the incretins, no effect of <b>3</b> on PYY or glucagon secretion was observed in KO mice.</div><div class="NLM_p">To assess the effects of <b>3</b> on islet glucose response in vivo, C-peptide levels were assessed in rats using the hyperglycemic clamp. The plasma glucose levels were elevated and maintained at similar (clamped) levels in both treatment groups throughout the glucose infusion. The glucose infusion rate required to maintain the clamp was significantly increased in the rats treated with <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), correlating with an increase in both first phase (0–5 min) and second phase (10–90 min) C-peptide profile (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), a direct reflection of insulin secretion.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(37)</a></div><figure id="fig6" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Glucose Infusion Rate with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hyperglycemic clamp with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With <b>3</b> having shown the ability to promote incretin secretion in vitro and in vivo, in addition to demonstrating its effects on insulin secretion in the whole animal, we sought to establish whether or not <b>3</b> would impact glucose levels as a reflection of these responses.<a onclick="showRef(event, 'cit19b'); return false;" href="javascript:void(0);" class="ref cit19b">(19b)</a> In normal rats, <b>3</b>, administered orally at 10 mg/kg, decreased the glucose excursion curve by 43% in a glucose tolerance test (data not shown) when glucose was administered intravenously and 38% when glucose was administered orally (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) (<i>n</i> = 7, <i>p</i> < 0.01 for each). This effect was similar to LAF237<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(38)</a> (vildagliptin), a DPP-IV inhibitor used as a positive control.</div><figure id="fig8" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Rat OGTT with <b>3</b> and a DPP-IV inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While there is a statistically significant increase of GLP-1 upon administration of <b>3</b>, we wondered whether the magnitude was sufficient to inhibit gastric emptying, as elevated GLP-1 levels are known to cause a delay. Compound <b>3</b>, dosed orally (10 mg/kg) to normal male, SD rats that had been fasted overnight resulted in a 27% reduction of the acetaminophen AUC (0–2 h) when compared to vehicle. It has been shown that acetaminophen is relatively unabsorbed in the stomach while rapidly absorbed and detected in the circulation upon gastric release to the small intestine, making it a suitable marker for determining the rate of gastric emptying.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(39)</a></div><div class="NLM_p last">In a separate species (mouse), we evaluated whether or not compound <b>3</b> would affect food intake. Individually housed male, C57BL/6 mice were fasted overnight, then treated with 10 mg/kg of <b>3</b>, and food intake was measure at 1, 2, 4, 6, and 24 h post dose (data not shown). There was no effect relative to vehicle-treated animals.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35638" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35638" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A novel series of indolines were found to be potent and selective GPR119 agonists. Optimization of this series led to the 6,7-dihydro-5<i>H</i>-pyrrolopyrimidines, best exemplified by compound <b>3</b>. SAR analysis of this novel series suggests that a hydrogen-bond acceptor group appended to the <i>N</i>-aryl ring significantly boosts potency, while lipophilic groups as extensions from the piperidine ring are preferred. The central region can accommodate a variety of scaffolds, and it has been shown that the bicyclic, 6,7-dihydro-5<i>H</i>-pyrrolopyrimidine ring system produces compounds that are potent and selective while possessing favorable pharmacokinetic properties.</div><div class="NLM_p">Accordingly, compound <b>3</b> was used in functional in vitro and in vivo studies. The data suggest that compound <b>3</b>-mediated GPR119 activation promotes in vitro (GluTag cells) GLP-1 secretion. It increases GLP-1 and GIP levels in vivo, and this effect is nutrient independent and GPR119 dependent. In vitro, compound <b>3</b> augments glucose-stimulated insulin secretion and, in vivo, enhances both first and second phase insulin secretion. Compound <b>3</b> also reduces glucose excursions and improves glucose tolerance. When administered orally, <b>3</b> has been shown to reduce gastric emptying, with no commensurate effect on food intake.</div><div class="NLM_p last">While the details of the mechanism of action of this receptor are not yet fully understood, small molecule <b>3</b> was used to support a role for GPR119 in the control of glucose levels in the rodent. These findings support preclinical reports of others that have identified GPR119 agonists and suggest that GPR119 may be an attractive target for the treatment of type 2 diabetes. Preliminary communications from clinical studies with a few GPR119 agonists, however, show mixed results. As observed in preclinical studies in animals, MBX-2982 showed dose-dependent reductions in glucose and increases in GLP-1 following a mixed meal.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(40)</a> Recently, Katz et al. demonstrated that a single-dose of a GPR119 agonist, JNJ-38431055, in healthy subjects increased postprandial GLP-1, GIP, and PYY but did not decreased glucose excursion or increase insulin.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(41)</a> Similarly, GSK1292263,<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(42)</a> a selective GPR119 agonist that comes from a structurally different class than the DHPPs, did not reduce glucose AUC (0–24 h) when administered alone or when codosed with metformin or sitagliptin.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(43)</a> Whether GPR119 agonists are able to deliver sustained glucose lowering in type 2 diabetics is at present unclear and awaits longer term studies.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12180" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12180" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Unless otherwise noted, all nonaqueous reactions were carried out under a nitrogen atmosphere using commercial grade solvents and reagents. <sup>1</sup>H NMR spectra were taken on a Varian (Agilent) Inova 400 NMR spectrometer. Chemical shifts are reported in parts per million (ppm, δ) using the residual solvent line as a reference. Splitting patterns are designated using the following abbreviations: s, singlet; d, doublet; t, triplet; dd, doublet of doublet; m, multiplet; br, broad. Coupling constants (<i>J</i>) are reported in hertz (Hz) where relevant. Mass spectrometric analyses were conducted on a Waters Acquity UPLC system and Waters Acquity SQD with alternating positive/negative electrospray ionization scanning from 125 to 1000 amu, with a scan time of 105 ms and an interscan delay of 20 ms. High resolution mass spectrometric analysis was performed on a Waters qTOF Premiere mass spectrometer operating in W mode. Reverse phase HPLC was performed on a Gilson preparative system. The purity of the compounds was established through analytical HPLC analysis on an Agilent HP1100, and all compounds reported in the manuscript have a chemical purity ≥95%.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> 1-Methylethyl 4-({1-[4-(Methylsulfonyl)phenyl]-2,3-dihydro-1<i>H</i>-indol-4-yl}oxy)-1-piperidinecarboxylate (<b>2</b>)</h3><div class="NLM_p last">A solution of 4-hydroxyindole (6.65 g, 50 mmol) in THF (600 mL) at 5 °C under N<sub>2</sub> was treated with 1,1-dimethylethyl 4-hydroxy-1-piperidinecarboxylate (20.1 g, 100 mmol) and triphenylphosphine (26.2 g, 100 mmol). Diisopropyl azodicarboxylate (19.4 mL, 100 mmol) was added dropwise over a 20 min period, and then the mixture was allowed to stir and warm to RT for 8 h. The reaction was concentrated to give an orange oil that was purified by flash chromatography (10→50% EtOAc/hexanes) to afford 1,1-dimethylethyl 4-(1<i>H</i>-indol-4-yloxy)-1-piperidinecarboxylate (<b>5</b>) (12.3 g, 77%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.03 (br s, 1H), 7.19 (t, <i>J</i> = 2.8 Hz, 1H), 6.99–6.93 (m, 2H), 6.54 (dd, <i>J</i> = 7.2, 1.2 Hz, 1H), 6.41 (app t, <i>J</i> = 2.4 Hz, 1H), 4.63 (m, 1H), 3.67–3.61 (m, 2H), 3.26–3.21 (m, 2H), 1.94–1.87 (m, 2H), 1.64–1.52 (m, 2H), 1.40 (s, 9H). LCMS (ESI): <i>m</i>/<i>z</i> 339 [M + Na]<sup>+</sup>. A solution of <b>5</b> (4.0 g, 12.6 mmol) in 1,4-dioxane (80 mL) at RT under N<sub>2</sub> was treated with CuI (240 mg, 1.3 mmol), K<sub>3</sub>PO<sub>4</sub> (4.0 g, 19 mmol), and <i>trans</i>-1,2-diaminocyclohexane (0.3 mL, 2.5 mmol), followed by 1,4-diiodobenzene (6.3 g, 19 mmol), and the mixture was heated to reflux for 15 h. The reaction mixture was allowed to cool to RT, diluted with EtOAc (250 mL), and then filtered through a plug of silica (EtOAc wash). The filtrate was concentrated, and the resultant residue was purified by flash chromatography (0→20% EtOAc/hexanes) to afford 524 mg of 1,1-dimethylethyl 4-{[1-(4-iodophenyl)-1<i>H</i>-indol-4-yl]oxy}-1-piperidinecarboxylate (<b>6</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.88 (t, <i>J</i> = 8.8 Hz, 2H), 7.51 (d, <i>J</i> = 3.2 Hz, 1H), 7.39 (d, <i>J</i> = 8.8 Hz, 2H), 7.12 (t, <i>J</i> = 5.6 Hz, 1H), 7.09 (t, <i>J</i> = 8.0 Hz, 1H), 6.72 (d, <i>J</i> = 7.2 Hz, 1H), 6.70 (d, <i>J</i> = 3.2 Hz, 1H), 4.70 (m, 1H), 3.66–3.60 (m, 2H), 3.28–3.24 (m, 2H), 1.94–1.89 (m, 2H), 1.66–1.58 (m, 2H), 1.39 (s, 9H). LCMS (ESI): <i>m</i>/<i>z</i> 518 [M + H]<sup>+</sup>. A solution of <b>6</b> (355 mg, 0.69 mmol) in DMSO (4 mL) in a 10 mL glass tube was treated with CuI (13 mg, 0.07 mmol), MeSO<sub>2</sub>Na (103 mg, 1.0 mmol), <span class="smallcaps smallerCapital">l</span>-proline (16 mg, 0.14 mmol), and NaOH (6 mg, 0.14 mmol). The tube was sealed and then heated at 110 °C for 18 h. The reaction mixture was allowed to cool and then poured onto EtOAc. The mixture was washed with water and brine and was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The resultant residue was purified by flash SiO<sub>2</sub> column chromatography to afford 314 mg (98%) of <b>7</b> as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.08 (d, <i>J</i> = 8.5 Hz, 2H), 7.87 (d, <i>J</i> = 8.5 Hz, 2H), 7.65 (d, <i>J</i> = 3.4 Hz, 1H), 7.27 (d, <i>J</i> = 8.4 Hz, 1H), 7.15 (t, <i>J</i> = 8.0 Hz, 1H), 6.78 (m, 1H), 6.77 (s, 1H), 4.72 (m, 1H), 3.68–3.60 (m, 2H), 3.33–3.22 (m, 2H), 3.28 (s, 3H), 1.97–1.88 (m, 2H), 1.70–1.58 (m, 2H), 1.40 (s, 9H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>30</sub>N<sub>2</sub>O<sub>5</sub>S [M + Na]<sup>+</sup> 493.1773, obsd 493.1771. A solution of <b>7</b> (310 mg, 0.66 mmol) in acetic acid (4 mL) at RT was treated with NaCNBH<sub>3</sub> (0.62 g, 9.9 mmol), and the mixture was stirred at RT for 36 h. The mixture was then diluted with H<sub>2</sub>O (40 mL) and stirred for 30 min. The resultant precipitant was filtered (water wash) and recrystallied from methanol to afford 1,1-dimethylethyl 4-({1-[4-(methylsulfonyl)phenyl]-2,3-dihydro-1<i>H</i>-indol-4-yl}oxy)-1-piperidinecarboxylate <b>9</b> (218 mg, 71%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.79 (t, <i>J</i> = 8.8 Hz, 2H), 7.35 (d, <i>J</i> = 8.8 Hz, 2H), 7.08 (app t, <i>J</i> = 8.4 Hz, 1H), 6.93 (d, <i>J</i> = 8.0 Hz, 1H), 6.60 (d, <i>J</i> = 8.0 Hz, 1H), 4.60–4.52 (m, 1H), 4.01 (t, <i>J</i> = 8.8 Hz, 2H), 3.61–3.55 (m, 2H), 3.30–3.21 (m, 2H), 3.13 (s, 3H), 3.01 (t, <i>J</i> = 8.4 Hz, 2H), 1.89–1.84 (m, 2H), 1.39 (s, 9H). LCMS (ESI): <i>m</i>/<i>z</i> 495 [M + Na]<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>32</sub>N<sub>2</sub>O<sub>5</sub>S [M + Na]<sup>+</sup> 495.1930, obsd 495.1926. A solution of <b>9</b> (140 mg, 0.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8 mL) at RT under N<sub>2</sub> was treated with CF<sub>3</sub>CO<sub>2</sub>H (2 mL), and the reaction mixture was stirred at RT for 2.5 h and then concentrated. The resultant crude material was redissolved in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) and treated with DIPEA (0.26 mL, 1.5 mmol), followed by the dropwise addition of a 1M solution of isopropyl chloroformate in toluene (3 mL, 3 mmol). The mixture was stirred at RT for 8 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (40 mL) and then washed with water (10 mL) and brine (10 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered, and the filtrate was concentrated to afford the crude material. The material was purified by flash chromatography (0→20% EtOAc/hexanes) to afford 74 g (54%) of <b>2</b> as white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.79 (t, <i>J</i> = 8.8 Hz, 2H), 7.35 (d, <i>J</i> = 8.8 Hz, 2H), 7.08 (app t, <i>J</i> = 8.4 Hz, 1H), 6.93 (d, <i>J</i> = 8.0 Hz, 1H), 6.60 (d, <i>J</i> = 8.4 Hz, 1H), 4.75 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.60 (m, 1H), 4.01 (t, <i>J</i> = 8.8 Hz, 2H), 3.60–3.55 (m, 2H), 3.2–3.26 (m, 2H), 3.13 (s, 3H), 3.01 (t, <i>J</i> = 8.4 Hz, 2H), 1.89–1.60 (m, 2H), 1.59–1.52 (m, 2H), 1.17 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>30</sub>N<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 459.1954, obsd 459.1954.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 1-Methylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>3</b>)</h3><div class="NLM_p last">A solution of sodium methoxide (0.5 M in MeOH, 1.89 L, 0.95 mol) was treated with formamidine hydrochloride (39.0 g, 0.48 mol) under N<sub>2</sub>. The mixture was stirred at RT for 1 h. Diethyl allylmalonate (91.5 mL, 0.46 mol) was added to the above mixture, and the resulting reaction mixture was stirred at RT for 36 h. The reaction mixture was filtered and the filtrate was concentrated to afford a crude solid material. The crude material was dissolved in H<sub>2</sub>O (1000 mL) and acidified with concentrated HCl. The solid was filtered and dried to afford 62.8 g (90%) of 6-hydroxy-5-(2-propen-1-yl)-4(1<i>H</i>)-pyrimidinone as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.65 (br s, 2H), 7.90 (s, 1H), 5.79–5.71 (m, 1H), 4.92 (app dd, <i>J</i> = 17.2, 2.0 Hz, 2H), 2.96 (d, <i>J</i> = 6.0 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 153 [M + H]<sup>+</sup>. Under N<sub>2</sub>, 6-hydroxy-5-(2-propen-1-yl)-4(1<i>H</i>)-pyrimidinone (19.0 g, 125.0 mmol) was treated with phosphorus oxychloride (200 mL). The mixture heated at reflux for 4 h and then allowed to cool to RT. The reaction mixture was poured very slowly onto ice-cold (5 °C) water (2000 mL) with vigorous stirring. The mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and the filtrate concentrated to afford 22.7 g (96%) of 4,6-dichloro-5-(2-propen-1-yl)pyrimidine (<b>17</b>) as a light-yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.08 (s, 1H), 5.90–5.80 (m, 1H), 5.17–5.09 (app m, 2H), 3.65 (app d, <i>J</i> = 6.4 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 190 [M + H]<sup>+</sup>. A slurry of NaH (7.94 g, 60% dispersion in mineral oil, washed with anhydrous toluene) in THF (50 mL) under N<sub>2</sub> at RT was treated with 2-fluoro-4-(methylsulfonyl)aniline (12.5 g, 66.1 mmol) in THF (150 mL). The mixture was stirred at RT for 1 h and then treated with a solution of <b>17</b> (12.5 g, 66.1 mmol) in THF (50 mL). The resulting reaction mixture was heated at reflux for 3 h, and then the mixture was allowed to cool to room temperature, poured slowly onto H<sub>2</sub>O (600 mL), and then extracted with EtOAc. The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and the filtrate concentrated. The crude product was crystallized from EtOAc to give 10.3 g of solid material. The mother liquor was concentrated and purified by flash chromatography to give an additional 9.35 g of product. A total yield of 19.7 g (87%) of 6-chloro-<i>N</i>-[2-fluoro-4-(methylsulfonyl)phenyl]-5-(2-propen-1-yl)-4-pyrimidinamine (<b>19</b>) was obtained as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.10 (s, 1H), 8.29 (s, 1H), 7.83 (dd, <i>J</i> = 9.2, 1.6 Hz, 1H), 7.78–7.72 (m, 2H), 5.96–5.86 (m, 1H), 5.10 (dd, <i>J</i> = 10.4, 1.2 Hz, 1H), 5.05 (dd, <i>J</i> = 16.0, 1.6 Hz, 1H), 3.58 (d, <i>J</i> = 5.6 Hz, 2H), 3.27 (s, 3H). LCMS (ESI): <i>m</i>/<i>z</i> 342 [M + H]<sup>+</sup>. A stream of ozone was bubbled into a solution of <b>19</b> (15 g, 44 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (600 mL) and MeOH (150 mL) at −78 °C for 4 h, at which time the solution turned light-blue. A stream of N<sub>2</sub> was bubbled through the solution until the blue disappeared. Solid NaBH<sub>4</sub> (6.7 g, 176 mmol) was added portionwise over 10 min, and the reaction was stirred at −78 °C for 4 h and allowed to warm to RT overnight. The reaction mixture was carefully poured onto 1N HCl (1 L) and then was extracted with EtOAc (4 × 500 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to afford crude 2-(4-chloro-6-((2-fluoro-4-(methylsulfonyl)phenyl)amino)pyrimidin-5-yl)ethanol (<b>20</b>, 15 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.57 (s, 1H), 8.38 (s, 1H), 8.03 (t, <i>J</i> = 8.2 Hz, 1H), 7.82 (dd, <i>J</i> = 10.4, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.6, 1.8 Hz, 1H), 3.73 (t, <i>J</i> = 5.8 Hz, 2H), 3.25 (s, 3H), 2.97 (t, <i>J</i> = 5.8 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 346 [M + H]<sup>+</sup>. A solution of <b>20</b> (15 g, 44 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (250 mL) was cooled to 5 °C and treated with Et<sub>3</sub>N (36.4 mL, 263 mmol) and Ms<sub>2</sub>O (15.3 g, 88 mmol), and the mixture was stirred and allowed to warm to RT over a 15 h period. The reaction was diluted with CH<sub>2</sub>Cl<sub>2</sub> (500 mL), quenched by the addition of water, and washed with water and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification by flash chromatography (0→2% MeOH/CHCl<sub>3</sub>) afforded 4-chloro-7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>21</b>, 6.6 g, 46%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.29 (s, 1H), 7.94 (app t, <i>J</i> = 7.6 Hz, 1H), 7.90 (dd, <i>J</i> = 15.6, 1.6 Hz, 1H), 7.79 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 4.20 (t, <i>J</i> = 8.4 Hz, 2H), 3.27 (s, 3H), 3.23 (t, <i>J</i> = 8.8 Hz, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 328 [M + H]<sup>+</sup>. A slurry of NaH (0.73 g, 60% dispersion in mineral oil, washed with anhydrous toluene) in anhydrous THF (15 mL) was treated with a solution of 1-methylethyl 4-hydroxy-1-piperidinecarboxylate (<b>22</b>, 1.09 g, 5.80 mmol) in THF (15 mL). The mixture was heated at reflux for 0.5 h and then allowed to cool to RT. A solution of <b>21</b> (2.0 g, mmol) in THF (30 mL) was added, and the reaction was heated at reflux for 1.5 h. The reaction mixture was allowed to cool to RT, poured onto H<sub>2</sub>O (150 mL), and then extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and then concentrated. The crude product was purified by flash chromatography (0→2% MeOH/CHCl<sub>3</sub>) to afford <b>3</b> (1.96 g, 71%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (app t, <i>J</i> = 8.4 Hz, 1H), 7.84 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.30 −5.24 (m, 1H), 4.76 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.70–3.64 (m, 2H), 3.25 (s, 3H), 3.40–3.21 (m, 2H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.95–1.90 (m, 2H), 1.67–1.51 (m, 2H), 1.17 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 479.1764, obsd 479.1765.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-Methylethyl 4-({1-[2-Fluoro-4-(methylsulfonyl)phenyl]-2,3-dihydro-1<i>H</i>-indol-4-yl}oxy)-1-piperidinecarboxylate (<b>10</b>)</h3><div class="NLM_p last">Compound <b>10</b> was prepared as a white solid in 10% overall yield from <b>5</b> in a similar manner to that described for <b>2</b> using 4-bromo-2-fluoro-1-iodobenzene. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.79 (dd, <i>J</i> = 11.6, 2.0 Hz, 1H), 7.68 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.59 (app t, <i>J</i> = 8.4 Hz, 1H), 7.03 (t, <i>J</i> = 8.0 Hz, 1H), 6.56 (d, <i>J</i> = 8.4 Hz, 2H), 6.36 (dd, <i>J</i> = 7.6, 4.4 Hz, 1H), 4.76 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.58 (m, 1H), 4.0 (t, <i>J</i> = 8.4 Hz, 1H), 3.68–3.57 (m, 2H), 3.30–3.21 (m, 2H), 3.22 (s, 3H), 3.02 (t, <i>J</i> = 8.8 Hz, 2H), 1.92–1.82 (m, 2H), 1.61–1.52 (m, 2H), 1.17 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>29</sub>FN<sub>2</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 461.1859, obsd 461.1860.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>tert</i>-Butyl 4-((7-(4-(Methylsulfonyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)oxy)piperidine-1-carboxylate (<b>14</b>)</h3><div class="NLM_p last">7-(4-Bromophenyl)-4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>12</b>) was prepared as an off-white solid in 30% yield from 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine in a similar manner to that described for <b>6</b> using 4-bromo-1-iodobenzene. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.70 (s, 1H), 8.15 (s, 1H), 7.93 (d, <i>J</i> = 8.5 Hz, 1H), 7.80 (m, 2H), 7.68 (d, <i>J</i> = 8.5 Hz, 1H), 6.89 (m, 1H). LRMS (ESI): <i>m</i>/<i>z</i> 310/308 [M + H]<sup>+</sup>. A solution of <b>12</b> (420 mg, 1.36 mmol) in DMF (5 mL) was treated with <i>tert</i>-butyl 4-hydroxy-1-piperidinecarboxylate (1.2 g, 3.6 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (0.72 g, 3.6 mmol), and the mixture was stirred at heated at 110 °C for 18 h under N<sub>2</sub>. The mixture was allowed to cool and then was diluted with EtOAc and water. The organic layer was washed with water and brine dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. The filtrate was concentrated and purified by flash chromatography to give <i>tert</i>-butyl 4-((7-(4-bromophenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)oxy)piperidine-1-carboxylate (<b>13</b>, 0.45 g, 70%) as a white foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.46 (s, 1H), 7.89 (d, <i>J</i> = 8.8 Hz, 1H), 7.84 (m, 2H), 7.74 (d, <i>J</i> = 8.9 Hz, 1H), 7.69 (d, <i>J</i> = 8.8 Hz, 1H), 6.75 (m, 1H), 5.48 (m, 1H), 3.70 (m, 2H), 3.23 (m, 2H), 1.98 (m, 2H), 1.66 (m, 2H), 1.40 (s, 9H). LRMS (ESI): <i>m</i>/<i>z</i> 475/473 [M + H]<sup>+</sup>. <i>tert</i>-Butyl 4-((7-(4-(methylsulfonyl)phenyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)oxy)piperidine-1-carboxylate (<b>14</b>) was prepared as an off-white solid in 84% yield from <b>13</b> in a similar manner to that described for <b>7</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.51 (s, 1H), 8.21 (d, <i>J</i> = 8.8 Hz, 2H), 8.09 (d, <i>J</i> = 8.8 Hz, 2H), 7.88 (d, <i>J</i> = 3.7 Hz, 1H), 6.83 (d, <i>J</i> = 3.7 Hz, 1H), 5.50 (m, 1H), 3.74–3.66 (m, 2H), 3.27 (s, 3H), 2.48 (m, 2H), 2.03–1.99 (m, 2H), 1.70–1.62 (m, 2H), 1.40 (s, 9H). LRMS (ESI): <i>m</i>/<i>z</i> 473 [M + H]<sup>+</sup>.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 1-Methylethyl 4-({7-[4-(Methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>23</b>)</h3><div class="NLM_p last">Compound <b>23</b> was prepared as an off-white solid in 34% overall yield from <b>17</b> in a similar manner to that described for <b>3</b> using 4-bromoaniline. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.39 (s, 1H), 7.98–7.90 (m, 4H), 5.38 (m, 1H), 4.93 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.15 (t, <i>J</i> = 8.8 Hz, 2H), 3.83 (br m, 2H), 3.37–3.30 (m, 2H), 3.12 (t, <i>J</i> = 8.8 Hz, 2H), 3.04 (s, 3H), 2.12–1.96 (m, 2H), 1.80–1.69 (m, 2H), 1.25 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>28</sub>N<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 477.1859, obsd 477.1857.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-Methylethyl 4-{[7-(4-Cyano-2-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>25</b>)</h3><div class="NLM_p last">1-Methylethyl 4-{[7-(4-bromo-2-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>24</b>) was prepared as an off-white solid in 19% overall yield from <b>17</b> in a similar manner to that described for <b>3</b> using 4-bromo-2-fluoroaniline. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.13 (s, 1H), 7.63 (dd, <i>J</i> = 10.8, 2.0 Hz, 1H), 7.56 (app t, <i>J</i> = 8.4 Hz, 1H), 7.42 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 5.25 (m, 1H), 4.75 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.00 (t, <i>J</i> = 9.2 Hz, 2H), 3.72–3.68 (m, 2H), 3.22 (m, 2H), 3.02 (t, <i>J</i> = 8.8 Hz, 2H), 1.94–1.89 (m, 2H), 1.60–1.55 (m, 2H), 1.17 (d, <i>J</i> = 6.4 Hz, 6H). LCMS (ESI): <i>m</i>/<i>z</i> 481 (M + H)<sup>+</sup>. A solution of <b>24</b> (100 mg, 0.209 mmol) in NMP (2 mL) was treated with CuCN (42 mg, 0.47 mmol) under N<sub>2</sub>. The resulting mixture was heated to 150 °C for 15 h. The mixture was cooled to RT, poured onto H<sub>2</sub>O (25 mL), and the mixture extracted with EtOAc. The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by flash SiO<sub>2</sub> column chromatography to afford <b>25</b> (76 mg, 85%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ8.23 (s, 2H), 7.95–7.89 (m, 2H), 7.68 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 5.27 (m, <i>J</i> = 4.0 Hz, 1H), 4.76 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.14 (t, <i>J</i> = 8.0 Hz, 2H), 3.70–3.64 (m, 2H), 3.25–3.21 (m, 2H), 3.04 (t, <i>J</i> = 8.4 Hz, 2H), 1.95–1.90 (m, 2H), 1.61–1.53 (m, 2H), 1.17 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 426.1942, obsd 426.1942.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-Methylethyl 4-({7-[2-Fluoro-4-(1,3-thiazol-2-yl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>26</b>)</h3><div class="NLM_p last">A solution of <b>24</b> (108 mg, 0.23 mmol) in THF (4 mL) under N<sub>2</sub> was treated with PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (16 mg, 0.023 mmol) and 2-(tributylstannanyl)-1,3-thiazole (85 mg, 0.23 mmol), and the reaction mixture was refluxed for 12 h. The mixture was quenched by the addition of water and extracted with EtOAc. The organic extracts were washed with brine, dried over MgSO<sub>4</sub>, and concentrated. Purification by flash chromatography afforded <b>26</b> (66 mg, 61%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.18 (s, 1H), 7.92 (d, <i>J</i> = 3.2 Hz, 1H), 7.84–7.79 (m, 2H), 7.78–7.74 (m, 2H), 5.26 (m, 1H), 4.76 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.10 (t, <i>J</i> = 8.8 Hz, 1H), 3.71–3.65 (m, 2H), 3.25–3.21 (m, 2H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.95–1.91 (m, 2H), 1.61–1.53 (m, 2H), 1.17 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>26</sub>FN<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 484.1819, obsd 484.1817.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-Methylethyl 4-({7-[2-Fluoro-4-(1-methyl-1<i>H</i>-pyrrol-2-yl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>27</b>)</h3><div class="NLM_p last">Compound <b>27</b> was prepared as a white solid in 12% yield from <b>24</b> in a similar manner to that described for <b>26</b> using 1-methyl-2-(tributylstannanyl)-1<i>H</i>-pyrrole. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.12 (s, 1H), 7.58 (t, <i>J</i> = 8.4 Hz, 1H), 7.36 (dd, <i>J</i> = 12.4, 2.0 Hz, 1H), 7.27 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 6.84 (t, <i>J</i> = 2.0 Hz, 1H), 6.23 (dd, <i>J</i> = 3.6, 2.0 Hz, 1H), 6.04 (t, <i>J</i> = 3.2 Hz, 1H), 5.28–5.22 (m, 1H), 4.76 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.04 (t, <i>J</i> = 9.2 Hz, 2H), 3.67 (s, 3H), 3.71–3.65 (m, 2H), 3.23 (app t, <i>J</i> = 10.0 Hz, 2H), 3.04 (t, <i>J</i> = 9.2 Hz, 2H), 1.95–1.90 (m, 2H), 1.61–1.52 (m, 2H), 1.17 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>26</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 480.2411, obsd 480.2411.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 1,1-Dimethylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>28</b>)</h3><div class="NLM_p last">Compound <b>28</b> was prepared as a light-yellow solid in 73% yield from <b>21</b> in a similar manner to that described for <b>3</b> using 1,1-dimethylethyl 4-hydroxy-1-piperidinecarboxylate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (app t, <i>J</i> = 7.6 Hz, 1H), 7.84 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.26 (m, 1H), 4.14 (t, <i>J</i> = 8.0 Hz, 2H), 3.68–3.62 (m, 2H), 3.25 (s, 3H), 3.18–3.16 (m, 2H), 3.05 (t, <i>J</i> = 9.2 Hz, 2H), 1.94–1.89 (m, 2H), 1.59–1.53 (m, 2H), 1.39 (s, 9H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 493.1921, obsd 493.1921.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Methyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>29</b>)</h3><div class="NLM_p last">A solution of <b>28</b> (1.0 g, 2.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL) was treated with CF<sub>3</sub>CO<sub>2</sub>H (10 mL) at RT and stirred for 2 h. The reaction mixture was concentrated and then redissolved in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and treated with Et<sub>3</sub>N (1.7 mL, ∼6 equiv). A portion of the material (2.2 mL, ∼0.20 mmol) was treated with methyl chloroformate (200 μL) at RT for 18 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and then washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated to afford the crude product, which was purified by flash chromatography to afford <b>29</b> (76 mg, 85%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.73 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 5.30–5.22 (m, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.58 (s, 3H), 3.70–3.64 (m, 2H), 3.28–3.24 (app br m, 2H), 3.25 (s, 3H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.96–1.91 (m, 2H), 1.64–1.54 (m, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 451.1451, obsd 451.1452.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Ethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>30</b>)</h3><div class="NLM_p last">Compound <b>30</b> was prepared as a white solid in 91% yield from <b>28</b> in a similar manner to that described for <b>29</b> using ethyl chloroformate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (t, <i>J</i> = 7.6 Hz, 1H), 7.83 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.28–5.24 (m, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 4.02 (q, <i>J</i> = 7.2 Hz, 2H), 3.71–3.65 (m, 2H), 3.26–3.24 (br s, 2H), 3.25 (s, 3H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.96–1.90 (br m, 2H), 1.62–1.54 (m, 2H), 1.17 (t, <i>J</i> = 6.8 Hz, 3H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 465.1605, obsd 465.1605.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>n</i>-Propyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>31</b>)</h3><div class="NLM_p last">Compound <b>31</b> was prepared as a white solid in 75% yield from <b>28</b> in a similar manner to that described for <b>29</b> using <i>n</i>-propyl chloroformate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 5.30–5.24 (m, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.94 (t, <i>J</i> = 6.8 Hz, 2H), 3.72–3.66 (m, 2H), 3.30–3.24 (br m, 2H), 3.05 (t, <i>J</i> = 8.4 Hz, 2H), 1.98–1.88 (m, 2H), 1.62–1.52 (m, 4H), 0.87 (t, <i>J</i> = 7.2 Hz, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 479.1764, obsd 479.1764.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>n</i>-Butyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>32</b>)</h3><div class="NLM_p last">Compound <b>32</b> was prepared as a white solid in 77% yield from <b>28</b> in a similar manner to that described for <b>29</b> using <i>n</i>-butyl chloroformate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 5.30–5.24 (m, 1H), 4.14 (t, <i>J</i> = 8.0 Hz, 2H), 3.98 (t, <i>J</i> = 6.4 Hz, 2H), 3.71–3.66 (m, 2H), 3.26–3.24 (br s, 2H), 3.25 (s, 3H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.96–1.90 (m, 2H), 1.62–1.49 (m, 4H), 1.36–1.26 (m, 2H), 0.88 (t, <i>J</i> = 7.6 Hz, 3H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 493.1921, obsd 493.1920.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 2-Methylpropyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>33</b>)</h3><div class="NLM_p last">Compound <b>33</b> was prepared as a white solid in 83% yield from <b>21</b> in a similar manner to that described for <b>3</b> using 2-methylpropyl 4-hydroxy-1-piperidinecarboxylate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (app t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 1.6 Hz, 1H), 7.74 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 5.28 (m, 1H), 4.14 (t, <i>J</i> = 8.0 Hz, 2H), 3.78 (d, <i>J</i> = 6.8 Hz, 2H), 3.71–3.68 (m, 2H), 3.25 (s, 3H), 3.30–3.27 (m, 2H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.97–1.91 (m, 2H), 1.88–1.80 (m, 1H), 1.63–1.54 (m, 2H), 0.87 (d, <i>J</i> = 6.8 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 493.1921, obsd 493.1920.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2,2-Dimethylpropyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>34</b>)</h3><div class="NLM_p last">Compound <b>34</b> was prepared as a white solid in 72% yield from <b>21</b> in a similar manner to that described for <b>3</b> using 2,2-dimethylpropyl 4-hydroxy-1-piperidinecarboxylate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.96 (app t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 1.6 Hz, 1H), 7.74 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 5.29 (m, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.70 (s, 2H), 3.73–3.64 (m, 2H), 3.25 (s, 3H), 3.30–3.27 (m, 2H), 3.06 (t, <i>J</i> = 8.8 Hz, 2H), 1.97–1.90 (m, 2H), 1.62–1.52 (m, 2H), 0.89 (s, 9H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 507.2077, obsd 507.2078.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-Fluoroethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>35</b>)</h3><div class="NLM_p last">Compound <b>35</b> was prepared as a white solid in 58% yield from <b>28</b> in a similar manner to that described for <b>29</b> using 2-fluoroethyl chloridocarbonate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 2.4 Hz, 1H), 7.74 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 5.31–5.25 (m, 1H), 4.65 (app t, <i>J</i> = 4.0 Hz, 1H), 4.53 (app t, <i>J</i> = 3.6 Hz, 1H), 4.27 (app t, <i>J</i> = 4.0 Hz, 1H), 4.19 (app t, <i>J</i> = 4.0 Hz, 1H), 4.14 (t, <i>J</i> = 8.0 Hz, 2H), 3.70 (m, 2H), 3.28–3.25 (br s, 2H), 3,25 (s, 3H), 3.06 (t, <i>J</i> = 8.8 Hz, 2H), 1.98–1.90 (m, 2H), 1.65–1.56 (m, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>F<sub>2</sub>N<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 483.1514, obsd 483.1514.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-(Methyloxy)ethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>36</b>)</h3><div class="NLM_p last">Compound <b>36</b> was prepared as a white solid in 65% yield from <b>28</b> in a similar manner to that described for <b>29</b> using 2-(methyloxy)ethyl chloroformate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (t, <i>J</i> = 7.6 Hz, 1H), 7.84 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.30–5.26 (m, 1H), 4.16–4.09 (m, 2H), 3.72–3.66 (m, 2H), 3.50 (t, <i>J</i> = 4.4 Hz, 2H), 3.24 (s, 3H), 3.28–3.24 (br s, 2H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 5.30–5.26 (m, 1H), 4.16–4.09 (m, 2H), 3.72–3.66 (m, 2H), 3.50 (t, <i>J</i> = 4.4 Hz, 2H), 3.28–3.24 (br s, 2H), 3.24 (s, 6H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 1.98–1.90 (m, 2H), 1.63–1.54 (m, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>6</sub>S [M + H]<sup>+</sup> 495.1714, obsd 495.1715.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>S</i>-Methyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarbothioate (<b>37</b>)</h3><div class="NLM_p last">Compound <b>37</b> was prepared as a white solid in 85% yield from <b>28</b> in a similar manner to that described for <b>29</b> using <i>S</i>-methyl chloroformate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.22 (s, 1H), 7.96 (app t, <i>J</i> = 8.4 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.36–5.28 (m, 2H), 4.14 (t, <i>J</i> = 8.0 Hz, 2H), 3.74 (br s, 2H), 3.42–3.34 (m, 2H), 3.25 (s, 3H), 3.06 (t, <i>J</i> = 8.8 Hz, 2H), 2.24 (s, 3H), 1.96 (br s, 2H), 1.62 (m, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>23</sub>FN<sub>4</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 467.1222, obsd 467.1222.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>S</i>-Ethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarbothioate (<b>38</b>)</h3><div class="NLM_p last">Compound <b>38</b> was prepared as a white solid in 87% yield from <b>28</b> in a similar manner to that described for <b>29</b> using <i>S</i>-ethyl chloroformate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.36–5.29 (m, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.76 (app br s, 2H), 3.41–3.36 (m, 2H), 3.25 (s, 3H), 3.06 (t, <i>J</i> = 8.8 Hz, 2H), 2.81 (q, <i>J</i> = 7.2 Hz, 2H), 1.96 (br s, 2H), 1.62 (br s, 2H), 1.18 (t, <i>J</i> = 7.6 Hz, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 481.1380, obsd 481.1380.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>S</i>-(1-Methylethyl) 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarbothioate (<b>39</b>)</h3><div class="NLM_p last">A solution of <b>28</b> (2.0 g, 4.1 mmol) was treated with a 20% solution of CF<sub>3</sub>CO<sub>2</sub>H in CH<sub>2</sub>Cl<sub>2</sub> (50 mL) at RT, and the mixture was stirred for 3 h. The reaction mixture was concentrated and then redissolved in CH<sub>2</sub>Cl<sub>2</sub> (150 mL) and treated with 1,1′-(oxomethanediyl)bis-1<i>H</i>-imidazole (725 mg, 4.47 mmol) at 5 °C. The reaction mixture was allowed to warm to ambient temperature and allowed to stir for 24 h. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (200 mL) and washed with water, and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub> and then concentrated to afford crude product, which was recrystallized from CH<sub>2</sub>Cl<sub>2</sub> to give (1.9 g, 97%) of 7-[2-fluoro-4-(methylsulfonyl)phenyl]-4-{[1-(1<i>H</i>-imidazol-1-ylcarbonyl)-4-piperidinyl]oxy}-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.24 (s, 1H), 8.02 (s, 1H), 7.96 (app t, <i>J</i> = 8.0 Hz, 1H), 7.84 (dd, <i>J</i> = 11.2, 2.4 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 7.47 (s, 1H), 7.02 (s, 1H), 5.40–5.28 (m, 1H), 4.15 (t, <i>J</i> = 8.4 Hz, 2H), 3.71 (m, 2H), 3.48–3.42 (m, 2H), 3.25 (s, 3H), 3.07 (t, <i>J</i> = 9.2 Hz, 2H), 2.10–2.02 (m, 2H), 1.83–1.75 (m, 2H); LRMS (ESI): <i>m</i>/<i>z</i> 487 (M + H)<sup>+</sup>. A solution of 7-[2-fluoro-4-(methylsulfonyl)phenyl]-4-{[1-(1<i>H</i>-imidazol-1-ylcarbonyl)-4-piperidinyl]oxy}-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (1.9 g, 3.90 mmol) in CH<sub>3</sub>CN (30 mL) and CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was treated with methyl iodide (1.46 mL, 23.5 mmol) at RT under N<sub>2</sub>. The reaction mixture was stirred at RT for 24 h and then concentrated to afford 1-{[4-({7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinyl]carbonyl}-3-methyl-1<i>H</i>-imidazol-3-ium iodide (2.46 g, 100%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.55 (s, 1H), 8.24 (s, 1H), 8.03 (app t, <i>J</i> = 3.6 Hz, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.86–7.82 (m, 2H), 7.75 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), (app t, <i>J</i> = 8.0 Hz, 1H), 5.42 (m, 1H), 4.16 (t, <i>J</i> = 8.4 Hz, 2H), 3.90 (s, 3H), 3.71 (br s, 2H), 3.50 (br s, 2H), 3.25 (s, 3H), 3.07 (t, <i>J</i> = 9.2 Hz, 2H), 2.12–2.04 (br m, 2H), 1.88–1.80 (m, 2H). A suspension of the above salt (315 mg, 0.5 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was treated with Et<sub>3</sub>N (70 μL, 0.5 mmol) and isopropylthiol (38 mg, 0.5 mmol) at RT under N<sub>2</sub>. The reaction mixture was stirred at RT for 18 h and then quenched by the addition of water. The aqueous was extracted with EtOAc, and the organic layer was dried over MgSO<sub>4</sub> and concentrated. Purification by flash chromatography afforded <b>39</b> (156 mg, 63%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.96 (app t, <i>J</i> = 8.0 Hz, 1H), 7.84 (app br d, <i>J</i> = 10.8 Hz, 1H), 7.74 (app br d, <i>J</i> = 6.8 Hz, 1H), 5.30–5.28 (m, 1H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.46 (m, 1H), 3.37–3.30 (br m, 2H), 3.25 (s, 3H), 3.06 (t, <i>J</i> = 8.4 Hz, 2H), 1.94 (app br s, 2H), 1.61 (app br s, 2H), 1.26 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 495.1536, obsd 495.1536.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Phenyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarbodithioate (<b>40</b>)</h3><div class="NLM_p last">Compound <b>40</b> was prepared as a white solid in 55% yield from <b>28</b> in a similar manner to that described for <b>29</b> using phenyl chloridodithiocarbonate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.25 (s, 1H), 7.96 (t, <i>J</i> = 8.0 Hz, 1H), 7.85 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 7.75 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 7.48–7.40 (m, 5H), 5.48–5.42 (m, 1H), 4.46 (app br s, 1H), 4.22 (br s, 2H), 4.16 (t, <i>J</i> = 8.4 Hz, 2H), 4.06 (br s, 2H), 3.26 (s, 3H), 3.09 (t, <i>J</i> = 8.8 Hz, 2H), 2.20–2.06 (br s, 2H), 1.92–1.72 (br s, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>25</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>3</sub>S<sub>3</sub> [M + H]<sup>+</sup> 545.1152, obsd 545.1152.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-{[1-(Ethylsulfonyl)-4-piperidinyl]oxy}-7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>41</b>)</h3><div class="NLM_p last">Compound <b>41</b> was prepared as a tan solid in 70% yield from <b>28</b> in a similar manner to that described for <b>29</b> using ethanesulfonyl chloride. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.27 (s, 1H), 7.86 (app t, <i>J </i> = 8.5 Hz, 1H), 7.78–7.68 (m, 2H), 5.42–5.25 (m, 1H), 4.26 (t, <i>J </i> = 8.5 Hz, 2H), 3.69–3.52 (m, 2H), 3.35–3.23 (m, 2H), 3.19 (t, <i>J </i> = 8.5 Hz, 2H), 3.06 (s, 3H), 2.99 (q, <i>J </i> = 7.8 Hz, 2H), 2.20–2.05 (m, 2H), 1.98–1.81 (m, 2H), 1.38 (t, <i>J </i> = 8.5 Hz 3H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>5</sub>S<sub>2</sub> [M + H]<sup>+</sup> 485.1329, obsd 485.1328.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 7-[2-Fluoro-4-(methylsulfonyl)phenyl]-4-({1-[(1-methylethyl)sulfonyl]-4-piperidinyl}oxy)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>42</b>)</h3><div class="NLM_p last">Compound <b>42</b> was prepared as a tan solid in 54% yield from <b>28</b> in a similar manner to that described for <b>29</b> using 2-propanesulfonyl chloride. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.31 (s, 1H), 7.91 (app t, <i>J </i> = 8.5 Hz, 1H), 7.87–7.60 (m, 2H), 5.49–5.20 (m, 1H), 4.31 (t, <i>J </i> = 8.5 Hz, 2H), 3.80–3.52 (m, 2H), 3.42–3.26 (m, 2H), 3.24–3.12 (m, 4 H), 2.23–1.99 (m, 2H), 1.98–1.81 (m, 2H), 1.97–1.75 (m, 2H), 1.32 (d, <i>J </i> = 6.8 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>S<sub>2</sub> [M + H]<sup>+</sup> 499.1485, obsd 499.1484.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-<i>N</i>,<i>N</i>-dimethyl-1-piperidinesulfonamide (<b>43</b>)</h3><div class="NLM_p last">Compound <b>43</b> was prepared as a tan solid in 54% yield from <b>28</b> in a similar manner to that described for <b>29</b> using <i>N</i>,<i>N</i>-dimethylsulfamoyl chloride. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (s, 1H), 8.00 (app t, <i>J </i> = 8.5 Hz, 1H), 7.76–7.67 (m, 2H), 5.38–5.29 (m, 1H), 4.19 (t, <i>J </i> = 8.5 Hz, 2H), 3.57–3.48 (m, 2H), 3.29–3.20 (m, 2H), 3.13 (t, <i>J </i> = 8.5 Hz, 2H), 3.04 (s, 3H), 2.84 (s, 6H), 2.13–2.02 (m, 2H), 1.96–1.85 (m, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>26</sub>FN<sub>5</sub>O<sub>5</sub>S<sub>2</sub> [M + H]<sup>+</sup> 500.1438, obsd 500.1438.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>N</i>,<i>N</i>-Diethyl-2-[4-({7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinyl]acetamide trifluoroacetate (<b>44</b>)</h3><div class="NLM_p last">Compound <b>44</b> was prepared as a white solid in 37% yield from <b>28</b> in a similar manner to that described for <b>29</b> using 2-chloro-<i>N</i>,<i>N</i>-dimethylacetamide, diisopropylethylamine and a catalytic amount of sodium iodide. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (s, 1H), 7.96 (app t, <i>J </i> = 8.5 Hz, 1H), 7.76–7.73 (m, 2H), 5.58–5.39 (m, 1H), 4.22 (t, <i>J </i> = 8.5 Hz, 2H), 4.08 (s, 2H), 3.74–3.58 (m, 2H), 3.56–3.43 (m, 2H), 3.41–3.16 (m, 6H), 3.06 (s, 3H), 2.43–2.30 (m, 2H), 2.29–2.17 (m, 2H), 1.18–1.12 (m, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>32</sub>FN<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 506.2237, obsd 506.2236.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 7-[2-Fluoro-4-(methylsulfonyl)phenyl]-4-({1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}oxy)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>55</b>)</h3><div class="NLM_p last">Sodium bicarbonate (41 g, 0.494 mol) was dissolved in water (20 mL) and cooled to 0 °C. A solution of 4-hydroxypiperidine (<b>45</b>, 25 g, 0.25 mol) in CH<sub>2</sub>Cl<sub>2</sub> (75 mL) was added to the above solution with vigorous stirring. A solution of cyanogen bromide (28 g, 0.27 mol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was then added and the ice bath was removed, and the mixture was stirred at ambient temperature for 18 h. Solid sodium carbonate (75 g) was then added until the pH was adjusted to ∼7, and then MgSO<sub>4</sub> (25 g) was added to remove water. The solids were removed via filtration and were washed several times with CH<sub>2</sub>Cl<sub>2</sub>. The filtrate was concentrated, and the resultant 4-hydroxy-1-piperidinecarbonitrile <b>46</b> (24.8 g) was used without purification. A solution of <b>46</b> (12.9 g, 0.1 mol) and <i>N</i>-hydroxy-2-methylpropanimidamide (12.8 g, 0.13 mol) in a mixture of EtOAc (500 mL) and ether (100 mL) was treated with a 1N solution of ZnCl<sub>2</sub> (120 mL, 0.12 mol) in ether. The mixture was stirred for 15 min, and the supernatant was decanted off. The residue was washed 2 times with 250 mL of ether, which was decanted off after each wash. The residue was then dissolved in a mixture of 4N HCl (50 mL) and EtOH (100 mL). The resulting solution was refluxed for 1 h, the solvent was reduced to about 25 mL, and 25 g of Na<sub>2</sub>CO<sub>3</sub> was added along with 100 mL of CH<sub>2</sub>Cl<sub>2</sub>. The solids were removed via filtration. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated to give 1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinol <b>47</b> (16 g) as a tan oil that was used without purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.04–3.74 (m, 3H), 3.44–3.20 (m, 2H), 2.78 (m, 1H), 2.05–1.80 (m, 2H), 1.74–1.49 (m, 2H), 1.38–1.13 (m, 6H). Compound <b>55</b> was prepared as a white solid in 55% yield from <b>21</b> in a similar manner to that described for <b>3</b> using <b>47</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.27 (s, 1H), 7.99 (app t, <i>J</i> = 7.6 Hz, 1H), 7.87 (app br d, <i>J</i> = 10.8 Hz,1H), 7.78 (app br t, <i>J</i> = 8.4 Hz, 1H), 5.36 (br m, 1H), 4.18 (t, <i>J</i> = 8.8 Hz, 2H), 3.82–3.78 (m, 2H), 3.56–3.50 (m, 2H), 3.28 (s, 3H), 3.10 (t, <i>J</i> = 8.4 Hz, 2H), 2.83 (septuplet, <i>J</i> = 6.8 Hz, 1H), 2.09 (m, 2H), 1.78 (m, 2H), 1.20 (d, <i>J</i> = 6.8 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>27</sub>FN<sub>6</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 503.1877, obsd 503.1879.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 7-[2-Fluoro-4-(methylsulfonyl)phenyl]-4-{[1-(5-fluoro-2-pyrimidinyl)-4-piperidinyl]oxy}-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>56</b>)</h3><div class="NLM_p last">A solution of 4-hydroxypiperidine (<b>45</b>, 1.53 g, 15.1 mmol) in acetonitrile (50 mL) was treated with diisopropylethylamine (7.9 mL, 45.3 mmol) and 5-fluoro-2-chloropyrimidine (<b>48</b>, 2.0 g, 15.1 mmol) under N<sub>2</sub>, and the reaction mixture was refluxed for 10 h. The reaction was concentrated and then purified by flash chromatography to afford 1-(5-fluoro-2-pyrimidinyl)-4-piperidinol (<b>50</b>, 2.46 g, 83%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.18 (s, 2H), 4.37–4.31 (m, 2H), 3.97–3.91 (m, 1H), 3.32–3.25 (m, 2H), 1.98–1.92 (m, 2H), 1.77 (br s, 1H), 1.57–1.48 (m, 2H). LCMS (ESI): <i>m</i>/<i>z</i> 198 [M + H]<sup>+</sup>. Compound <b>56</b> was prepared as a white solid in 39% yield from <b>21</b> in a similar manner to that described for <b>3</b> using 1-(5-fluoro-2-pyrimidinyl)-4-piperidinol (<b>50</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.44 (s, 2H), 8.24 (s, 1H), 7.96 (app t, <i>J</i> = 7.6 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 5.36 (m, 1H), 4.16–4.10 (m, 2H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.55–3.44 (m, 2H), 3.25 (s, 3H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 2.03–1.98 (m, 2H), 1.66–1.60 (m, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>22</sub>F<sub>2</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 461.1859, obsd 461.1859</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 4-{[1-(5-Ethyl-2-pyrimidinyl)-4-piperidinyl]oxy}-7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>57</b>)</h3><div class="NLM_p last">1-(5-Ethyl-2-pyrimidinyl)-4-piperidinol (<b>51</b>) was prepared in a similar manner to that described for 1-(5-fluoro-2-pyrimidinyl)-4-piperidinol (<b>50</b>) using 5-ethyl-2-chloropyrimidine (<b>49</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.19 (s, 1H), 4.67 (br s, 1H), 4.24–4.18 (m, 2H), 3.68 (m, 2H), 3.19–3.12 (m, 2H), 2.38 (q, <i>J</i> = 7.6 Hz, 2H), 1.75–1.69 (m, 2H), 1.31–1.22 (m, 2H), 1.09 (t, <i>J</i> = 7.2 Hz, 3H). LRMS (ESI): <i>m</i>/<i>z</i> 207 (M + H)<sup>+</sup>. Compound <b>57</b> was prepared as a white solid in 50% yield from <b>21</b> in a similar manner to that described for <b>3</b> using 1-(5-ethyl-2-pyrimidinyl)-4-piperidinol (<b>51</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ8.24 (s, 3H), 7.96 (app t, <i>J</i> = 8.4 Hz, 1H), 7.84 (dd, <i>J</i> = 10.8, 2.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 5.36 (m, 1H), 4.20–4.18 (m, 2H), 4.14 (t, <i>J</i> = 8.4 Hz, 2H), 3.51–3.45 (m, 2H), 3.25 (s, 3H), 3.05 (t, <i>J</i> = 8.8 Hz, 2H), 2.41 (q, <i>J</i> = 7.6 Hz, 2H), 2.01–1.97 (m, 2H), 1.65–1.48 (m, 2H), 1.11 (t, <i>J</i> = 7.6 Hz, 3H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>27</sub>FN<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 499.1928, obsd 499.1932.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 7-[2-Fluoro-4-(methylsulfonyl)phenyl]-4-{[1-(1,4,5,6-tetrahydro-2-pyrimidinyl)-4-piperidinyl]oxy}-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>58</b>)</h3><div class="NLM_p last">1-(2-Pyrimidinyl)-4-piperidinol (<b>53</b>) was prepared in 81% yield as a white solid in a similar manner to that described for <b>50</b> using 2-chloropyrimidine. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.28 (d, <i>J </i> = 4.6 Hz, 2H), 6.49 (t, <i>J </i> = 4.8 Hz, 1H), 4.49–4.33 (m, 2H), 4.01–3.88 (m, 1H), 3.37–3.21 (m, 2H), 2.02–1.90 (m, 2H), 1.60–1.45 (m, 2H). LRMS (ESI): <i>m</i>/<i>z</i> 180 (M + H)<sup>+</sup>. A solution of 1-(2-pyrimidinyl)-4-piperidinol (<b>53</b>, 300 mg, 1.67 mmol) in acetic acid (10 mL) was treated with 10% palladium on carbon (Degussa type, 100 mg) and concentrated hydrochloric acid (0.5 mL), and the mixture was placed under an atmosphere of hydrogen (40 psi) for 18 h at room temperature. The reaction mixture was then filtered and the solvent was removed to give 1-(1,4,5,6-tetrahydro-2-pyrimidinyl)-4-piperidinol <b>54</b> (304 mg, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.25 (m, 2H), 4.03–3.41 (m, 3H), 2.95–2.86 (m, 4H), 2.09–1.55 (m, 6H), 1.55–1.18 (m, 2H). Compound <b>58</b> was prepared as a white solid in 6% yield from <b>21</b> in a similar manner to that described for <b>3</b> using <b>54</b> and DMF as solvent. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD): δ 8.46 (s, 1H), 8.17 (s, 1H), 7.95 (app t, <i>J </i> = 8.5 Hz, 1H), 7.88–7.66 (m, 2H), 5.54–5.37 (m, 1H), 4.20 (t, <i>J </i> = 8.5 Hz, 2H), 3.75–3.57 (m, 2H), 3.49–3.33 (m, 6H), 3.19–3.07 (m, 5H), 2.21–2.06 (m, 2H), 2.01–1.76 (m, 4H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 475.1928, obsd 475.1927.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1,1-Dimethylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-2-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>60</b>)</h3><div class="NLM_p last">Compound <b>60</b> was prepared as a white solid in 15% overall yield from ethanimidamide hydrochloride and <b>16</b> in addition to 2-fluoro-4-(methylsulfonyl)aniline and 1,1-dimethylethyl 4-hydroxy-1-piperidinecarboxylate in a similar manner to that described for <b>3</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.13 (m, 1H), 7.69 (m, 2H), 5.38 (m, 1H), 4.25 (t, <i>J </i> = 7.3 Hz, 2H), 3.87 (m, 2H), 3.32 (m, 2H), 3.04 (m, 5H), 1.97 (m, 2H), 1.73 (m, 2H), 1.46 (s, 9H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>31</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 507.2077, obsd 507.2078.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-Methylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-2-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>61</b>)</h3><div class="NLM_p last">Compound <b>61</b> was prepared as a white solid in 98% overall yield from <b>56</b> in a similar manner to that described for the Boc deprotection and isopropylcarbamate formation of <b>2</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.15 (m, 2H), 7.69 (m, 2H), 5.38 (m, 1H), 4.93 (m, 1H), 4.19 (t, <i>J </i> = 7.3 Hz, 2H), 3.75 (m, 2H), 3.35 (m, 2H) 3.05 (m, 5H), 2.47 (s, 3H), 1.95 (m, 2H), 1.71 (m, 2H), 1.17 (d, <i>J</i> = 6.8 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 493.1921, obsd 493.1920.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-Methylethyl 4-({2-Amino-7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>73</b>)</h3><div class="NLM_p last">A solution of 2-fluoro-4-(methylsulfonyl)aniline (<b>19</b>, 3.3 g, 17.3 mmol) in acetonitrile (10 mL) under N<sub>2</sub> was treated with 6,6-dimethyl-5,6-dioxaspiro[2.5]octane (<b>63</b>, 9.7 g, 57 mmol) and stirred and heated at 60 °C for 3 h. The reaction mixture was allowed to cool to RT and was concentrated. The residue was heated at 70 °C for 5 h to afford <b>64</b>. Methanol (15 mL) and concentrated H<sub>2</sub>SO<sub>4</sub> (0.2 mL) were added, and the mixture was heated to reflux for 2 h. The mixture was concentrated, and the residue was purified by flash chromatography to give methyl 1-[2-fluoro-4-(methylsulfonyl)phenyl]-2-oxo-3-pyrrolidinecarboxylate <b>65</b> (2.3 g, 43%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.89 (br d, <i>J</i> = 10.0 Hz, 1H), 7.81–7.73 (m, 2H), 3.85 (br t, <i>J</i> = 7.2 Hz, 2H), 3.75 (t, <i>J</i> = 8.7 Hz, 1H), 3.68 (s, 3H), 3.30–3.25 (br s, 3H), 2.45–2.35 (m, 2H). LRMS (ESI): <i>m</i>/<i>z</i> 316 (M + H)<sup>+</sup>. A solution of <b>65</b> (2.3 g, 7.2 mmol) in THF (100 mL) under N<sub>2</sub> was treated with P<sub>2</sub>S<sub>5</sub> (3.9 g, 8.7 mmol) and was heated at 70 °C for 12 h. The mixture was filtered and the solid washed twice with EtOAc. The filtrate was concentrated and the residue was purified by flash chromatography to afford methyl 1-[2-fluoro-4-(methylsulfonyl)phenyl]-2-thioxo-3-pyrrolidinecarboxylate <b>66</b> (1.2 g, 50%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.98 (br d, <i>J</i> = 9.3 Hz, 1H), 7.89 (br d, <i>J</i> = 8.3 Hz, 1H), 7.81 (app t, <i>J</i> = 7.5 Hz, 1H), 4.12–4.08 (m, 3H), 3.70 (s, 3H), 3.30 (s, 3H), 2.60–2.50 (m, 2H). LRMS (ESI): <i>m</i>/<i>z</i> 332 [M + H]<sup>+</sup>. A solution of guanidine hydrochloride (<b>67</b>, 0.3 g, 3.2 mmol) in anhydrous MeOH (3 mL) was treated with freshly prepared 1M NaOMe/MeOH (3.2 mL, 3.2 mmol), and the mixture was stirred for 30 min at ambient temperature under N<sub>2</sub>. The mixture was filtered and the filtrate added to <b>62</b> (0.22 g, 0.64 mmol). The yellow mixture was stirred for 5 min then concentrated and heated stepwise from 60 to 90 °C with a slight vacuum for 1 h. The mixture was allowed to cool to ambient temperature, and H<sub>2</sub>O was added. The pH was adjusted to 6 with 1 M HCl/H<sub>2</sub>O, and the mixture was stirred at ambient temperature for 18 h. The solid was filtered and dried in vacuum for 2 h to provide 2-amino-7-[2-fluoro-4-(methylsulfonyl)phenyl]-1,5,6,7-tetrahydro-4<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-one <b>69</b> (0.12 g) as an yellow solid. LRMS (ESI): <i>m</i>/<i>z</i> 325 [M + H]<sup>+</sup>. A suspension of the crude <b>69</b> (0.12 g, 0.36 mmol) in POCl<sub>3</sub> (1.2 mL) was carefully treated with (<i>i</i>-Pr)<sub>2</sub>NEt (0.13 mL, 0.1 g, 0.72 mmol), and the mixture was slowly heated to 70 °C. After 1 h, the mixture was concentrated and the residue was partitioned between EtOAc/CH<sub>2</sub>Cl<sub>2</sub> and saturated NaHCO<sub>3</sub>/H<sub>2</sub>O. The organic phase was filtered, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford 4-chloro-7-[2-fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine <b>71</b> (51 mg) as a dark-green solid. LRMS (ESI): <i>m</i>/<i>z</i> 343 [M + H]<sup>+</sup>. Compound <b>73</b> was prepared as an off-white solid in 7% yield from <b>71</b> in a similar manner to that described for <b>3</b> using 1-methylethyl 4-hydroxy-1-piperidinecarboxylate. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.10–8.00 (br s, 1H), 7.70–7.65 (m, 2H), 5.30 (br s, 1H), 4.90 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.85–4.60 (m, 2H), 4.15 (br t, <i>J</i> = 7.7 Hz, 2H), 3.85–3.70 (m, 2H), 3.40–3.30 (m, 2H), 3.05 (s, 3H), 2.95 (t, <i>J</i> = 8.5 Hz, 2H), 2.00–1.95 (m, 2H), 1.85–1.80 (m, 2H), 1.24 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 494.1873, obsd 494.1872.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 1-Methylethyl 4-{[7-[2-Fluoro-4-(methylsulfonyl)phenyl]-2-(methylamino)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1- piperidinecarboxylate (<b>74</b>)</h3><div class="NLM_p last">Compound <b>74</b> was prepared as an off-white foam in 15% overall yield from <i>N</i>-methylguanidine hydrochloride (<b>68</b>) and <b>66</b> in a similar manner to that described for <b>73</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.15–8.05 (br s, 1H), 7.70–7.65 (m, 2H), 5.30 (br s, 1H), 4.90 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.85–4.60 (m, 1H), 4.15 (br t, <i>J</i> = 7.3 Hz, 2H), 3.85–3.70 (m, 2H), 3.40–3.30 (m, 2H), 3.05 (s, 3H), 2.95 (t, <i>J</i> = 8.5 Hz, 2H), 2.92 (d, <i>J</i> = 4.9 Hz, 3H), 2.00–1.95 (m, 2H), 1.85–1.80 (m, 2H), 1.24 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 508.2030, obsd 508.2030.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 1-Methylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}amino)-1-piperidinecarboxylate trifluoroacetate (<b>77</b>)</h3><div class="NLM_p last">A solution of 1,1-dimethylethyl 4-piperidinylcarbamate (512 mg, 2.6 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL) was treated with Et<sub>3</sub>N (0.71 mL, 5.1 mmol) followed by the dropwise addition of isopropylchloroformate (1.0M in toluene, 2.8 mL, 2.8 mmol) via addition funnel at RT. The reaction mixture was stirred at RT for 17 h, then washed with water, dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 1-methylethyl 4-({[(1,1-dimethylethyl)oxy]carbonyl}amino)-1-piperidinecarboxylate <b>75</b> (585 mg, 80%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.85 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.63–4.48 (m, 1H), 4.13–3.89 (m, 2H), 3.55 (br s, 1H), 2.82 (t, <i>J</i> = 11.7 Hz, 2H), 1.88–1.85 (m, 2H), 1.39 (s, 9H), 1.29–1.22 (m, 2H), 1.19 (d, <i>J</i> = 6.1 Hz, 6H). A solution of <b>21</b> (50 mg, 0.15 mmol) in DMF (1.5 mL) was treated with <b>75</b> (87 mg, 0.31 mmol) and K<sub>2</sub>CO<sub>3</sub> (42 mg, 0.31 mmol), and the reaction mixture was sealed and heated in a microwave for 20 min at 200 °C. The reaction mixture was then heated in a microwave an additional 60 min at 220 °C. The reaction mixture was then diluted with water and extracted with EtOAc. The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by reverse phase HPLC to give <b>77</b> (11 mg, 12%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.09 (s, 1H), 7.81–7.77 (m, 2H), 7.72–7.69 (m, 1H), 4.91 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.29 (t, <i>J</i> = 9.0 Hz, 2H), 4.23–4.12 (m, 2H), 3.79–3.68 (m, 1H), 3.43–3.38 (m, 2H), 3.09 (s, 3H), 2.96–2.86 (m, 2H), 1.97–1.93 (m, 2H), 1.77–1.67 (m, 2H), 1.25 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>28</sub>FN<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 478.1924, obsd 478.1924.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 1-Methylethyl 4-[{7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}(methyl)amino]-1-piperidinecarboxylate trifluoroacetate (<b>78</b>)</h3><div class="NLM_p last">Compound <b>76</b> was prepared as a colorless oil in 87% yield from from 1,1-dimethylethyl methyl(4-piperidinyl)carbamate in a similar manner to that described for <b>75</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.88 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.28–4.16 (m, 3H), 2.77–2.71 (m, 2H), 2.68 (s, 3H), 1.62–1.57 (m, 2H), 1.55–1.50 (m, 2H), 1.44 (s, 9H), 1.21 (d, <i>J</i> = 6.4 Hz, 6H). Compound <b>78</b> was prepared as a yellow solid in 9% yield from <b>21</b> and <b>75</b> in a similar manner to that described for <b>77</b>. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>30</sub>FN<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 492.2081, obsd 492.2083.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 1-Methylethyl 4-({7-[4-(Methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}thio)-1-piperidinecarboxylate (<b>80</b>)</h3><div class="NLM_p last">A solution of 4-bromopiperidine hydrochloride (5.0 g, 20.4 mmol) in dichloromethane (100 mL) under N<sub>2</sub> at 0 °C was treated with diisopropylethylamine (7.8 mL, 44.9 mmol) followed by the dropwise addition of a 1.0 M solution of isopropyl chloroformate in toluene (20.4 mL, 20.4 mmol). The mixture was stirred and allowed to warm to 25 °C over a 3 h period. The reaction was quenched by the addition of 1N HCl and diluted with EtOAc. The aqueous layer was extracted with EtOAc, and the combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried (MgSO<sub>4</sub>), and concentrated to give 1-methylethyl 4-bromo-1-piperidinecarboxylate as a colorless oil that was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ4.91 (septuplet, <i>J</i> = 6.2 Hz, 1H), 4.35 (m, <i>J</i> = 3.8 Hz, 1H), 3.71 (m, 2H), 3.36 (m, 2H), 2.09 (m, 2H), 1.93 (m, 2H), 1.24 (d, <i>J</i> = 6.2 Hz, 6H). A solution of 1-methylethyl 4-bromo-1-piperidinecarboxylate (4.0 g, 16 mmol) in DMF (40 mL) under N<sub>2</sub> at 25 °C was treated with potassium thioacetate (3.4 g, 29.8 mmol), and the mixture was stirred and heated at 100 °C for 3.5 h. The reaction mixture was allowed to cool to 25 °C and was quenched by the addition of water and diluted with EtOAc. The aqueous layer was extracted with EtOAc, and the combined organic extracts were washed with water, saturated aqueous NaHCO<sub>3</sub>, and brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to dark-brown oil. Purification by flash chromatography (80 g silica column, 10→20% EtOAc/hexane) afforded 1-methylethyl 4-(acetylthio)-1-piperidinecarboxylate (2.3 g, 59%) as a brown oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 4.91 (septuplet, <i>J</i> = 6.2 Hz, 1H), 4.35 (m, <i>J</i> = 3.8 Hz, 1H), 3.71 (m, 2H), 3.36 (m, 2H), 2.09 (m, 2H), 1.93 (m, 2H), 1.24 (d, <i>J</i> = 6.2 Hz, 6H). A solution of 1-methylethyl 4-(acetylthio)-1-piperidinecarboxylate (2.3 g, 9.4 mmol) in THF:water (1:1, 50 mL) under N<sub>2</sub> at 0 °C was treated with 1N NaOH (11.2 mL, 11.2 mmol), and the mixture was stirred at 0 °C for 2 h. The reaction mixture was quenched by the addition of aqueous citric acid, and the aqueous layer was extracted with EtOAc. The combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub> and brine and were dried (MgSO<sub>4</sub>) and concentrated to give a brown oil. Purification by flash chromatography (40 g silica column, 10→25% EtOAc/hexane) afforded 1-methylethyl 4-mercapto-1-piperidinecarboxylate <b>79</b> (1.6 g, 89%) as an amber oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 4.72 (septuplet, <i>J</i> = 6.4 Hz, 1H), 3.80 (overlapping br s, 2H), 2.96–2.79 (br m, 3H), 2.64 (d, <i>J</i> = 7.1 Hz, 1H), 1.90–1.82 (m, 2H), 1.38–1.27 (m, 2H), 1.15 (d, <i>J</i> = 6.4 Hz, 6H). A solution of <b>79</b> (82 mg, 0.43 mmol) in acetone (2 mL) was treated with <b>21</b> under N<sub>2</sub> at 25 °C followed by K<sub>2</sub>CO<sub>3</sub> (89 mg, 0.64 mmol), and the mixture was stirred and heated in a sealed vial at 60 °C for 62 h. The reaction mixture was allowed to cool to 25 °C and was concentrated to ∼<sup>1</sup>/<sub>3</sub> volume and purified by flash chromatography (12 g silica column, 10→60% EtOAc/hexane, 35 min gradient) to afford <b>80</b> (150 mg, 71%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.35 (s, 1H), 7.96 (t, <i>J</i> = 8.1 Hz, 1H), 7.85 (d, <i>J</i> = 11.2 Hz, 1H), 7.75 (d, <i>J</i> = 8.5 Hz, 1H), 4.74 (septuplet, <i>J</i> = 6.2 Hz, 1H), 4.15 (app t, <i>J</i> = 8.5 Hz, 2H), 4.11 (obscured m, 1H), 3.82 (br d, <i>J</i> = 12.7 Hz, 2H), 3.25 (s, 3H), 3.07 (br m, 2H), 2.99 (app t, <i>J</i> = 8.5 Hz, 2H), 2.01 (br d, <i>J</i> = 12.7 Hz, 2H), 1.52 (m, 2H), 1.16 (d, <i>J</i> = 6.2 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>S<sub>2</sub> [M + H]<sup>+</sup> 495.1536, obsd 495.1537.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 1-Methylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}sulfonyl)-1-piperidinecarboxylate (<b>81</b>)</h3><div class="NLM_p last">A solution of <b>80</b> (145 mg, 0.29 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL) was treated with <i>m</i>-CPBA (77% maximum by weight, 105 mg, 0.47 mmol) under N<sub>2</sub> at 0 °C, and the mixture was stirred at 0 °C for 1.5 h. The reaction mixture was quenched by the addition of methanol, concentrated to ∼<sup>1</sup>/<sub>3</sub> volume, and purified by reverse phase HPLC (C18 column, 10→100% CH<sub>3</sub>CN/H<sub>2</sub>O + 0.5% trifluoroacetic acid, 10 min gradient) to give <b>81</b> (28 mg, 18%) as a white solid after lyophilization. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.57 (s, 1H), 8.02–7.97 (overlapping m, 2H), 7.88 (d, <i>J</i> = 8.2 Hz, 1H), 4.79 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.26 (app t, <i>J</i> = 8.0 Hz, 2H), 4.08 (br m, 2H), 3.84 (br m, 2H), 3.55 (app t, <i>J</i> = 8.0 Hz, 2H), 3.34 (s, 3H), 2.89 (br m, 2H), 1.95 (br d, <i>J</i> = 11.4 Hz, 2H), 1.54 (m, 2H), 1.20 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>6</sub>S<sub>2</sub> [M + H]<sup>+</sup> 527.1432, obsd 527.1435.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (±)-1-Methylethyl 4-({7-[2-Fluoro-4-(methylsulfonyl)phenyl]-6-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>86</b> and <b>87</b>)</h3><div class="NLM_p last">A solution of allyl <b>19</b> (3.42 g, 10 mmol) in 3:2 acetone/H<sub>2</sub>O (250 mL) was treated with K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (147 mg, 0.4 mmol). Solid NaIO<sub>4</sub> (8.56 g, 40 mmol) was added portionwise, and the reaction was stirred for 4 h. The workup gave 1,1-dimethylethyl [6-chloro-5-(2-oxoethyl)-4-pyrimidinyl][2-fluoro-4-(methylsulfonyl)phenyl]carbamate (<b>82</b>, 5.0 g, 100%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.63 (s, 1H), 8.82 (s, 1H), 7.95 (dd, <i>J</i> = 9.6, 2.0 Hz, 1H), 7.77 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 7.59 (app t, <i>J</i> = 7.6 Hz, 1H), 3.93 (s, 2H), 3.30 (s, 3H), 1.38 (s, 9H). A solution of <b>82</b> (2.0 g, 4.51 mmol) in anhydrous THF (50 mL) was treated with a 1.4 M solution of methylmagnesium bromide in THF (6.5 mL, 9.1 mmol) at RT under N<sub>2</sub>. The resultant mixture was stirred at RT for 3 h. The reaction mixture was poured onto 10% aqueous HCl (200 mL), and the mixture was extracted with EtOAc. The combined organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and then concentrated to afford the crude product, which was purified by flash chromatography to afford (±)-1,1-dimethylethyl [6-chloro-5-(2-hydroxypropyl)-4-pyrimidinyl][2-fluoro-4-(methylsulfonyl)phenyl]carbamate (<b>83</b>, 0.82 g, 39%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.15 (s, 1H), 8.28 (s, 1H), 7.84 (dd, <i>J</i> = 9.6, 2.0 Hz, 1H), 7.80–7.68 (m, 2H), 5.06–4.99 (m, 1H), 3.28 (s, 3H), 3.14–3.10 (m, 1H), 3.05–3.02 (m, 1H), 1.33 (d, <i>J</i> = 6.2 Hz, 3H), 1.25 (s, 9H). LRMS (ESI): <i>m</i>/<i>z</i> 460 (M + H)<sup>+</sup>. A solution of <b>83</b> (0.8 g, 1.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was treated with CF<sub>3</sub>CO<sub>2</sub>H (5 mL) at RT under N<sub>2</sub>. The reaction mixture was stirred at RT for 3 h and then concentrated to afford (±)-1-(4-chloro-6-{[2-fluoro-4-(methylsulfonyl)phenyl]amino}-5-pyrimidinyl)-2-propanol <b>84</b>, which was used without further purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.84 (s, 1H), 8.42 (s, 1H), 8.16 (app, t, <i>J</i> = 8.0 Hz, 1H), 7.82 (dd, <i>J</i> = 10.4, 2.0 Hz, 1H), 7.73 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 5.87 (d, <i>J</i> = 2.8 Hz, 1H), 4.07 (app br s, 1H), 3.24 (s, 3H), 2.94–2.83 (m, 2H), 1.20 (d, <i>J</i> = 6.4 Hz, 3H). LRMS (ESI): <i>m</i>/<i>z</i> 360 (M + H)<sup>+</sup>. A solution of <b>84</b> (1.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added Et<sub>3</sub>N (0.72 mL, 5.2 mmol) followed by methanesulfonic anhydride (0.61 g, 3.5 mmol) at RT for 24 h. The reaction was diluted with CH<sub>2</sub>Cl<sub>2</sub> and quenched by the addition of water. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Purification by flash chromatography afforded (±)-4-chloro-7-[2-fluoro-4-(methylsulfonyl)phenyl]-6-methyl-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine <b>85</b> (0.27 g, 47% overall for two steps) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.23 (s, 1H), 7.93 (app dd, <i>J</i> = 10.8, 1.2 Hz, 1H), 7.87–7.81 (m, 2H), 4.80–4.72 (m, 1H), 3.45 (dd, <i>J</i> = 17.2, 9.6 Hz, 1H), 3.30 (s, 3H), 2.87 (dd, <i>J</i> = 17.2, 7.2 Hz, 1H), 1.21 (d, <i>J</i> = 6.0 Hz, 3H). LRMS (ESI): <i>m</i>/<i>z</i> 342 (M + H)<sup>+</sup>. A racemic mixture of <b>86</b> and <b>87</b> was prepared as a white solid in 82% yield from <b>85</b> and 1-methylethyl 4-hydroxy-1-piperidinecarboxylate in a similar manner to that described for <b>3</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.16 (s, 1H), 7.87 (app br d, <i>J</i> = 10.4 Hz, 1H), 7.82 (app br d, <i>J</i> = 7.6 Hz, 1H), 7.77 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 5.30–5.22 (m, 1H), 4.78–4.66 (m, 2H), 3.68–3.64 (m, 2H), 3.32–3.28 (m, 1H), 3.28 (s, 3H), 3.28–3.22 (m, 2H), 2.68 (app dd, <i>J</i> = 16.0, 7.2 Hz, 1H), 1.96–186 (m, 2H), 1.62–1.50 (m, 2H), 1.19 (app d, <i>J</i> = 5.6 Hz, 3H), 1.17 (d, <i>J</i> = 6.0 Hz, 6H). LRMS (ESI): <i>m</i>/<i>z</i> 493 (M + H)<sup>+</sup>. The racemic mixture (200 mg) was subjected to Chiral HPLC [column: Chiralpak OJ (analytical), Chiralpak OJ (prep); mobile phase, 95% CO<sub>2</sub>, 5% MeOH:CHCl<sub>3</sub> (90:1); 2 mL/min; pressure 140 bar, temperature 30 °C, 215 nm, and 280 nm) ] analysis and then separated into two (+ and −) enantiomers. Enantiomer 1, (+)-<b>86</b>: Retention time = 19.96 min, 46 mg (%ee >98%). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 493.1921, obsd 493.1920. Specific rotation in 50:50 DCM:methanol vol/vol, 25 °C, 589 nm = +119.17°. Enantiomer 2, (−)-<b>87</b>: Retention time = 21.0 min, 66 mg (%ee >98%). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 493.1921, obsd 493.1921. Specific rotation in 50:50 DCM:methanol vol/vol, 25 °C, 589 nm = −97.06°.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 1-Methylethyl 4-({7-[5-(Methylsulfonyl)-2-pyridinyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate Hydrochloride (<b>97</b>)</h3><div class="NLM_p last">A solution of 2-amino-5-iodopyridine (11.6 g, 52.6 mmol) in MeOH (250 mL) was treated with sodium thiomethoxide (5.16 g, 73.6 mmol) and copper powder (1.07 g, 16.8 mmol) at RT. The reaction mixture was heated in a sealed tube at 120 °C for 68 h. The reaction mixture was then cooled to RT and filtered through a pad of Celite. The pad was rinsed with MeOH, and the combined organics were concentrated and redissolved in EtOAc. The organic layer was washed with water, and the aqueous layer was extracted with EtOAc. The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 5-(methylthio)-2-pyridinamine <b>89</b> (6.23 g, 84%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.09 (s, 1H), 7.51–7.48 (m, 1H), 6.48–6.45 (m, 1H), 4.35 (br s, 2H), 2.38 (s, 3H). A solution of <b>17</b> (18.9 g, 0.1 mol) in acetone/water (1:1, 1 L) was treated with K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O (1.47 g, 4 mmol) followed by the portiowise addition of NaIO<sub>4</sub> (64.2 g, 0.4 mol). The reaction mixture was stirred at RT for 4 h and then filtered through a plug of silica (CH<sub>2</sub>Cl<sub>2</sub> wash). The filtrate was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the extracts were concentrated. Purification by flash chromatography afforded (4,6-dichloro-5-pyrimidinyl)acetaldehyde <b>88</b> (10 g, 45%). A solution of <b>88</b> (3.4 g, 17.8 mmol) in MeOH (180 mL) was treated with <b>89</b> (3.0 g, 21.4 mmol) at RT. The reaction mixture was cooled to −15 °C with an ice/methanol bath and glacial acetic acid (3.1 mL, 53.4 mmol) and NaBH<sub>3</sub>CN (3.4 g, 53.4 mmol) were added. The reaction mixture was stirred at −15 °C for 15 min and then allowed to warm to RT and stir for 19 h. The reaction mixture was then diluted with water (50 mL) and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to afford <i>N</i>-[2-(4,6-dichloro-5-pyrimidinyl)ethyl]-5-(methylthio)-2-pyridinamine <b>91</b> as a yellow oil. The crude oil was dissolved in THF (500 mL) and then treated with <i>t</i>-BuOK (5.99 g, 53.4 mmol) at RT. The reaction mixture immediately changed to a brown color and was stirred at RT for 22 h. The reaction mixture was quenched with water (50 mL), concentrated, and then redissolved in EtOAc (200 mL). The organic layer was washed with water, and the aqueous layer was extracted with EtOAc. The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated to a brown oil. The crude oil was purified by flash chromatography (20→40% EtOAc/hexanes; monitoring at 319 nm) to afford 4-chloro-7-[5-(methylthio)-2-pyridinyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine <b>93</b> (550 mg, 11%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.57 (d, <i>J</i> = 9.0 Hz, 1H), 8.43 (s, 1H), 8.29 (d, <i>J</i> = 2.4 Hz, 1H), 7.67 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 4.37–4.33 (m, 2H), 3.16 (t, <i>J</i> = 8.8 Hz, 2H), 2.47 (s, 3H). 1-Methylethyl 4-({7-[5-(methylthio)-2-pyridinyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>95</b>) was prepared as a off-white solid in 88% yield from <b>93</b> and 1-methylethyl 4-hydroxypiperidinecarboxylate in a similar manner to that described for <b>3</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.73–8.66 (m, 1H), 8.42–8.39 (m, 1H), 8.30 (d, <i>J</i> = 2.4 Hz, 1H), 8.77–8.70 (m, 1H), 5.39–5.32 (m, 1H), 4.92 (septuplet, <i>J</i> = 6.1 Hz, 1H), 4.46–4.36 (m, 2H), 3.85–3.76 (m, 2H), 3.36–3.30 (m, 2H), 3.12–3.05 (m, 2H), 2.48 (s, 3H), 2.03–1.95 (m, 2H), 1.79–1.70 (m, 2H), 1.25 (d, <i>J</i> = 6.4 Hz, 6H). LRMS (ESI): <i>m</i>/<i>z</i> 430 (M + H)<sup>+</sup>. A solution of <b>95</b> (186 mg, 0.43 mmol) in MeOH (4 mL) and acetone (3 mL) was treated with a solution of Oxone (798 mg, 1.3 mmol) in water (4 mL) via pipet at RT. A white solid precipitated immediately, and the reaction mixture was stirred at RT for 1 h. The reaction mixture was quenched with saturated aqueous Na<sub>2</sub>SO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. The resulting solid was dissolved in a mixture of Et<sub>2</sub>O (8 mL) and acetone (3 mL) warmed with a heat gun and was treated with HCl (1.0M in Et<sub>2</sub>O, 0.88 mL), during which time a white solid precipitated. The solid was filtered, washed with Et<sub>2</sub>O, and dried under high vacuum to afford <b>97</b> (190 mg, 81%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.01 (d, <i>J</i> = 2.4 Hz, 1H), 8.83 (s, 1H), 8.18 (dd, <i>J</i> = 8.8, 2.2 Hz, 1H), 7.70 (d, <i>J</i> = 8.8 Hz, 1H), 5.56 (septuplet, <i>J</i> = 4.2 Hz, 1H), 4.93 (app quintuplet, <i>J</i> = 6.4 Hz, 1H), 4.57 (t, <i>J</i> = 8.8 Hz, 2H), 3.89–3.83 (m, 2H), 3.38–3.29 (m, 4H), 3.05 (s, 3H), 2.10–2.04 (m, 2H), 1.84–1.76 (m, 2H), 1.26 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>27</sub>FN<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 462.1811, obsd 462.1810.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 1-Methylethyl 4-({7-[6-(Methylsulfonyl)-3-pyridinyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate Hydrochloride (<b>98</b>)</h3><div class="NLM_p last">6-(Methylthio)-3-pyridinamine <b>90</b> was prepared as a brown solid in 26% yield from 5-amino-2-bromopyridine in a similar manner to that described for <b>89</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.00 (d, <i>J</i> = 2.9 Hz, 1H), 7.06–7.00 (m, 1H), 6.92–6.89 (m, 1H), 3.50 (br s, 2H), 2.51 (s, 3H). Compound <b>98</b> was prepared as a white solid in 7% overall yield from <b>88</b> and <b>90</b> in a similar manner to that described for <b>97</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.02 (d, <i>J</i> = 2.4 Hz, 1H), 8.57 (dd, <i>J</i> = 8.8, 2.7 Hz, 1H), 8.37 (s, 1H), 8.04 (d, <i>J</i> = 8.8 Hz, 1H), 5.36 (septuplet, <i>J</i> = 3.9 Hz, 1H), 4.91 (app quintuplet, <i>J</i> = 6.4 Hz, 1H), 4.14 (t, <i>J</i> = 8.8 Hz, 2H), 3.84–3.76 (m, 2H), 3.35–3.28 (m, 2H), 3.18 (s, 3H), 3.15 (t, <i>J</i> = 8.8 Hz, 2H), 2.02–1.95 (m, 2H), 1.77–1.68 (m, 2H), 1.24 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>27</sub>FN<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 462.1811, obsd 462.1811.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 1-Methylethyl 4-{[7-(5-Cyano-2-pyridinyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>99</b>)</h3><div class="NLM_p last">Compound <b>99</b> was prepared as a white solid in 5% overall yield from <b>88</b> and 2-amino-5-cyanopyridine in a similar manner to that described for <b>97</b>, except that Na(OAc)<sub>3</sub>BH and CF<sub>3</sub>CO<sub>2</sub>H was used in the reduction amination step in place of NaCNBH<sub>3</sub> and acetic acid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.90–8.85 (m, 1H), 8.61–8.57 (m, 1H), 8.42 (s, 1H), 7.87–7.82 (m, 1H), 5.42–5.33 (m, 1H), 4.99–4.90 (m, 1H), 4.35 (t, <i>J</i> = 8.61 Hz, 2H), 3.89–3.74 (m, 2H), 3.42–3.29 (m, 2H), 3.07 (t, <i>J</i> = 8.1 Hz, 2H), 2.08–1.94 (m, 2H), 1.83–1.70 (m, 2H), 1.27 (d, <i>J</i> = 6.2 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>FN<sub>6</sub>O<sub>3</sub> [M + H]<sup>+</sup> 409.1988, obsd 409.1989.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 1-Methylethyl 4-{[7-(5-Fluoro-2-pyridinyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>100</b>)</h3><div class="NLM_p last">Compound <b>100</b> was prepared as a white solid in 15% overall yield from <b>88</b> and 2-amino-5-fluoropyridine in a similar manner to that described for <b>99</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.66 (dd, <i>J</i> = 9.3, 4.0 Hz, 1H), 8.35 (s, 1H), 8.17 (d, <i>J</i> = 3.11 Hz, 1H), 7.47–7.40 (m, 1H), 5.41–5.30 (m, 1H), 5.00–4.89 (m, 1H), 4.30 (t, <i>J</i> = 8.6 Hz, 2H), 3.89–3.73 (m, 2H), 3.42–3.30 (m, 2H), 3.04 (t, <i>J</i> = 8.6 Hz, 2H), 2.07–1.93 (m, 2H), 1.84–1.67 (m, 2H), 1.26 (d, <i>J</i> = 6.2 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 402.1942, obsd 402.1942.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 1-Methylethyl 4-{[7-(2-Methyl-3-pyridinyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>101</b>)</h3><div class="NLM_p last"><i>N</i>-[2-(4,6-Dichloro-5-pyrimidinyl)ethyl]-2-methyl-3-pyridinamine was prepared from <b>88</b> and 2-methyl-3-pyridinamine in a similar manner to that described for <b>91</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.81 (s, 1H), 7.95–7.94 (m, 1H), 7.71–7.66 (m, 2H), 6.63 (app t, <i>J</i> = 5.6 Hz, 1H), 3.59 (app q, <i>J</i> = 6.0 Hz, 2H), 3.08 (t, <i>J</i> = 6.4 Hz, 2H), 2.40 (s, 3H), LRMS (ESI): <i>m</i>/<i>z</i> 285 (M + H)<sup>+</sup>. A solution of <i>N</i>-[2-(4,6-dichloro-5-pyrimidinyl)ethyl]-2-methyl-3-pyridinamine (∼11.0 g) in toluene (200 mL) was treated with PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub> (1.36 g, 2 mmol), potassium <i>tert</i>-butoxide (8.7 g, 77.7 mmol), and K<sub>2</sub>CO<sub>3</sub> (10.7 g, 77.7 mmol) at RT under N<sub>2</sub>. The reaction mixture was stirred and refluxed for 18 h. The reaction mixture was allowed to cool to RT and then filtered through a pad of Celite. The filtrate was concentrated and purified by flash chromatography to afford 4-chloro-7-(2-methyl-3-pyridinyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (0.85 g). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.41 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 8.11 (s, 1H), 7.75 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.31 (dd, <i>J</i> = 8.0, 4.8 Hz, 1H), 4.03 (t, <i>J</i> = 8.8 Hz, 2H), 3.20 (t, <i>J</i> = 8.4 Hz, 2H), 2.34 (s, 3H), LRMS (ESI): <i>m</i>/<i>z</i> 247 (M + H)<sup>+</sup>. Compound <b>101</b> was prepared as a white solid in 55% overall yield from 4-chloro-7-(2-methyl-3-pyridinyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine and 1-methylethyl 4-hydroxypiperidinecarboxylate in a similar manner to that described for <b>3</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.36 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 8.05 (s, 1H), 7.69 (dd, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.26 (dd, <i>J</i> = 8.0, 4.8 Hz, 1H), 5.27–5.20 (m, 1H), 4.27 (septuplet, <i>J</i> = 6.4 Hz, 1H), 3.94 (t, <i>J</i> = 8.8 Hz, 2H), 3.71–3.66 (m, 2H), 3.21 (app br t, <i>J</i> = 10.0 Hz, 2H), 3.04 (t, <i>J</i> = 9.2 Hz, 2H), 2.35 (s, 3H), 1.95–1.89 (m, 2H), 1.60–1.50 (m, 2H), 1.17 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>27</sub>N<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 398.2191, obsd 398.2191.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 1-Methylethyl 4-{[7-(4-Cyano-3-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>103</b>)</h3><div class="NLM_p last">1-Methylethyl 4-{[7-(4-bromo-3-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate (<b>102</b>) was prepared as a white solid in 38% overall yield from <b>88</b> and 4-bromo-3-fluoroaniline in a similar manner to that described for <b>97</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.33 (s, 1H), 7.84 (dd, <i>J</i> = 12.0, 2.4 Hz, 1H), 7.47 (t, <i>J</i> = 8.0 Hz, 1H), 7.34 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 5.37–5.32 (m, 1H), 4.93 (septuplet, <i>J</i> = 6.0 Hz, 1H), 4.04 (t, <i>J</i> = 8.8 Hz, 2H), 3.82–3.76 (br m, 2H), 3.36–3.30 (m, 2H), 3.07 (t, <i>J</i> = 8.8 Hz, 2H), 2.02–1.95 (m, 2H), 1.77–1.69 (m, 2H), 1.25 (d, <i>J</i> = 6.4 Hz, 6H). LRMS (ESI): <i>m</i>/<i>z</i> 481 [M + H]<sup>+</sup>. Compound <b>103</b> was prepared as a white solid in 19% yield from 1-methylethyl 4-{[7-(4-bromo-3-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate in a similar manner to that described for <b>25</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42 (s, 1H), 8.11 (dd, <i>J</i> = 13.6, 1.6 Hz, 1H), 7.84 (app t, <i>J</i> = 8.0 Hz, 1H), 7.74 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 5.32–5.25 (m, 1H), 4.75 (septuplet, <i>J</i> = 6.4 Hz, 1H), 4.10 (t, <i>J</i> = 8.8 Hz, 2H), 3.70–3.64 (m, 2H), 3.24 (app <i>J</i> = 9.6 Hz, 2H), 3.03 (t, <i>J</i> = 8.8 Hz, 2H), 1.96–1.89 (m, 2H), 1.61–1.53 (m, 2H), 1.16 (d, <i>J</i> = 6.0 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>24</sub>FN<sub>5</sub>O<sub>3</sub> [M + H]<sup>+</sup> 426.1941, obsd 426.1943.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 1-Methylethyl 4-({7-[3-Fluoro-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>104</b>)</h3><div class="NLM_p last">1-Methylethyl 4-{[7-(4-bromo-3-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate was prepared as a white solid in 38% overall yield from 4-bromo-3-fluoroaniline and <b>88</b> in a similar manner to that described for <b>97</b>, except the cyclization occurred spontaneously. Compound <b>104</b> was prepared from 1-methylethyl 4-{[7-(4-bromo-3-fluorophenyl)-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl]oxy}-1-piperidinecarboxylate and sodium methanesulfinate using the sulfonylation reaction conditions described for <b>2</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.40 (s, 1H), 8.15 (d, <i>J</i> = 13.5 Hz, 1H), 7.88 (dt, <i>J</i> = 8.7, 2.2 Hz, 1H), 7.43 (d, <i>J</i> = 9.0 Hz, 1H), 7.26 (d, <i>J</i> = 2.2 Hz, 1H), 5.35 (m, 1H), 4.93 (septuplet, <i>J</i> = 6.2 Hz, 1H), 4.11 (t, <i>J</i> = 8.0 Hz, 2H), 3.80 (m, 2H), 3.37–3.31 (m, 2H), 3.20 (s, 3H), 3.12 (t, <i>J</i> = 8.4 Hz, 2H), 2.94 (m, 2H), 2.02–1.90 (m, 2H), 1.80–1.70 (m, 2H), 1.25 (d, <i>J</i> = 6.3 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 479.1764, obsd 479.1764.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> 1-Methylethyl 4-[(7-{4-[(Dimethylamino)sulfonyl]phenyl}-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)oxy]-1-piperidinecarboxylate (<b>105</b>)</h3><div class="NLM_p last">Compound <b>105</b> was prepared as a white solid in 17% overall yield from 4-amino-<i>N</i>,<i>N</i>-dimethylbenzenesulfonamide and <b>88</b> in a similar manner to that described for <b>99</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.38 (s, 1H), 7.96 (d, <i>J</i> = 9.0 Hz, 2H), 7.77 (d, <i>J</i> = 8.8 Hz, 2H), 5.42–5.30 (m, 1H), 4.99–4.86 (m, 1H), 4.14 (t, <i>J</i> = 8.8 Hz, 2H), 3.91–3.75 (m, 2H), 3.41–3.27 (m, 2H), 3.12 (t, <i>J</i> = 8.8 Hz, 2H), 2.70 (s, 6H), 2.09–1.92 (m, 2H), 1.83–1.66 (m, 2H), 1.26 (d, <i>J</i> = 6.2 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>31</sub>N<sub>5</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 490.2124, obsd 490.2124.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-Methylethyl 4-({7-[2-Fluoro-4-(methylthio)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>106</b>)</h3><div class="NLM_p last">A slurry of nickel(II) bromide (9.12 g, 42 mmol), 2,2′-dipyridyl (6.56 g, 42 mmol), and zinc dust (55 g, 844 mmol) in anhydrous DMF (300 mL) were treated with 2-fluoro-4-iodoaniline (100 g, 0.42 mol) and dimethyldisulfide (96 mL, 1.06 mol) under N<sub>2</sub>. The resultant mixture was stirred at 75 °C for 1.5 h. The reaction mixture was concentrated. The crude residue was dissolved in Et<sub>2</sub>O (500 mL), filtered through a pad of Celite, and washed with Et<sub>2</sub>O. The filtrate was concentrated and purified by flash chromatography to afford [2-fluoro-4-(methylthio)phenyl]amine (48.7 g, 73%) as a brown liquid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 9.72 (s, 1H), 8.86 (s, 1H), 7.00 (dd, <i>J</i> = 11.2, 2.0 Hz, 1H), 6.93 (dd, <i>J</i> = 8.4, 4.0 Hz, 1H), 6.70 (t, <i>J</i> = 8.8 Hz, 1H), 4.21 (s, 2H), 3.69 (br s, 2H), 2.40 (s, 3H). LRMS (ESI): <i>m</i>/<i>z</i> 158 (M + H)<sup>+</sup>. Compound <b>106</b> was prepared as an off-white solid in 34% overall yield from [2-fluoro-4-(methylthio)phenyl]amine in a similar manner to that described for <b>99</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub><i>6</i></sub>): δ 8.10 (s, 1H), 7.46 (t, <i>J</i> = 8.4 Hz, 1H), 7.21 (dd, <i>J</i> = 12.0, 2.0 Hz, 1H), 7.09 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 5.26–5.20 (m, 1H), 4.75 (septuplet, <i>J</i> = 6.4 Hz, 1H), 3.96 (t, <i>J</i> = 8.8 Hz, 2H), 3.70–3.64 (m, 2H), 3.22 (app t, <i>J</i> = 9.6 Hz, 2H), 3.01 (t, <i>J</i> = 8.8 Hz, 2H), 1.94–1.88 (m, 2H), 1.59–1.50 (m, 2H), 1.17 (d, <i>J</i> = 6.4 Hz, 6H). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 447.1866, obsd 447.1865.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (±)-1,1-Dimethylethyl 4-({1-[4-(Methylsulfinyl)phenyl]-2,3-dihydro-1<i>H</i>-indol-4-yl}oxy)-1-piperidinecarboxylate (<b>107</b> and <b>108</b>)</h3><div class="NLM_p last">A solution of <b>106</b> (200 mg, 0.454 mmol) and hexafluoroisopropanol (2.5 mL) was treated with 30% aqueous H<sub>2</sub>O<sub>2</sub> (100 μL). The mixture was stirred at RT for 0.5 h. A saturated sodium sulfide solution (8 mL) was introduced to the above mixture and stirred for 5 min. Layers were separated, and the organic layer was concentrated and purified by flash chromatography (0→20% EtOAc/hexanes) to afford a racemic mixture of <b>107</b> and <b>108</b> (178 mg, 86%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.61 (t, <i>J</i> = 8.8 Hz, 2H), 7.34 (d, <i>J</i> = 8.8 Hz, 2H), 7.04 (app t, <i>J</i> = 8.0 Hz, 1H), 6.83 (d, <i>J</i> = 8.0 Hz, 1H), 6.54 (d, <i>J</i> = 8.4 Hz, 1H), 4.56 (septuplet, <i>J</i> = 3.2 Hz, 1H), 3.98 (t, <i>J</i> = 8.8 Hz, 2H), 3.60–3.55 (m, 2H), 3.25–3.22 (m, 2H), 2.99 (t, <i>J</i> = 8.4 Hz, 2H), 2.69 (s, 3H), 1.88–1.83 (m, 2H), 1.58–1.49 (m, 2H), 1.39 (s, 9H). LRMS (ESI): <i>m</i>/<i>z</i> 457 (M + H)<sup>+</sup>.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (<i>R</i>)-1,1-Dimethylethyl 4-({1-[4-(Methylsulfinyl)phenyl]-2,3-dihydro-1<i>H</i>-indol-4-yl}oxy)-1-piperidinecarboxylate (<b>107</b>)</h3><div class="NLM_p last">The racemic sulfoxide (150 mg) was subjected to Chiral HPLC (column: Chiralpak AS (analytical), Chiralpak (prep); mobile phase, 78% CO<sub>2</sub>, 22% MeOH (14 mL/min), pressure 140 bar, temperature 40 °C, 240 nm)) analysis and then was separated into its (<i>R</i> and <i>S</i>) enantiomers. Retention time was 11.57 min for the first eluting enantiomer, which provided 33 mg (%ee >98%). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 463.1815, obsd 463.1816.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>S</i>)-1,1-Dimethylethyl 4-({1-[4-(Methylsulfinyl)phenyl]-2,3-dihydro-1<i>H</i>-indol-4-yl}oxy)-1-piperidinecarboxylate (<b>108</b>)</h3><div class="NLM_p last">Retention time was 14.04 min for the second eluting isomer, 38 mg (%ee >97%). HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>27</sub>FN<sub>4</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 463.1815, obsd 463.1815.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> 1-Methylethyl 4-({7-[2-Methyl-4-(methylsulfonyl)phenyl]-6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)-1-piperidinecarboxylate (<b>113</b>)</h3><div class="NLM_p last">A solution of 4-fluoro-2-methyl-1-nitrobenzene (<b>109</b>, 2.4 g, 19.3 mmol) in DMF was treated with sodium methoxide (1.5 g, 21.3 mmol) and stirred and heated at 85 °C for 1 h. The mixture was allowed to cool to RT and was treated with water and extracted with EtOAc (3×). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 2-methyl-4-(methylthio)-1-nitrobenzene (<b>110</b>, 3.1 g, 88%) as an orange residue. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.95 (d, <i>J </i> = 8.6 Hz, 1H), 7.32 (d, <i>J </i> = 8.6 Hz, 1H), 7.27 (dd, <i>J </i> = 8.6, 2.0 Hz, 1H), 2.54 (s, 3H). LRMS (ESI): <i>m</i>/<i>z</i> 184 (M + H)<sup>+</sup>. Tin(II) chloride (10.7 g, 56.4 mmol) was added portionwise to concentrated HCl (20 mL) at RT. The mixture was treated with a solution of 2-methyl-4-(methylthio)-1-nitrobenzene (3.1 g, 17.1 mmol) in ethanol (10 mL). The mixture was stirred and heated at 80 °C for 1 h. The mixture was allowed to cool to RT, the pH was adjusted to ∼10 with 10N NaOH, and extracted with EtOAc (3×). The combined organic extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford 2-methyl-4-(methylthio)aniline (<b>111</b>, 2.1 g, 81%) as a dark oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.00 (s, 1H), 6.96 (dd, <i>J </i> = 8.3, 2.0 Hz, 1H), 6.71 (d, <i>J</i> = 8.2 Hz, 1H), 2.34 (s, 3H), 2.07 (s, 3H). LRMS (ESI): <i>m</i>/<i>z</i> 154 (M + H)<sup>+</sup>. Compound <b>104</b> was prepared as a white solid in 5% overall yield from <b>111</b> and <b>88</b> in a similar manner to that described for <b>97</b>, with the exception that CF<sub>3</sub>CO<sub>2</sub>H was used for the cyclization step. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.19 (s, 1H), 7.86 (s, 1H), 7.79 (dd, <i>J</i> = 8.4, 1.7 Hz, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 5.37–5.29 (m, 1H), 5.00–4.83 (m, 1H), 3.99 (t, <i>J</i> = 8.8 Hz, 2H), 3.80 (d, <i>J</i> = 11.4 Hz, 2H), 3.40–3.23 (m, <i>2</i>H), 3.13 (t, <i>J</i> = 8.8 Hz, 2H), 3.03 (s, 3H), 2.34 (s, 3H), 1.92 (dt, <i>J</i> = 6.3, 3.0 Hz, 2H), 1.23 (d, <i>J</i> = 6.2 Hz, 6H). LRMS (ESI): <i>m</i>/<i>z</i> 475 (M + H)<sup>+</sup>. HRMS (ESI): <i>m</i>/<i>z</i> calcd for C<sub>23</sub>H<sub>30</sub>N<sub>4</sub>O<sub>5</sub>S [M + H]<sup>+</sup> 475.2015, obsd 475.2014.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> GLP-1 Release from GluTag Cells with <b>3</b></h3><div class="NLM_p">GLUTag cells were cultured in Dulbecco’s Modified Eagles Medium (Sigma-Aldrich) containing 5.5 mM glucose, 10% fetal bovine serum, and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine.</div><div class="NLM_p">GLUTag cells were plated in 384-well cell culture plates coated with Matrigel (BD Biosciences) and grown to 80% confluence in Dulbecco’s Modified Eagle’S Medium (Sigma-Aldrich) containing 1000 mg/L glucose, pyroxidine HCl, and sodium bicarbonate and supplemented with 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine and 10% fetal bovine serum. On the day of the experiment, cell media was removed and cells were preincubated for 30 min in Kreb’s Ringers assay buffer (120 mM NaCl, 5 mM KCl, 2 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 22 mM NaHCO<sub>3</sub>, 10 mM Hepes, 0.1% BSA, 10 mM <span class="smallcaps smallerCapital">d</span>-glucose, and DPP-IV inhibitor (Millipore DPP4–010). Following preincubation, media was again removed and replaced with KRB assay buffer containing GSK252 at varying concentrations. Cells were incubated for 2 h in a 37 °C, 5% CO<sub>2</sub> incubator. After the incubation period, media was collected and centrifuged to remove any floating cells and assayed for GLP-1.</div><div class="NLM_p last">Capture antibody (Abcam ab23468) was biotinylated using the QuickPlex Biotin NHS Ester kit (MSD R91DS-1) according to the manufacturer’s protocol. Detection antibody (Abcam ab26278) was sulfo-tagged using a MSD SULFO-TAG NHS Ester kit according to the manufacturer’s protocol (MSD R91AN-1). Active GLP-1 was measured using a chemiluminescent detection assay specific for amidated forms of GLP-1 (1–36 amide, 7–36 amide, and 9–36 amide). Briefly, 15 μL of cell supernatant plus 5 μL of assay buffer containing 2 μg/mL biotinylated anti-GLP-1 capture antibody, 2 μg/mL sulfo-tagged anti-GLP-1 detection antibody, 8% BSA Fraction V (Sigma-Aldrich), 4× DPP-IV inhibitor (Millipore) in PBS pH = 7.4 were added to each well of a 384 Standard avidin-coated plate (MSD L21AA-1). Plates were sealed, shaken briefly, and incubated overnight at 40 °C. The following day, samples were aspirated from wells and washed 3 times with 1× Tris wash buffer (MSD R61TX-1). Wash buffer was aspirated, and 35 μL 1× Read T buffer (MSD R92TC-2) was added. Plates were read on an MSD Sector 6000 instrument.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> Primary Colonic Crypt Secretion of GLP-1 with <b>3</b></h3><div class="NLM_p last">Primary colonic crypts were prepared from 6–8 week old C57BL/6 male mice. Intestine was removed, cecum to rectum, filled and flushed three times with cold PBS, and then slit open longitudinally and cut into 2–3 mm lengths. Tissue sections from five animals were pooled and washed with Hank’s Balanced Salt Solution (Gibco) five times, allowing sections to sediment under gravity each time, and then transferred to a Petri dish and diced to a very fine mince. The tissue slurry was incubated in 0.1% Collagenase II–S (Sigma), 0.2% Dispase I (Becton Dickenson), 2000 Kunitz DNase-I (Sigma), and 0.1% Hyaluronidase I–S (Sigma) in culture media (Dulbecco’s Modified Eagles Medium Hi Glucose (Gibco), 10% heat inactivated FBS (Gibco), 1× Pen/Strep (Gibco)) for 15 min at 37 °C while gently rocking. First digest was triturated 50 times with a 10 mL pipet, and the contents allowed to sediment under gravity for 1 min. Then 20 mL of the supernatant was carefully removed . Two additional digests were performed on the remaining tissue fragments with fresh enzyme solution as described above, saving the supernatant each time. All digest fractions were pooled for gentle spins (3 min, 300 rpm in swinging bucket centrifuge) and washed in Hank’s Balanced Salt Solution containing 5 mM β-mercaptoethanol until the supernatant was clear. The pellet of crypts was resuspended in culture media and seeded on 384-well cell culture plates coated with Matrigel (BD Biosciences) and allowed to attach for 24 h. GLP-1 levels were measured as described above.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> Incretin Secretion in WT and KO Mice with <b>3</b></h3><div class="NLM_p last">First, 17-week-old transgenic male (WT) and GPR119 knockout (KO) mice (Charles River Laboratories, USA) were fasted overnight and then randomly distributed into treatment groups (<i>n</i> = 8 and 10 per group, repsectively). Animals received wither vehicle (0.5% HPMC/0.1% Tween80) or compound <b>3</b> (30 mg/kg) by oral gavage at a dose volume of 10 mL/kg. Then 60 min after the oral gavage, mice were anesthetized using isofluorane and a blood sample was collected by cardiac puncture. All mice were euthanized by cervical dislocation immediately following cardiac puncture. Blood samples were placed in chilled K<sub>2</sub>-EDTA coated capiject tubes (cat. no. T-MQK, Terumo Medical Corp., Elkton, MD) supplemented with a DPP-4 inhibitor and Aprotenin (Trasylol; Bayer Pharmaceuticals, West Haven, CT), yielding a final concentration of 30 μL and 250 KIU/mL, respectively. The tubes were immediately centrifuged at 4 °C and the plasma collected and stored at −80 °C for subsequent hormone measurements. Total GLP-1 levels were determined using a Multi-Array electrochemoluminescence assay from Meso Scale Discovery (cat. no. K110-FAC-2; Gaithersburg, MD). Total GIP levels were determined using an ELISA assay (cat. no. EZRMGIP-55K, Linco Diagnostic Services, St. Charles, MO). Data are represented as box plots summarizing the distribution of data for each treatment group. Horizontal lines represent the mean data.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> Hyperglycemic Clamp in Rats with <b>3</b></h3><div class="NLM_p last">Male Wistar rats (Taconic Farms, USA), weighing 300–350 g, had catheters surgically implanted into the jugular and femoral veins and allowed to recover for one week following the surgery. Animals were fasted overnight. Animals were then randomly assigned to treatment groups, vehicle (<i>n</i> = 19), compound <b>3</b> (1 mg/kg, <i>n</i> = 8), or compound <b>3</b> (10 mg/kg, <i>n</i> = 8), and baseline blood samples were collected from the jugular vein. Animals were administered vehicle or compound <b>3</b> by oral gavage. A second blood sample was collected approximately 90 min after the oral gavage and immediately prior to starting the hyperglycemic clamp. The clamp was initiated by infusing an empirically determined glucose bolus over 15–30 s into the femoral vein, followed by a variable rate glucose infusion adjusted to achieve a stable plasma glucose level of 190–210 mg/dL. After infusion of the glucose bolus, blood samples were collected every 5 min for glucose measurements. Samples for C-peptide levels were collected at 2, 5, 10, 15, 20, 25, 30, 45, 60, 90, and 120 min during the hyperglycemic clamp. All blood samples were placed in individual tubes containing a gel clot activator (cat. no. T-MG, Terumo Medical Corporation, Elkton, MD) and allowed to clot at room temperature for 20 min before centrifugation and collection of serum. Glucose levels were measured using an Olympus AU640 analyzer (Olympus America Inc., Melville, NY) and C-peptide levels by an RIA (Linco Diagnostic Services, St. Charles, MO).</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Mouse Food Intake with <b>3</b></h3><div class="NLM_p last">Individually housed, male C57BL/6 mice were fasted overnight. Body weights were recorded, and compound <b>3</b> (10 mg/kg in dose volume of 10 mL/kg, 10% DMSO:30% solutol:60% HP-β-CD) was delivered by oral gavage at time = −60 min. Control (Exendin-4, 100 μg/kg in dose volume of 10 mL/kg, Polypeptide) was delivered IP at time = −30 min. At time = 0 min, food hoppers containing normal chow (Purina) were weighed and reintroduced. Hopper wights were recorded after 1, 2, 4, 6, and 24 h</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Rat Gastric Emptying with <b>3</b></h3><div class="NLM_p last">Male Sprague–Dawley rats (Charles River Laboratories, USA) were fasted overnight and administered vehicle (dose volume of 10 mL/kg, 0.5% HPMC/0.1% Tween80) or compound <b>3</b> (10 mg/kg in dose volume of 10 mL/kg) orally at time = −120 min. At time = −15 min, the positive control rat cohort was administered Pramlintide (15 μg in dose volume of 10 mL/kg, Polypeptide). At time = 0, baseline plasma samples were collected, followed by gavage of acetominophen (65 mg in vehicle at a dose volume of 10 mL/kg). The concentration time profile of acetominophen was measured over the next 3 h.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm301404a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67063" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67063" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Subba R. Katamreddy</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a5d6cec4d1c4c8d7c0c1c1dce5cbc68bd7d78bc6cac885c4cbc1d7c0d28bcf8bc6c4d7d5c0cbd1c0d7e5c2d6ce8bc6cac8"><span class="__cf_email__" data-cfemail="d4a7bfb5a0b5b9a6b1b0b0ad94bab7faa6a6fab7bbb9">[email protected]</span> <span class="__cf_email__" data-cfemail="7b1a151f091e0c551155181a090b1e150f1e093b1c081055181416">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew J. Carpenter</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8dfee6ecf9ece0ffe8e9e9f4cde3eea3ffffa3eee2e0adece3e9ffe8faa3e7a3eeecfffde8e3f9e8ffcdeafee6a3eee2e0"><span class="__cf_email__" data-cfemail="67140c0613060a150203031e2709044915154904080a">[email protected]</span> <span class="__cf_email__" data-cfemail="5e3f303a2c3b297034703d3f2c2e3b302a3b2c1e392d35703d3133">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carina E. Ammala</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric E. Boros</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ron L. Brashear</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Celia P. Briscoe</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah R. Bullard</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard D. Caldwell</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Conlee</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dallas K. Croom</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shane M. Hart</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis O. Heyer</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul R. Johnson</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer A. Kashatus</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Doug J. Minick</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory E. Peckham</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean A. Ross</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shane G. Roller</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vicente A. Samano</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Howard R. Sauls</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarva M. Tadepalli</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James B. Thompson</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Xu</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James M. Way</span> - <span class="hlFld-Affiliation affiliation">GlaxoSmithKline
Research & Development, Five Moore
Drive, Research Triangle Park, North Carolina 27709, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3451e9392-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12225" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12225" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Analytical Chemistry group of Matt Lochansky and Iris Scherer for performing HRMS analysis for the compounds reported and Manon Villeneuve, Yang Zhao, Eric Pullen, Eric Wentz, and Bill Hall for performing chiral separations. We also thank Brad Henke for preparing compound <b>114</b> to be used as the standard in the in vitro assay.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i81" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i81"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i82" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i82"> Abbreviations Used</h2><tr><td class="NLM_term">T2D</td><td class="NLM_def"><p class="first last">type 2 diabetes</p></td></tr><tr><td class="NLM_term">GPR119</td><td class="NLM_def"><p class="first last">G protein-coupled receptor 119</p></td></tr><tr><td class="NLM_term">GIP</td><td class="NLM_def"><p class="first last">glucose-dependent insulinotropic peptide</p></td></tr><tr><td class="NLM_term">DPP-4</td><td class="NLM_def"><p class="first last">dipeptidyl peptidase-4</p></td></tr><tr><td class="NLM_term">LPC</td><td class="NLM_def"><p class="first last">lysophosphatidylcholine</p></td></tr><tr><td class="NLM_term">OEA</td><td class="NLM_def"><p class="first last">oleoylethanolamide</p></td></tr><tr><td class="NLM_term">NAPE</td><td class="NLM_def"><p class="first last"><i>N</i>-acylethanolamide</p></td></tr><tr><td class="NLM_term">OLDA</td><td class="NLM_def"><p class="first last"><i>N</i>-oleoyldopamine</p></td></tr><tr><td class="NLM_term">DHPP</td><td class="NLM_def"><p class="first last">6,7-dihydro-5<i>H</i>-pyrrolopyrimidine</p></td></tr><tr><td class="NLM_term">DIAD</td><td class="NLM_def"><p class="first last">diisopropyl azodicarboxylate</p></td></tr><tr><td class="NLM_term">1,2-DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">pEC<sub>50</sub></td><td class="NLM_def"><p class="first last">negative logarithm of the EC<sub>50</sub></p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">effective concentration at half-maximal response</p></td></tr><tr><td class="NLM_term">av</td><td class="NLM_def"><p class="first last">average</p></td></tr><tr><td class="NLM_term">StDev</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">AUC<sub>0–24h</sub></td><td class="NLM_def"><p class="first last">area under the curve from 0 to 24 h</p></td></tr><tr><td class="NLM_term">DNAUC<sub>0–24h</sub></td><td class="NLM_def"><p class="first last">dose normalized area under the curve from 0 to 24 h</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">Cl<sub>b</sub></td><td class="NLM_def"><p class="first last">blood clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">KO</td><td class="NLM_def"><p class="first last">knockout</p></td></tr><tr><td class="NLM_term">PYY</td><td class="NLM_def"><p class="first last">peptide YY</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">Sprague–Dawley</p></td></tr><tr><td class="NLM_term">nd</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">HPMC</td><td class="NLM_def"><p class="first last">hydroxypropylmethylcellulose</p></td></tr><tr><td class="NLM_term">HP-β-CD</td><td class="NLM_def"><p class="first last">hydroxypropyl-β-cyclodextrin</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 43 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>National Diabetes Fact Sheet, 2011; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf" class="extLink">http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf</a> (accessed November 7,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Diabetes+Fact+Sheet%2C+2011%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2011%3B+http%3A%2F%2Fwww.cdc.gov%2Fdiabetes%2Fpubs%2Fpdf%2Fndfs_2011.pdf+%28accessed+November+7%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNational%2520Diabetes%2520Fact%2520Sheet%252C%25202011%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2011%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Wild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roglic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, H.</span><span> </span><span class="NLM_article-title">Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.2337%2Fdiacare.27.5.1047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=15111519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1047-1053&author=S.+Wildauthor=G.+Roglicauthor=A.+Greenauthor=R.+Sicreeauthor=H.+King&title=Global+prevalence+of+diabetes%3A+Estimates+for+the+year+2000+and+projections+for+2030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span></div><div class="casAuthors">Wild Sarah; Roglic Gojka; Green Anders; Sicree Richard; King Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-53</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.  RESEARCH DESIGN AND METHODS:  Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030.  Urban and rural populations were considered separately for developing countries.  RESULTS:  The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030.  The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.  The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men.  The urban population in developing countries is projected to double between 2000 and 2030.  The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.  CONCLUSIONS:  These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant.  Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS1_5FBm4QLEbxh97K6Vt6fW6udTcc2eaciY9fVFetaLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D&md5=93096de002d513e4fdd49028be51d85d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.27.5.1047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.27.5.1047%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DS.%26aulast%3DRoglic%26aufirst%3DG.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DSicree%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DH.%26atitle%3DGlobal%2520prevalence%2520of%2520diabetes%253A%2520Estimates%2520for%2520the%2520year%25202000%2520and%2520projections%2520for%25202030%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D1047%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Koro, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedder, D. O.</span><span> </span><span class="NLM_article-title">Glycemic Control From 1988 to 2000 among U.S. Adults Diagnosed with Type 2 Diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=17-20&author=C.+E.+Koroauthor=S.+J.+Bowlinauthor=N.+Bourgeoisauthor=D.+O.+Fedder&title=Glycemic+Control+From+1988+to+2000+among+U.S.+Adults+Diagnosed+with+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoro%26aufirst%3DC.%2BE.%26aulast%3DBowlin%26aufirst%3DS.%2BJ.%26aulast%3DBourgeois%26aufirst%3DN.%26aulast%3DFedder%26aufirst%3DD.%2BO.%26atitle%3DGlycemic%2520Control%2520From%25201988%2520to%25202000%2520among%2520U.S.%2520Adults%2520Diagnosed%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Philippe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raccah, D.</span><span> </span><span class="NLM_article-title">Treating type 2 diabetes: how safe are current therapeutic agents?</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1111%2Fj.1742-1241.2008.01980.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=19196370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVKms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=321-332&author=J.+Philippeauthor=D.+Raccah&title=Treating+type+2+diabetes%3A+how+safe+are+current+therapeutic+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Treating type 2 diabetes: how safe are current therapeutic agents?</span></div><div class="casAuthors">Philippe, J.; Raccah, D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-332</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sulfonylureas (SUs) and biguanides (metformin) are the current mainstays in the treatment of type 2 diabetes (T2DM) and represent the most commonly used oral hypoglycemic agents (OHAs).  In recent years, a variety of new OHAs have become available, including thiazolidinediones, glinides, α-glucosidase inhibitors, glucagon-like peptide-1 agonists, amylin analogs and dipeptidyl peptidase-IV inhibitors, providing physicians with a larger therapeutic catalog than ever before.  The traditional drugs metformin and SUs have an established safety profile through long-term use.  However, long-term clin. trials and routine use are lacking for many of the new agents, and some potentially serious side effects have been reported with several of these compds.  Until adequate data is obtained, it is difficult to assess the risk-benefit ratio of these agents in relation to the traditional drugs.  Until that becomes fully documented, it may be wise to start pharmacol. treatment of patients on an individual basis, weighing the benefits and costs of each medication.  Thus, there remains a place for well-established drugs that have a proven safety record and are supported by years of clin. use for the treatment of T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy-QJ6BKnjvrVg90H21EOLACvtfcHk0li9JnGkFEiL7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVKms7w%253D&md5=097fdaf5f7b7e98c3f2b1b86914f0abe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2008.01980.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2008.01980.x%26sid%3Dliteratum%253Aachs%26aulast%3DPhilippe%26aufirst%3DJ.%26aulast%3DRaccah%26aufirst%3DD.%26atitle%3DTreating%2520type%25202%2520diabetes%253A%2520how%2520safe%2520are%2520current%2520therapeutic%2520agents%253F%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2009%26volume%3D63%26spage%3D321%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilsbøll, T.</span><span> </span><span class="NLM_article-title">Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1111%2Fj.1742-1241.2009.02086.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=19624785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=1154-1160&author=K.+B.+Hansenauthor=F.+K.+Knopauthor=J.+J.+Holstauthor=T.+Vilsb%C3%B8ll&title=Treatment+of+type+2+diabetes+with+glucagon-like+peptide-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists</span></div><div class="casAuthors">Hansen, K. B.; Knop, F. K.; Holst, J. J.; Vilsboell, T.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1154-1160</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The incretin system is an area of great interest for the development of new therapies for the management of type 2 diabetes.  Existing antidiabetic drugs are often insufficient at getting patients to glycemic goals.  Furthermore, current treatment modalities are not able to prevent the continued ongoing decline in pancreatic beta-cell function and, lastly, they have a no. of side effects including hypoglycemia and wt. gain.  Glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of pharmacol. agents, which improve glucose homeostasis in a multifaceted way.  Their effects include potentiation of glucose-stimulated insulin secretion, glucose-dependent inhibition of glucagon secretion and redn. in gastric emptying, appetite, food intake and body wt.  Addnl., preclin. data suggest that they may preserve beta-cell mass and function.  The incidence of hypoglycemia with GLP-1 receptor agonists is low, the compds. have clin. relevant effects on body wt., and data are suggesting beneficial effects on cardiovascular risk factors.  Exenatide was released in 2005 for the treatment of type 2 diabetes and liraglutide is expected to be approved by the Food and Drug Administration in US and the European Medical Agency in Europe for use in 2009.  In this review, the available data on the two drugs are presented and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCOv1S4HptubVg90H21EOLACvtfcHk0li9JnGkFEiL7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVeqsbg%253D&md5=9a0bc77ce997e69140ecc6c81b46ced5</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2009.02086.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2009.02086.x%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DVilsb%25C3%25B8ll%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520type%25202%2520diabetes%2520with%2520glucagon-like%2520peptide-1%2520receptor%2520agonists%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2009%26volume%3D63%26spage%3D1154%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mohler, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Recent and Emerging Anti-Diabetes Targets</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1002%2Fmed.20142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=18855890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Srtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=125-195&author=M.+L.+Mohlerauthor=Y.+Heauthor=Z.+Wuauthor=D.+J.+Hwangauthor=D.+D.+Miller&title=Recent+and+Emerging+Anti-Diabetes+Targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent and emerging anti-diabetes targets</span></div><div class="casAuthors">Mohler, Michael L.; He, Yali; Wu, Zhongzhi; Hwang, Dong Jin; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-195</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Diabetes is a disease that affects over 150 million people worldwide for which there are multiple oral and injectable medications.  Because of trends in obesity and sedentary lifestyles, diabetes rates in both developed and developing countries are increasing at an alarming rate.  Current medications are not adequately effective in maintaining long-term glycemic control in most patients, even when used in combination, leaving diabetics susceptible to developing life threatening and debilitating complications such as cardiovascular disease, blindness, kidney complications, and amputations.  Consequently, there is a crit. need for more potent pharmacotherapies with novel mechanisms of action.  A panel of 20 emerging diabetes targets is presented, and small mol. modulators for each target will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHxHdB-PSdtbVg90H21EOLACvtfcHk0li8YXvmlU0jUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Srtb4%253D&md5=78fd3b689994598729ad2f77c2030c75</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fmed.20142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20142%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DRecent%2520and%2520Emerging%2520Anti-Diabetes%2520Targets%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D125%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ashiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. E.</span><span> </span><span class="NLM_article-title">Non-insulin therapies for type 2 diabetes</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=777-778&author=M.+Ashiyaauthor=R.+E.+Smith&title=Non-insulin+therapies+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshiya%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%2BE.%26atitle%3DNon-insulin%2520therapies%2520for%2520type%25202%2520diabetes%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D777%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Soga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushime, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span> </span><span class="NLM_article-title">Lyophosphatidylcholine enhances glucose-dependent insulin secretion via orphan G-protein-coupled receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2005&pages=744-751&author=T.+Sogaauthor=T.+Ohishiauthor=T.+Matsuiauthor=T.+Saitoauthor=M.+Matsumotoauthor=J.+Takasakiauthor=S.+Matsumotoauthor=M.+Kamoharaauthor=H.+Hiyamaauthor=S.+Yoshidaauthor=K.+Momoseauthor=Y.+Uedaauthor=H.+Matsushimeauthor=M.+Koboriauthor=K.+Furuichi&title=Lyophosphatidylcholine+enhances+glucose-dependent+insulin+secretion+via+orphan+G-protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DTakasaki%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DKamohara%26aufirst%3DM.%26aulast%3DHiyama%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DMomose%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMatsushime%26aufirst%3DH.%26aulast%3DKobori%26aufirst%3DM.%26aulast%3DFuruichi%26aufirst%3DK.%26atitle%3DLyophosphatidylcholine%2520enhances%2520glucose-dependent%2520insulin%2520secretion%2520via%2520orphan%2520G-protein-coupled%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D326%26spage%3D744%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fredriksson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höglund, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloriam, D. E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerström, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiöth, H. B.</span><span> </span><span class="NLM_article-title">Seven evolutionary conserved human rhodopsin G protein-coupled receptors lacking close relatives</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">554</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=554&publication_year=2003&pages=381-388&author=R.+Fredrikssonauthor=P.+J.+H%C3%B6glundauthor=D.+E.+I.+Gloriamauthor=M.+C.+Lagerstr%C3%B6mauthor=H.+B.+Schi%C3%B6th&title=Seven+evolutionary+conserved+human+rhodopsin+G+protein-coupled+receptors+lacking+close+relatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DH%25C3%25B6glund%26aufirst%3DP.%2BJ.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%2BI.%26aulast%3DLagerstr%25C3%25B6m%26aufirst%3DM.%2BC.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DSeven%2520evolutionary%2520conserved%2520human%2520rhodopsin%2520G%2520protein-coupled%2520receptors%2520lacking%2520close%2520relatives%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D554%26spage%3D381%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bonini, J. A.; Borowsky, B. E.; Adham, N.; Boyle, N.; Thompson, T. O.</span><span> </span><span class="NLM_article-title">DNA encoding SNORF25 receptor</span>. US Patent 6,221,660-B1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+A.+Bonini&author=B.+E.+Borowsky&author=N.+Adham&author=N.+Boyle&author=T.+O.+Thompson&title=DNA+encoding+SNORF25+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonini%26aufirst%3DJ.%2BA.%26atitle%3DDNA%2520encoding%2520SNORF25%2520receptor%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bonini, J. A.; Borowsky, B. E.; Adham, N.; Boyle, N.; Thompson, T. O.</span><span> </span><span class="NLM_article-title">Methods of identifying compounds that bind to SNORF25 receptors</span>. US Patent 6,468,756-B1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+A.+Bonini&author=B.+E.+Borowsky&author=N.+Adham&author=N.+Boyle&author=T.+O.+Thompson&title=Methods+of+identifying+compounds+that+bind+to+SNORF25+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonini%26aufirst%3DJ.%2BA.%26atitle%3DMethods%2520of%2520identifying%2520compounds%2520that%2520bind%2520to%2520SNORF25%2520receptors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sakamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itakura, M.</span><span> </span><span class="NLM_article-title">Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=474-480&author=Y.+Sakamotoauthor=H.+Inoueauthor=S.+Kawakamiauthor=K.+Miyawakiauthor=T.+Miyamotoauthor=K.+Mizutaauthor=M.+Itakura&title=Expression+and+distribution+of+Gpr119+in+the+pancreatic+islets+of+mice+and+rats%3A+predominant+localization+in+pancreatic+polypeptide-secreting+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DKawakami%26aufirst%3DS.%26aulast%3DMiyawaki%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DT.%26aulast%3DMizuta%26aufirst%3DK.%26aulast%3DItakura%26aufirst%3DM.%26atitle%3DExpression%2520and%2520distribution%2520of%2520Gpr119%2520in%2520the%2520pancreatic%2520islets%2520of%2520mice%2520and%2520rats%253A%2520predominant%2520localization%2520in%2520pancreatic%2520polypeptide-secreting%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D351%26spage%3D474%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moloney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mondala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span> </span><span class="NLM_article-title">A Role for β-Cell-Expressing G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=2601-2609&author=Z.-L.+Chuauthor=R.+M.+Jonesauthor=H.+Heauthor=C.+Carrollauthor=V.+Gutierrezauthor=A.+Lucmanauthor=M.+Moloneyauthor=H.+Gaoauthor=H.+Mondalaauthor=D.+Bagnolauthor=D.+Unettauthor=Y.+Liangauthor=K.+Demarestauthor=G.+Sempleauthor=D.+P.+Behanauthor=J.+Leonard&title=A+Role+for+%CE%B2-Cell-Expressing+G+Protein-Coupled+Receptor+119+in+Glycemic+Control+by+Enhancing+Glucose-Dependent+Insulin+Release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DGutierrez%26aufirst%3DV.%26aulast%3DLucman%26aufirst%3DA.%26aulast%3DMoloney%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DMondala%26aufirst%3DH.%26aulast%3DBagnol%26aufirst%3DD.%26aulast%3DUnett%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DJ.%26atitle%3DA%2520Role%2520for%2520%25CE%25B2-Cell-Expressing%2520G%2520Protein-Coupled%2520Receptor%2520119%2520in%2520Glycemic%2520Control%2520by%2520Enhancing%2520Glucose-Dependent%2520Insulin%2520Release%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D2601%26epage%3D2609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mondala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span> </span><span class="NLM_article-title">A Role for Intestinal Endocrine Cell-Expressing G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">2038</span><span class="NLM_x">–</span> <span class="NLM_lpage">2647</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=2038-2647&author=Z.-L.+Chuauthor=C.+Carrollauthor=J.+Alfonsoauthor=V.+Gutierrezauthor=H.+Heauthor=A.+Lucmanauthor=M.+Pedrazaauthor=H.+Mondalaauthor=H.+Gaoauthor=D.+Bagnolauthor=R.+Chenauthor=R.+M.+Jonesauthor=D.+P.+Behanauthor=J.+Leonard&title=A+Role+for+Intestinal+Endocrine+Cell-Expressing+G+Protein-Coupled+Receptor+119+in+Glycemic+Control+by+Enhancing+Glucagon-Like+Peptide-1+and+Glucose-Dependent+Insulinotropic+Peptide+Release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DAlfonso%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DV.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLucman%26aufirst%3DA.%26aulast%3DPedraza%26aufirst%3DM.%26aulast%3DMondala%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DBagnol%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DJ.%26atitle%3DA%2520Role%2520for%2520Intestinal%2520Endocrine%2520Cell-Expressing%2520G%2520Protein-Coupled%2520Receptor%2520119%2520in%2520Glycemic%2520Control%2520by%2520Enhancing%2520Glucagon-Like%2520Peptide-1%2520and%2520Glucose-Dependent%2520Insulinotropic%2520Peptide%2520Release%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D2038%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parker, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, F.</span><span> </span><span class="NLM_article-title">Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=289-298&author=H.+E.+Parkerauthor=A.+M.+Habibauthor=G.+J.+Rogersauthor=F.+M.+Gribbleauthor=F.+Reimann&title=Nutrient-dependent+secretion+of+glucose-dependent+insulinotropic+polypeptide+from+primary+murine+K+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DH.%2BE.%26aulast%3DHabib%26aufirst%3DA.%2BM.%26aulast%3DRogers%26aufirst%3DG.%2BJ.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DReimann%26aufirst%3DF.%26atitle%3DNutrient-dependent%2520secretion%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520from%2520primary%2520murine%2520K%2520cells%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Jones, R. M.; Leonard, J. N.</span><span> </span><span class="NLM_article-title">The Emergence of GPR119 Agonists as Anti-Diabetic Agents</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>, Vol.  <span class="NLM_volume">44</span>; <span class="NLM_contrib-group">Macor, J. E.; Stamford, A. W.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=149-170&author=R.+M.+Jones&author=J.+N.+Leonardauthor=J.+E.+Macor&author=A.+W.+Stamford&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DThe%2520Emergence%2520of%2520GPR119%2520Agonists%2520as%2520Anti-Diabetic%2520Agents%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26volume%3D44%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26pub%3DAcademic%2520Press%26date%3D2009%26spage%3D149%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasamison, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang-Christensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1016%2Fj.cmet.2006.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=16517404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=167-175&author=H.+A.+Overtonauthor=A.+J.+Babbsauthor=S.+M.+Doelauthor=M.+C.+T.+Fyfeauthor=L.+S.+Gardnerauthor=G.+Griffinauthor=H.+C.+Jacksonauthor=M.+J.+Procterauthor=C.+M.+Rasamisonauthor=M.+Tang-Christensenauthor=P.+S.+Widdowsonauthor=G.+M.+Williamsauthor=C.+Reynet&title=Deorphanization+of+a+G+protein-coupled+receptor+for+oleoylethanolamide+and+its+use+in+the+discovery+of+small-molecule+hypophagic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span></div><div class="casAuthors">Overton, Hilary A.; Babbs, Adam J.; Doel, Sheila M.; Fyfe, Matthew C. T.; Gardner, Lisa S.; Griffin, Graeme; Jackson, Helen C.; Procter, Martin J.; Rasamison, Chrystelle M.; Tang-Christensen, Mads; Widdowson, Peter S.; Williams, Geoffery M.; Reynet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body wt. gain in rat feeding models.  This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor.  Furthermore, we have used the recombinant receptor to discover novel selective small-mol. GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body wt. gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats.  GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8xt3VqDV07Vg90H21EOLACvtfcHk0lgkzTpMXo_LIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D&md5=85c2756aa0809be0069ea515e2a1574d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DDoel%26aufirst%3DS.%2BM.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DGardner%26aufirst%3DL.%2BS.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DRasamison%26aufirst%3DC.%2BM.%26aulast%3DTang-Christensen%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BM.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DDeorphanization%2520of%2520a%2520G%2520protein-coupled%2520receptor%2520for%2520oleoylethanolamide%2520and%2520its%2520use%2520in%2520the%2520discovery%2520of%2520small-molecule%2520hypophagic%2520agents%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Gillum, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamison, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanabrough, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duenas, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acylphosphatidylethanolamine, a Gut-Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=813-824&author=M.+P.+Gillumauthor=D.+Zhangauthor=X.-M.+Zhangauthor=D.+M.+Erionauthor=R.+A.+Jamisonauthor=C.+Choiauthor=J.+Dongauthor=M.+Shanabroughauthor=H.+R.+Duenasauthor=D.+W.+Frederickauthor=J.+J.+Hsiaoauthor=T.+L.+Horvathauthor=C.+M.+Loauthor=P.+Tsoauthor=G.+W.+Clineauthor=G.+I.+Shulman&title=N-Acylphosphatidylethanolamine%2C+a+Gut-Derived+Circulating+Factor+Induced+by+Fat+Ingestion%2C+Inhibits+Food+Intake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillum%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.-M.%26aulast%3DErion%26aufirst%3DD.%2BM.%26aulast%3DJamison%26aufirst%3DR.%2BA.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DShanabrough%26aufirst%3DM.%26aulast%3DDuenas%26aufirst%3DH.%2BR.%26aulast%3DFrederick%26aufirst%3DD.%2BW.%26aulast%3DHsiao%26aufirst%3DJ.%2BJ.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DLo%26aufirst%3DC.%2BM.%26aulast%3DTso%26aufirst%3DP.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26atitle%3DN-Acylphosphatidylethanolamine%252C%2520a%2520Gut-Derived%2520Circulating%2520Factor%2520Induced%2520by%2520Fat%2520Ingestion%252C%2520Inhibits%2520Food%2520Intake%26jtitle%3DCell%26date%3D2008%26volume%3D135%26spage%3D813%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span> </span><span class="NLM_article-title"><i>N</i>-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1210%2Fme.2009-0239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=19901198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=161-170&author=Z.-L.+Chuauthor=C.+Carrollauthor=R.+Chenauthor=J.+Alfonsoauthor=V.+Gutierrezauthor=H.+Heauthor=A.+Lucmanauthor=C.+Xingauthor=K.+Sebringauthor=J.+Zhouauthor=B.+Wagnerauthor=D.+Unettauthor=R.+M.+Jonesauthor=D.+P.+Behanauthor=J.+Leonard&title=N-Oleoyldopamine+Enhances+Glucose+Homeostasis+through+the+Activation+of+GPR119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119</span></div><div class="casAuthors">Chu, Zhi-Liang; Carroll, Chris; Chen, Ruoping; Alfonso, Jean; Gutierrez, Veronica; He, Hongmei; Lucman, Annette; Xing, Charles; Sebring, Kristen; Zhou, Jinyao; Wagner, Brandee; Unett, David; Jones, Robert M.; Behan, Dominic P.; Leonard, James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">G protein-coupled receptor 119 (GPR119) is largely restricted to pancreatic insulin-producing β-cells and intestinal glucagon-like peptide-1-producing L-cells.  Synthetic agonists of this receptor elicit glucose-dependent release of these endocrine factors, thereby enhancing glycemic control.  Oleoylethanolamide also activates GPR119, but it remains unclear whether endogenous prodn. of this lipid modulates GPR119 activity under normal or dysglycemic conditions.  We show here that a relatively diverse set of lipid amides activate GPR119.  Among these, the endovallinoid N-oleoyldopamine (OLDA) stimulated cAMP accumulation in GPR119-transfected cells as effectively as oleoylethanolamide and the previously described synthetic agonist AR 231453.  None of these lipid amides increased cAMP in control-transfected cells or in cells transfected with a no. of other G protein-coupled receptors.  OLDA stimulated both cAMP accumulation and insulin release in HIT-T15 cells, which express GPR119 endogenously, and in GPR119-transfected RIN-5F cells.  Oral administration of OLDA to C57bl/6 mice elicited significant improvement in glucose tolerance, whereas GPR119-deficient mice were essentially unresponsive.  OLDA also acutely elevated plasma gastric inhibitory peptide levels, a known hallmark of GPR119 activation.  OLDA represents a possible paracrine modulator of GPR119 in pancreatic islets, where markers of dopamine synthesis correlated well with GPR119 expression.  However, no such correlation was seen in the colon.  Collectively, these studies indicate that multiple, distinct classes of lipid amides, acting via GPR119, may be important modulators of glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbj9QqAT_6VbVg90H21EOLACvtfcHk0liGONa6mT-3lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVGhtg%253D%253D&md5=e5248ec2e73719f06dfd9256bab07916</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0239%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DAlfonso%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DV.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLucman%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DSebring%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DUnett%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DJ.%26atitle%3DN-Oleoyldopamine%2520Enhances%2520Glucose%2520Homeostasis%2520through%2520the%2520Activation%2520of%2520GPR119%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kogure, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyamuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span> </span><span class="NLM_article-title">5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2011&pages=58-63&author=R.+Kogureauthor=K.+Toyamaauthor=S.+Hiyamutaauthor=I.+Kojimaauthor=S.+Takeda&title=5-Hydroxy-eicosapentaenoic+acid+is+an+endogenous+GPR119+agonist+and+enhances+glucose-dependent+insulin+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKogure%26aufirst%3DR.%26aulast%3DToyama%26aufirst%3DK.%26aulast%3DHiyamuta%26aufirst%3DS.%26aulast%3DKojima%26aufirst%3DI.%26aulast%3DTakeda%26aufirst%3DS.%26atitle%3D5-Hydroxy-eicosapentaenoic%2520acid%2520is%2520an%2520endogenous%2520GPR119%2520agonist%2520and%2520enhances%2520glucose-dependent%2520insulin%2520secretion%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D416%26spage%3D58%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Carpenter, A.; Ammala, C.; Briscoe, C.; Bullard, S.; Kashatus, J.; Katamreddy, S.; Mertz, R.; Ross, S.</span><span> </span><span class="NLM_article-title">The in vitro and in vivo effects of a GPR119 agonist</span>. <span class="NLM_conf-name">Keystone Symposium, Diabetes Mellitis, Insulin Action and Resistance</span>, <span class="NLM_conf-loc">Breckenridge, CO</span>, <span class="NLM_conf-date">January 22–27, 2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Carpenter%2C+A.%3B+Ammala%2C+C.%3B+Briscoe%2C+C.%3B+Bullard%2C+S.%3B+Kashatus%2C+J.%3B+Katamreddy%2C+S.%3B+Mertz%2C+R.%3B+Ross%2C+S.+The+in+vitro+and+in+vivo+effects+of+a+GPR119+agonist.+Keystone+Symposium%2C+Diabetes+Mellitis%2C+Insulin+Action+and+Resistance%2C+Breckenridge%2C+CO%2C+January+22%E2%80%9327%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DA.%26atitle%3DThe%2520in%2520vitro%2520and%2520in%2520vivo%2520effects%2520of%2520a%2520GPR119%2520agonist" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lauffer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iakoubov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brubaker, P. L.</span><span> </span><span class="NLM_article-title">GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=1058-1066&author=L.+M.+Laufferauthor=R.+Iakoubovauthor=P.+L.+Brubaker&title=GPR119+Is+Essential+for+Oleoylethanolamide-Induced+Glucagon-Like+Peptide-1+Secretion+From+the+Intestinal+Enteroendocrine+L-Cell"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauffer%26aufirst%3DL.%2BM.%26aulast%3DIakoubov%26aufirst%3DR.%26aulast%3DBrubaker%26aufirst%3DP.%2BL.%26atitle%3DGPR119%2520Is%2520Essential%2520for%2520Oleoylethanolamide-Induced%2520Glucagon-Like%2520Peptide-1%2520Secretion%2520From%2520the%2520Intestinal%2520Enteroendocrine%2520L-Cell%26jtitle%3DDiabetes%26date%3D2009%26volume%3D58%26spage%3D1058%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Flock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=374-383&author=G.+Flockauthor=D.+Hollandauthor=Y.+Seinoauthor=D.+J.+Drucker&title=GPR119+Regulates+Murine+Glucose+Homeostasis+Through+Incretin+Receptor-Dependent+and+Independent+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlock%26aufirst%3DG.%26aulast%3DHolland%26aufirst%3DD.%26aulast%3DSeino%26aufirst%3DY.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DGPR119%2520Regulates%2520Murine%2520Glucose%2520Homeostasis%2520Through%2520Incretin%2520Receptor-Dependent%2520and%2520Independent%2520Mechanisms%26jtitle%3DEndocrinology%26date%3D2011%26volume%3D152%26spage%3D374%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parker, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, F.</span><span> </span><span class="NLM_article-title">Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=289-298&author=H.+E.+Parkerauthor=A.+M.+Habibauthor=G.+J.+Rogersauthor=F.+M.+Gribbleauthor=F.+Reimann&title=Nutrient-dependent+secretion+of+glucose-dependent+insulinotropic+polypeptide+from+primary+murine+K+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DH.%2BE.%26aulast%3DHabib%26aufirst%3DA.%2BM.%26aulast%3DRogers%26aufirst%3DG.%2BJ.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DReimann%26aufirst%3DF.%26atitle%3DNutrient-dependent%2520secretion%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520from%2520primary%2520murine%2520K%2520cells%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ammala, C.; Bullard, S.; Kashatus, J.; Katamreddy, S.; Way, J.; Carpenter, A.</span><span> </span><span class="NLM_article-title">GPR119 dependent hormone secretion: insulin, GLP-1 and more</span>. <span class="NLM_conf-name">Keystone Symposium, Islet and β-Cell Biology</span>, <span class="NLM_conf-loc">Snowbird, UT</span>, <span class="NLM_conf-date">April 6-11, 2008</span>,  <span class="NLM_fpage">Abstract 102</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ammala%2C+C.%3B+Bullard%2C+S.%3B+Kashatus%2C+J.%3B+Katamreddy%2C+S.%3B+Way%2C+J.%3B+Carpenter%2C+A.+GPR119+dependent+hormone+secretion%3A+insulin%2C+GLP-1+and+more.+Keystone+Symposium%2C+Islet+and+%CE%B2-Cell+Biology%2C+Snowbird%2C+UT%2C+April+6-11%2C+2008%2C+Abstract+102."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DAmmala%26aufirst%3DC.%26atitle%3DGPR119%2520dependent%2520hormone%2520secretion%253A%2520insulin%252C%2520GLP-1%2520and%2520more%26spage%3DAbstract%2520102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">GPR119 agonists for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1340</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1517%2F13543770903153878" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1340-1359&issue=10&author=R.+M.+Jonesauthor=J.+N.+Leonardauthor=D.+J.+Buzardauthor=J.+Lehmann&title=GPR119+agonists+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543770903153878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903153878%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DLeonard%26aufirst%3DJ.%2BN.%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DGPR119%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26issue%3D10%26spage%3D1340%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">S76</span><span class="NLM_x">–</span> <span class="NLM_lpage">S81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=S76-S81&author=H.+A.+Overtonauthor=M.+C.+T.+Fyfeauthor=C.+Reynet&title=GPR119%2C+a+novel+G+protein-coupled+receptor+target+for+the+treatment+of+type+2+diabetes+and+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DGPR119%252C%2520a%2520novel%2520G%2520protein-coupled%2520receptor%2520target%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520and%2520obesity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3DS76%26epage%3DS81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=403-413&author=M.+C.+T.+Fyfeauthor=J.+G.+McCormackauthor=H.+A.+Overtonauthor=M.+J.+Procterauthor=C.+Reynet&title=GPR119+agonists+as+potential+new+oral+agents+for+the+treatment+of+type+2+diabetes+and+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DMcCormack%26aufirst%3DJ.%2BG.%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DGPR119%2520agonists%2520as%2520potential%2520new%2520oral%2520agents%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520and%2520obesity%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jones, R. M.; Semple, G.; Xiong, Y.; Shin, Y.-J.; Ren, A. S.; Calderon, I.; Fioravanti, B.; Choi, J. S. K.; Sage, C. R.</span><span> </span><span class="NLM_article-title">Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto</span>. WO 2005/007658A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+M.+Jones&author=G.+Semple&author=Y.+Xiong&author=Y.-J.+Shin&author=A.+S.+Ren&author=I.+Calderon&author=B.+Fioravanti&author=J.+S.+K.+Choi&author=C.+R.+Sage&title=Fused-aryl+and+heteroaryl+derivatives+as+modulators+of+metabolism+and+the+prophylaxis+and+treatment+of+disorders+related+thereto"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DFused-aryl%2520and%2520heteroaryl%2520derivatives%2520as%2520modulators%2520of%2520metabolism%2520and%2520the%2520prophylaxis%2520and%2520treatment%2520of%2520disorders%2520related%2520thereto%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioravanti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5172</span><span class="NLM_x">–</span> <span class="NLM_lpage">5175</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5172-5175&author=G.+Sempleauthor=B.+Fioravantiauthor=G.+Pereiraauthor=I.+Calderonauthor=J.+Uyauthor=K.+Choiauthor=Y.+Xiongauthor=A.+Renauthor=M.+Morganauthor=V.+Daveauthor=W.+Thomsenauthor=D.+J.+Unettauthor=C.+Xingauthor=S.+Bossieauthor=C.+Carrollauthor=Z.-L.+Chuauthor=A.+J.+Grottickauthor=E.+K.+Hauserauthor=J.+Leonardauthor=R.+M.+Jones&title=Discovery+of+the+First+Potent+and+Orally+Efficacious+Agonist+of+the+Orphan+G-Protein+Coupled+Receptor+119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119</span></div><div class="casAuthors">Semple, Graeme; Fioravanti, Beatriz; Pereira, Guillherme; Calderon, Imelda; Uy, Jane; Choi, Karoline; Xiong, Yifeng; Ren, Albert; Morgan, Michael; Dave, Vibha; Thomsen, William; Unett, David J.; Xing, Charles; Bossie, Stuart; Carroll, Chris; Chu, Zhi-Liang; Grottick, Andrew J.; Hauser, Erin K.; Leonard, James; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5172-5175</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR119 is a rhodopsin-like GPCR expressed in pancreatic β-cells and incretin releasing cells in the GI tract.  As with incretins, GPR119 increases cAMP levels in these cell types, thus making it a highly attractive potential target for the treatment of diabetes.  The discovery of the first reported potent agonist of GPR119, (2-fluoro-4-methanesulfonylphenyl)-{6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitro-pyrimidin-4-yl}-amine (8g, AR231453), is described starting from an initial inverse agonist screening hit.  Compd. 8g showed in vivo activity in rodents and was active in an oral glucose tolerance test in mice following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhpbZwXhitc7Vg90H21EOLACvtfcHk0liN7CGkq4SByg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslahuro%253D&md5=92b03eb4e221bb3956c59a486758016e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8006867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006867%26sid%3Dliteratum%253Aachs%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DFioravanti%26aufirst%3DB.%26aulast%3DPereira%26aufirst%3DG.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DUy%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DDave%26aufirst%3DV.%26aulast%3DThomsen%26aufirst%3DW.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DBossie%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DHauser%26aufirst%3DE.%2BK.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Potent%2520and%2520Orally%2520Efficacious%2520Agonist%2520of%2520the%2520Orphan%2520G-Protein%2520Coupled%2520Receptor%2520119%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5172%26epage%3D5175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Katamreddy, S. R.; Caldwell, R. D.; Heyer, D.; Samano, V.; Thompson, J. B.; Carpenter, A. J.; Conlee, C. R.; Boros, E. E.; Thompson, B. D.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolo[2,3-<i>d</i>]pyrimidine derivatives as GPR119 agonists</span>. WO 2008/008887A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+R.+Katamreddy&author=R.+D.+Caldwell&author=D.+Heyer&author=V.+Samano&author=J.+B.+Thompson&author=A.+J.+Carpenter&author=C.+R.+Conlee&author=E.+E.+Boros&author=B.+D.+Thompson&title=Preparation+of+pyrrolo%5B2%2C3-d%5Dpyrimidine+derivatives+as+GPR119+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKatamreddy%26aufirst%3DS.%2BR.%26atitle%3DPreparation%2520of%2520pyrrolo%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520GPR119%2520agonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ammala, C.; Briscoe, C.</span><span> </span><span class="NLM_article-title">GPR119 agonists for the treatment of diabetes and related disorders</span>. WO 2008/008895A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+Ammala&author=C.+Briscoe&title=GPR119+agonists+for+the+treatment+of+diabetes+and+related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmmala%26aufirst%3DC.%26atitle%3DGPR119%2520agonists%2520for%2520the%2520treatment%2520of%2520diabetes%2520and%2520related%2520disorders%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">For a review, see:</p></div><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl halides and sulfonates</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1016%2FS0022-328X%2898%2901054-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=125-146&author=B.+H.+Yangauthor=S.+L.+Buchwald&title=Palladium-catalyzed+amination+of+aryl+halides+and+sulfonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed amination of aryl halides and sulfonates</span></div><div class="casAuthors">Yang, Bryant H.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">125-146</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">In this review, with 96 refs., the progress made in the Pd-catalyzed amination of aryl halides and sulfonates is described with particular attention given to applications in synthetic org. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmrEGXq9DOLVg90H21EOLACvtfcHk0lgtJV_qHIojog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsrw%253D&md5=ca681694d1700bbd4e02135465dc29e0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901054-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901054-7%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520halides%2520and%2520sulfonates%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D125%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span> </span><span class="NLM_article-title">Synthesis of aryl sulfones via <span class="smallcaps smallerCapital">l</span>-proline-promoted CuI-catalyzed coupling reaction of aryl halides with sulfinic acid salts</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2696</span><span class="NLM_x">–</span> <span class="NLM_lpage">2700</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo047758b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=2696-2700&author=W.+Zhuauthor=D.+Ma&title=Synthesis+of+aryl+sulfones+via+l-proline-promoted+CuI-catalyzed+coupling+reaction+of+aryl+halides+with+sulfinic+acid+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo047758b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo047758b%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520aryl%2520sulfones%2520via%2520l-proline-promoted%2520CuI-catalyzed%2520coupling%2520reaction%2520of%2520aryl%2520halides%2520with%2520sulfinic%2520acid%2520salts%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D2696%26epage%3D2700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gribble, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. H.</span><span> </span><span class="NLM_article-title">Reactions of sodium borohydride in acidic media; VI. Reduction of indoles with cyanoborohydride in acetic acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1055%2Fs-1977-24606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1977&pages=859-860&author=G.+W.+Gribbleauthor=J.+H.+Hoffman&title=Reactions+of+sodium+borohydride+in+acidic+media%3B+VI.+Reduction+of+indoles+with+cyanoborohydride+in+acetic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1055%2Fs-1977-24606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1977-24606%26sid%3Dliteratum%253Aachs%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DHoffman%26aufirst%3DJ.%2BH.%26atitle%3DReactions%2520of%2520sodium%2520borohydride%2520in%2520acidic%2520media%253B%2520VI.%2520Reduction%2520of%2520indoles%2520with%2520cyanoborohydride%2520in%2520acetic%2520acid%26jtitle%3DSynthesis%26date%3D1977%26volume%3D12%26spage%3D859%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><div class="note"><p class="first last">For a previously reported synthesis of 6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines, see: </p></div><span class="NLM_contrib-group">Di Fabio, R.; Marchionni, C.; Micheli, F.; Pasquarello, A.; Perini, B.; St.-Denis, Y.</span><span> </span><span class="NLM_article-title">Preparation of substituted 6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as corticotropin releasing factor antagonists</span>. WO 2002/100863A1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+Di+Fabio&author=C.+Marchionni&author=F.+Micheli&author=A.+Pasquarello&author=B.+Perini&author=Y.+St.-Denis&title=Preparation+of+substituted+6%2C7-dihydro-5H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+corticotropin+releasing+factor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFabio%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520substituted%25206%252C7-dihydro-5H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520corticotropin%2520releasing%2520factor%2520antagonists%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Boros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katamreddy, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. J.</span><span> </span><span class="NLM_article-title">Facile Reductive Amination of Aldehydes with Electron-Deficient Anilines by Acyloxyborohydrides in TFA: Application to a Diazaindoline Scale-Up</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">–</span> <span class="NLM_lpage">3590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo900157z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=3587-3590&author=E.+Borosauthor=J.+B.+Thompsonauthor=S.+R.+Katamreddyauthor=A.+J.+Carpenter&title=Facile+Reductive+Amination+of+Aldehydes+with+Electron-Deficient+Anilines+by+Acyloxyborohydrides+in+TFA%3A+Application+to+a+Diazaindoline+Scale-Up"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Facile Reductive Amination of Aldehydes with Electron-Deficient Anilines by Acyloxyborohydrides in TFA: Application to a Diazaindoline Scale-Up</span></div><div class="casAuthors">Boros, Eric E.; Thompson, James B.; Katamreddy, Subba R.; Carpenter, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3587-3590</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scale-up of diazaindoline I was achieved in four stages and 32% overall yield.  The key step involved rapid reductive amination of (4,6-dichloro-5-pyrimidinyl)acetaldehyde with 2-fluoro-4-(methylsulfonyl)aniline by sodium triacetoxyborohydride (STAB-H) and TFA followed by ring closure of an intermediate amine to I in the same pot.  These reaction conditions were also applied to facile reductive aminations with anilines known to have little reactivity under STAB-H/AcOH conditions.  Spectral data supported the tris(trifluoroacetoxy)borohydride anion as the active reducing agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8239xRckeLVg90H21EOLACvtfcHk0lgtJV_qHIojog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemtLY%253D&md5=48cadd9073736b14543b1e37d4021d04</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo900157z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900157z%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DKatamreddy%26aufirst%3DS.%2BR.%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26atitle%3DFacile%2520Reductive%2520Amination%2520of%2520Aldehydes%2520with%2520Electron-Deficient%2520Anilines%2520by%2520Acyloxyborohydrides%2520in%2520TFA%253A%2520Application%2520to%2520a%2520Diazaindoline%2520Scale-Up%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D3587%26epage%3D3590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shechter, H.</span><span> </span><span class="NLM_article-title">Dimethylformamide as a useful solvent in preparing nitriles from aryl halides and cuprous cyanide; improved isolation techniques</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2522</span><span class="NLM_x">–</span> <span class="NLM_lpage">2524</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01351a092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=2522-2524&author=L.+Friedmanauthor=H.+Shechter&title=Dimethylformamide+as+a+useful+solvent+in+preparing+nitriles+from+aryl+halides+and+cuprous+cyanide%3B+improved+isolation+techniques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo01351a092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01351a092%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DShechter%26aufirst%3DH.%26atitle%3DDimethylformamide%2520as%2520a%2520useful%2520solvent%2520in%2520preparing%2520nitriles%2520from%2520aryl%2520halides%2520and%2520cuprous%2520cyanide%253B%2520improved%2520isolation%2520techniques%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D2522%26epage%3D2524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hermann, W.</span><span> </span><span class="NLM_article-title">The Suzuki Cross-Coupling</span>. In  <span class="citation_source-book">From Applied Homogeneous Catalysis with Organometallic Compounds</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group">Cornils, B.; Herrmann, W. A.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">, </span>pp  <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1002%2F9783527618231.ch2k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=591-598&author=W.+Hermannauthor=B.+Cornils&author=W.+A.+Herrmann&title=From+Applied+Homogeneous+Catalysis+with+Organometallic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F9783527618231.ch2k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527618231.ch2k%26sid%3Dliteratum%253Aachs%26aulast%3DHermann%26aufirst%3DW.%26atitle%3DThe%2520Suzuki%2520Cross-Coupling%26btitle%3DFrom%2520Applied%2520Homogeneous%2520Catalysis%2520with%2520Organometallic%2520Compounds%26aulast%3DCornils%26aufirst%3DB.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%26date%3D2002%26spage%3D591%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Preparation of the thiocarbamates was accomplished by two different methods.</p></div><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">An example of a secondary, cyclic amine with <i>S</i>-methyl chlorothioformate in the presence of triethylamine:</p></div><span class="NLM_contrib-group">Fishbein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, H.</span><span> </span><span class="NLM_article-title">Synthesis and Antineoplastic Activity of 1a-Formyl and 1a-Thioformyl Derivatives of Mitomycin C and 2-Methylaziridine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00393a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1767-1773&author=P.+L.+Fishbeinauthor=H.+Kohn&title=Synthesis+and+Antineoplastic+Activity+of+1a-Formyl+and+1a-Thioformyl+Derivatives+of+Mitomycin+C+and+2-Methylaziridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjm00393a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00393a015%26sid%3Dliteratum%253Aachs%26aulast%3DFishbein%26aufirst%3DP.%2BL.%26aulast%3DKohn%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Antineoplastic%2520Activity%2520of%25201a-Formyl%2520and%25201a-Thioformyl%2520Derivatives%2520of%2520Mitomycin%2520C%2520and%25202-Methylaziridine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1767%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grzyb, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span> </span><span class="NLM_article-title">Carbamoylimidazolium salts as diversification reagents: an application to the synthesis of tertiary amides from carboxylic acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">7485</span><span class="NLM_x">–</span> <span class="NLM_lpage">7488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=7485-7488&author=J.+A.+Grzybauthor=R.+A.+Batey&title=Carbamoylimidazolium+salts+as+diversification+reagents%3A+an+application+to+the+synthesis+of+tertiary+amides+from+carboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrzyb%26aufirst%3DJ.%2BA.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DCarbamoylimidazolium%2520salts%2520as%2520diversification%2520reagents%253A%2520an%2520application%2520to%2520the%2520synthesis%2520of%2520tertiary%2520amides%2520from%2520carboxylic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D7485%26epage%3D7488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Danishefsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R. K.</span><span> </span><span class="NLM_article-title">A Highly Activated Cyclopropane for Homoconjugate Reactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">3239</span><span class="NLM_x">–</span> <span class="NLM_lpage">3241</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00844a065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1975&pages=3239-3241&author=S.+Danishefskyauthor=R.+K.+Singh&title=A+Highly+Activated+Cyclopropane+for+Homoconjugate+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja00844a065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00844a065%26sid%3Dliteratum%253Aachs%26aulast%3DDanishefsky%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26atitle%3DA%2520Highly%2520Activated%2520Cyclopropane%2520for%2520Homoconjugate%2520Reactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1975%26volume%3D97%26spage%3D3239%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Ravikumar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bégué, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet-Delpon, D.</span><span> </span><span class="NLM_article-title">A Selective Conversion of Sulfide to Sulfoxide in Hexafluoro-2-propanol</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3141</span><span class="NLM_x">–</span> <span class="NLM_lpage">3144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=3141-3144&author=K.+S.+Ravikumarauthor=J.-P.+B%C3%A9gu%C3%A9author=D.+Bonnet-Delpon&title=A+Selective+Conversion+of+Sulfide+to+Sulfoxide+in+Hexafluoro-2-propanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavikumar%26aufirst%3DK.%2BS.%26aulast%3DB%25C3%25A9gu%25C3%25A9%26aufirst%3DJ.-P.%26aulast%3DBonnet-Delpon%26aufirst%3DD.%26atitle%3DA%2520Selective%2520Conversion%2520of%2520Sulfide%2520to%2520Sulfoxide%2520in%2520Hexafluoro-2-propanol%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D3141%26epage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Stephens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devlin, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.-J.</span><span> </span><span class="NLM_article-title">The Determination of the Absolute Configurations of Chiral Molecules Using Vibrational Circular Dichroism (VCD) Spectroscopy</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1002%2Fchir.20477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=17955495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlCjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=643-663&author=P.+J.+Stephensauthor=F.+J.+Devlinauthor=J.-J.+Pan&title=The+Determination+of+the+Absolute+Configurations+of+Chiral+Molecules+Using+Vibrational+Circular+Dichroism+%28VCD%29+Spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The determination of the absolute configurations of chiral molecules using vibrational circular dichroism (VCD) spectroscopy</span></div><div class="casAuthors">Stephens, Philip J.; Devlin, Frank J.; Pan, Jian-Jung</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-663</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The vibrational CD (VCD) spectra of the two enantiomers of a chiral mol. are of equal magnitude and opposite sign: i.e. mirror-image enantiomers give mirror-image VCD spectra.  In principle, the abs. configuration (AC) of a chiral mol. can therefore be detd. from its VCD spectrum.  In practice, the detn. of the AC of a chiral mol. from its exptl. VCD spectrum requires a methodol. which reliably predicts the VCD spectra of its enantiomers.  The only reliable methodol. developed to date uses the Stephens quantum-mech. theory of the rotational strengths of fundamental vibrational transitions, developed in the early 1980s, implemented using ab initio d. functional theory in the GAUSSIAN program in the mid 1990s.  This methodol. has by now been widely used in detg. ACs from exptl. VCD spectra.  In this article we discuss the protocol for detg. the ACs of chiral mols. with optimum reliability and its implementation for a variety of mols., including the D3 symmetry perhydrotriphenylene, a thiazino-oxadiazolone recently shown to be a highly active calcium entry channel blocker, the alkaloid natural products schizozygine, iso-schizogaline, and iso-schizogamine, and the iridoid natural products plumericin, iso-plumericin, and prismatomerin.  The power of VCD spectroscopy in detg. ACs, even for large org. mols. and for substantially conformationally-flexible org. mols. is clearly documented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphb2yuC19HTLVg90H21EOLACvtfcHk0ljVveki9VSaVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlCjsb0%253D&md5=21c2c1bb7fafdd188978333ac828c860</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fchir.20477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.20477%26sid%3Dliteratum%253Aachs%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DDevlin%26aufirst%3DF.%2BJ.%26aulast%3DPan%26aufirst%3DJ.-J.%26atitle%3DThe%2520Determination%2520of%2520the%2520Absolute%2520Configurations%2520of%2520Chiral%2520Molecules%2520Using%2520Vibrational%2520Circular%2520Dichroism%2520%2528VCD%2529%2520Spectroscopy%26jtitle%3DChirality%26date%3D2008%26volume%3D20%26spage%3D643%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="note"><p class="first last">The assay consists of CHO-K1 6CRE-luciferase cells that stably express human GPR119 receptor plated at 15000 cells/well in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F12 (DMEM/F12), 5% fetal bovine serum (FBS), and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine in black 384-well assay plates. On the following day, the media is removed by aspiration and replaced with 20 μL of DMEM/F12, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (no FBS) utilizing a Matrix Multidrop. Test compounds (20 μL) are then pipetted into the assay plate using a Packard Minitrak. The plates are then incubated for 5 h at 37 °C. Under subdued light conditions, 15 μL of a 1:1 solution containing SteadyLite and Dulbecco’s Phosphate Biffered Saline with 1 mM CaCl<sub>2</sub> and 1 mM MgCl<sub>2</sub> is added to the plates using a Matrix Multidrop Plates are then sealed with self-adhesive clear plate seals and the amount of luciferase generated is quantified in a Wallac Viewlux. Compounds are also tested in the same manner against cells without the GPR119 receptor so as to check for false positives.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">All compounds are referenced to a small molecule GPR119 agonist for evaluation of intrinsic efficacy (%max response) because this reporter assay is not sensitive enough to demonstrate robust activity of putative endogenous ligands (OEA, LPC, etc.). Our experience with the ∼3000 compounds made for the program is that compounds with ∼80–200% max response are likely full agonists. Compounds with consistent levels of receptor activation below 80% may be partial agonists. The degree of variability in the assay accounts for the large range considered as full agonists. The structure of our standard compound <b>114</b>, with an EC<sub>50</sub> = 0.2 μM (max response = 100%), is shown below. This compound is reported<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> to have an EC<sub>50</sub> = 0.13 μM in a cAMP assay.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0023.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Jones, R. M.; Semple, G.; Fioravanti, B.; Pereira, G.; Calderon, I.; Uy, J.; Duvvuri, K.; Choi, J. S. K.; Xiong, Y.; Dave, V.</span><span> </span><span class="NLM_article-title">1,2,3-Trisubstituted Aryl and Heteroaryl Derivatives as Modulators of Metabolism and the Prophylaxis and Treatment of Disorders Related Thereto Such as Diabetes and Hyperglycemia</span>. WO 2004/065380 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+M.+Jones&author=G.+Semple&author=B.+Fioravanti&author=G.+Pereira&author=I.+Calderon&author=J.+Uy&author=K.+Duvvuri&author=J.+S.+K.+Choi&author=Y.+Xiong&author=V.+Dave&title=1%2C2%2C3-Trisubstituted+Aryl+and+Heteroaryl+Derivatives+as+Modulators+of+Metabolism+and+the+Prophylaxis+and+Treatment+of+Disorders+Related+Thereto+Such+as+Diabetes+and+Hyperglycemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3D1%252C2%252C3-Trisubstituted%2520Aryl%2520and%2520Heteroaryl%2520Derivatives%2520as%2520Modulators%2520of%2520Metabolism%2520and%2520the%2520Prophylaxis%2520and%2520Treatment%2520of%2520Disorders%2520Related%2520Thereto%2520Such%2520as%2520Diabetes%2520and%2520Hyperglycemia%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="note"><p class="first last">All studies were conducted after review by the GSK Institutional Animal Care and Use Committee and in accordance with the GSK Policy on the Care, Welfare and Treatment of Laboratory Animals.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asa, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">Glucagon Gene 5′-Flanking Sequences Direct Expression of Simian Virus 40 Large T Antigen to the Intestine, Producing Carcinoma of the Large Bowel in Transgenic Mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">10705</span><span class="NLM_x">–</span> <span class="NLM_lpage">10709</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=10705-10709&author=Y.+C.+Leeauthor=S.+L.+Asaauthor=D.+J.+Drucker&title=Glucagon+Gene+5%E2%80%B2-Flanking+Sequences+Direct+Expression+of+Simian+Virus+40+Large+T+Antigen+to+the+Intestine%2C+Producing+Carcinoma+of+the+Large+Bowel+in+Transgenic+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DAsa%26aufirst%3DS.%2BL.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DGlucagon%2520Gene%25205%25E2%2580%25B2-Flanking%2520Sequences%2520Direct%2520Expression%2520of%2520Simian%2520Virus%252040%2520Large%2520T%2520Antigen%2520to%2520the%2520Intestine%252C%2520Producing%2520Carcinoma%2520of%2520the%2520Large%2520Bowel%2520in%2520Transgenic%2520Mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D10705%26epage%3D10709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kaneko, T.; Kaneto, A.; Yanaihara, N.; Yasuda, H.; Suzuki, S.; Oka, H.; Oda, T.</span><span> </span><span class="NLM_article-title">Insulin and C-peptide secretion in animals</span>.  <span class="citation_source-book">Int. Congr. Ser.</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">468</span>, <div class="note"><p class="first last">Proinsulin, Insulin, C-Pept.</p></div>, pp  <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&pages=138-147&author=T.+Kaneko&author=A.+Kaneto&author=N.+Yanaihara&author=H.+Yasuda&author=S.+Suzuki&author=H.+Oka&author=T.+Oda&title=Int.+Congr.+Ser."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DT.%26atitle%3DInsulin%2520and%2520C-peptide%2520secretion%2520in%2520animals%26btitle%3DInt.%2520Congr.%2520Ser.%26date%3D1979%26volume%3D468%26spage%3D138%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">LAF-237 Novartis</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1094-1100&author=D.+Barlocco&title=LAF-237+Novartis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DLAF-237%2520Novartis%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1094%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Hatanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawarabayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuhama, K.</span><span> </span><span class="NLM_article-title">The Measurement of Gastric Emptying in Conscious Rats by Monitoring Serial Changes in Serum Acetaminophen Level</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1016%2F1056-8719%2894%2990079-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=8068978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADyaK2cXlsVyhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1994&pages=161-165&author=S.+Hatanakaauthor=M.+Kondohauthor=K.+Kawarabayashiauthor=K.+Furuhama&title=The+Measurement+of+Gastric+Emptying+in+Conscious+Rats+by+Monitoring+Serial+Changes+in+Serum+Acetaminophen+Level"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The measurement of gastric emptying in conscious rats by monitoring serial changes in serum acetaminophen level</span></div><div class="casAuthors">Hatanaka, Satoshi; Kondoh, Masaki; Kawarabayashi, Keiko; Furuhama, Kazuhisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-5</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">A method for evaluation of gastric emptying via monitoring serial serum levels of acetaminophen (APAP) as an indicator, without involving animal sacrifice, has been developed in conscious rats.  The authors administered orally suspended test meals of 0.5, 1,2, or 4 mL/rat each, contg. 20 mg APAP.  The animals were repeatedly bleed at 15, 30, 45, 60, or 90 min after APAP treatment.  Serum APAP level was detd. by a high-performance liq. chromatog.  As a result, a 2-mL meal was found optimal to attain continuous levels of APAP in serum.  The APAP method showed a close correlation (r = 0.77) with the phenol red method, a std. procedure for quant. detection of gastric emptying entailing rat sacrifice.  The blood loss (approx. 2 mL) resulting from the APAP method did not significantly modify the rate of gastric emptying.  In addn., data was presented to substantiate the validity of the APAP method in demonstrating enhancement and inhibition of gastric emptying using cisapride and cholecystokinin-octapeptide (CCK), resp.  These results suggest that the APAP method is easy, versatile, and reliable, and requires only a minimal no. of animals for the evaluation of sequential changes in gastric emptying.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_0zwZSDfXFbVg90H21EOLACvtfcHk0ljYrI86Pa6iLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsVyhsrc%253D&md5=7fd0cfe8014594a451f7244e644070fa</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2894%2990079-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252894%252990079-5%26sid%3Dliteratum%253Aachs%26aulast%3DHatanaka%26aufirst%3DS.%26aulast%3DKondoh%26aufirst%3DM.%26aulast%3DKawarabayashi%26aufirst%3DK.%26aulast%3DFuruhama%26aufirst%3DK.%26atitle%3DThe%2520Measurement%2520of%2520Gastric%2520Emptying%2520in%2520Conscious%2520Rats%2520by%2520Monitoring%2520Serial%2520Changes%2520in%2520Serum%2520Acetaminophen%2520Level%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D1994%26volume%3D31%26spage%3D161%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Roberts, B.; Gregoire, F. M.; Karpe, D. B.; Clemens, E.; Lavan, B.; Johnson, J.; McWherter, C. A.; Martin, R.; Wilson, M.</span><span> </span><span class="NLM_article-title">MBX-2982, a Novel Oral GPR119 Agonist for the Treatment of Type 2 Diabetes: Results of Single & Multiple Dose Studies</span>. <span class="NLM_conf-name">American Diabetes Association Meeting</span>, <span class="NLM_conf-loc">New Orleans, LA</span>, <span class="NLM_conf-date">2009</span>,  <span class="NLM_fpage">164-OR</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Roberts%2C+B.%3B+Gregoire%2C+F.+M.%3B+Karpe%2C+D.+B.%3B+Clemens%2C+E.%3B+Lavan%2C+B.%3B+Johnson%2C+J.%3B+McWherter%2C+C.+A.%3B+Martin%2C+R.%3B+Wilson%2C+M.+MBX-2982%2C+a+Novel+Oral+GPR119+Agonist+for+the+Treatment+of+Type+2+Diabetes%3A+Results+of+Single+%26+Multiple+Dose+Studies.+American+Diabetes+Association+Meeting%2C+New+Orleans%2C+LA%2C+2009%2C+164-OR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%26atitle%3DMBX-2982%252C%2520a%2520Novel%2520Oral%2520GPR119%2520Agonist%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%253A%2520Results%2520of%2520Single%2520%2526%2520Multiple%2520Dose%2520Studies%26spage%3D164-OR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Katz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vets, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarich, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, P. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1038%2Fclpt.2011.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=21975348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=685-692&issue=5&author=L.+B.+Katzauthor=J.+J.+Gambaleauthor=P.+L.+Rothenbergauthor=S.+R.+Vanapalliauthor=N.+Vaccaroauthor=L.+Xiauthor=D.+C.+Polidoriauthor=E.+Vetsauthor=T.+C.+Sarichauthor=P.+P.+Stein&title=Pharmacokinetics%2C+Pharmacodynamics%2C+Safety%2C+and+Tolerability+of+JNJ-38431055%2C+a+Novel+GPR119+Receptor+Agonist+and+Potential+Antidiabetes+Agent%2C+in+Healthy+Male+Subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span></div><div class="casAuthors">Katz, L. B.; Gambale, J. J.; Rothenberg, P. L.; Vanapalli, S. R.; Vaccaro, N.; Xi, L.; Polidori, D. C.; Vets, E.; Sarich, T. C.; Stein, P. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The incidence of type 2 diabetes mellitus is increasing worldwide.  Several G-protein-coupled receptor agonists are being studied for their efficacy as antidiabetes agents.  JNJ-38431055 is a novel, potent, and orally available selective agonist of the glucose-dependent insulinotropic (GPR119) receptor.  Double-blind, randomized, placebo-controlled studies were conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of JNJ-38431055 (2.5-800 mg) in healthy male volunteers.  The systemic exposure of JNJ-38431055 in plasma increased in proportion to the dose and was not influenced by coadministration of food.  The terminal elimination half-life was ∼13 h when administered as an oral suspension formulation.  JNJ-38431055 was well tolerated and was not assocd. with hypoglycemia.  As compared with placebo, single-dose oral JNJ-38431055 increased postmeal plasma glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and peptide YY (PYY) concns. but did not significantly decrease glucose excursion or increase insulin secretion.  However, in a graded glucose infusion study, JNJ-38431055 was shown to induce a higher insulin secretion rate (ISR) relative to placebo at elevated plasma glucose levels.  These studies provide evidence for the potential efficacy of JNJ-38431055 as an antidiabetes agent in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu9J3wfDOF_LVg90H21EOLACvtfcHk0ljYrI86Pa6iLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP&md5=a9345cd8b438a8568505c0ff327f522f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.169%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%2BB.%26aulast%3DGambale%26aufirst%3DJ.%2BJ.%26aulast%3DRothenberg%26aufirst%3DP.%2BL.%26aulast%3DVanapalli%26aufirst%3DS.%2BR.%26aulast%3DVaccaro%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DL.%26aulast%3DPolidori%26aufirst%3DD.%2BC.%26aulast%3DVets%26aufirst%3DE.%26aulast%3DSarich%26aufirst%3DT.%2BC.%26aulast%3DStein%26aufirst%3DP.%2BP.%26atitle%3DPharmacokinetics%252C%2520Pharmacodynamics%252C%2520Safety%252C%2520and%2520Tolerability%2520of%2520JNJ-38431055%252C%2520a%2520Novel%2520GPR119%2520Receptor%2520Agonist%2520and%2520Potential%2520Antidiabetes%2520Agent%252C%2520in%2520Healthy%2520Male%2520Subjects%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26issue%3D5%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Carpenter, A. J.</span><span> </span><span class="NLM_article-title">Discovery of GSK1292263A, a GPR119 Agonist for the Treatment of T2D</span>. <span class="NLM_conf-name">National Medicinal Chemistry Symposium</span>, <span class="NLM_conf-loc">Minneapolis, MN</span>, <span class="NLM_conf-date">2010</span>,  <span class="NLM_fpage">OS2–2</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Carpenter%2C+A.+J.+Discovery+of+GSK1292263A%2C+a+GPR119+Agonist+for+the+Treatment+of+T2D.+National+Medicinal+Chemistry+Symposium%2C+Minneapolis%2C+MN%2C+2010%2C+OS2%E2%80%932."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520GSK1292263A%252C%2520a%2520GPR119%2520Agonist%2520for%2520the%2520Treatment%2520of%2520T2D%26spage%3DOS2%25E2%2580%25932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Nuñez, D. J.; Bush, M. A.; Collins, D. A.; McMullen, S. L.; Feldman, P. L.; Jackson, T. D.; Ross, S. A.</span><span> </span><span class="NLM_article-title">Evaluation of GSK1292263, a Novel GPR119 Agonist, in Type 2 Diabetes Mellitus (T2DM): Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses</span>. <span class="NLM_conf-name">American Diabetes Association Meeting</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">2011</span>,  <span class="NLM_fpage">996-P</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nu%C3%B1ez%2C+D.+J.%3B+Bush%2C+M.+A.%3B+Collins%2C+D.+A.%3B+McMullen%2C+S.+L.%3B+Feldman%2C+P.+L.%3B+Jackson%2C+T.+D.%3B+Ross%2C+S.+A.+Evaluation+of+GSK1292263%2C+a+Novel+GPR119+Agonist%2C+in+Type+2+Diabetes+Mellitus+%28T2DM%29%3A+Safety%2C+Tolerability%2C+Pharmacokinetics+%28PK%29+and+Pharmacodynamics+%28PD%29+of+Single+and+Multiple+Doses.+American+Diabetes+Association+Meeting%2C+San+Diego%2C+CA%2C+2011%2C+996-P."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DNu%25C3%25B1ez%26aufirst%3DD.%2BJ.%26atitle%3DEvaluation%2520of%2520GSK1292263%252C%2520a%2520Novel%2520GPR119%2520Agonist%252C%2520in%2520Type%25202%2520Diabetes%2520Mellitus%2520%2528T2DM%2529%253A%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%2520%2528PK%2529%2520and%2520Pharmacodynamics%2520%2528PD%2529%2520of%2520Single%2520and%2520Multiple%2520Doses%26spage%3D996-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e'],'ref15':['cit15'],'ref16':['cit16a','cit16b'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':[],'ref32':[],'ref33':['cit33'],'ref34':['cit34'],'ref35':[],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kurt  Ritter</span>, <span class="hlFld-ContribAuthor ">Christian  Buning</span>, <span class="hlFld-ContribAuthor ">Nis  Halland</span>, <span class="hlFld-ContribAuthor ">Christoph  Pöverlein</span>, and <span class="hlFld-ContribAuthor ">Lothar  Schwink</span>  . </span><span class="cited-content_cbyCitation_article-title">G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3579-3592. <a href="https://doi.org/10.1021/acs.jmedchem.5b01198" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01198%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DG%252BProtein-Coupled%252BReceptor%252B119%252B%252528GPR119%252529%252BAgonists%252Bfor%252Bthe%252BTreatment%252Bof%252BDiabetes%25253A%252BRecent%252BProgress%252Band%252BPrevailing%252BChallenges%26aulast%3DRitter%26aufirst%3DKurt%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D30072015%26date%3D09112015%26date%3D28042016%26date%3D29102015%26volume%3D59%26issue%3D8%26spage%3D3579%26epage%3D3592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Suzanne S.  Bowker</span>, <span class="hlFld-ContribAuthor ">Katy J.  Brocklehurst</span>, <span class="hlFld-ContribAuthor ">Hayley S.  Brown</span>, <span class="hlFld-ContribAuthor ">David S.  Clarke</span>, <span class="hlFld-ContribAuthor ">Alison  Easter</span>, <span class="hlFld-ContribAuthor ">Anne  Ertan</span>, <span class="hlFld-ContribAuthor ">Kristin  Goldberg</span>, <span class="hlFld-ContribAuthor ">Julian A.  Hudson</span>, <span class="hlFld-ContribAuthor ">Stefan  Kavanagh</span>, <span class="hlFld-ContribAuthor ">David  Laber</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Leach</span>, <span class="hlFld-ContribAuthor ">Philip A.  MacFaul</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Martin</span>, <span class="hlFld-ContribAuthor ">Darren  McKerrecher</span>, <span class="hlFld-ContribAuthor ">Paul  Schofield</span>, <span class="hlFld-ContribAuthor ">Per H.  Svensson</span>, and <span class="hlFld-ContribAuthor ">Joanne  Teague</span>  . </span><span class="cited-content_cbyCitation_article-title">Circumventing Seizure Activity in a Series of G Protein Coupled Receptor 119 (GPR119) Agonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 8984-8998. <a href="https://doi.org/10.1021/jm5011012" title="DOI URL">https://doi.org/10.1021/jm5011012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5011012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5011012%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCircumventing%252BSeizure%252BActivity%252Bin%252Ba%252BSeries%252Bof%252BG%252BProtein%252BCoupled%252BReceptor%252B119%252B%252528GPR119%252529%252BAgonists%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D21072014%26date%3D03112014%26date%3D13112014%26date%3D06102014%26volume%3D57%26issue%3D21%26spage%3D8984%26epage%3D8998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ajay  Manaithiya</span>, <span class="hlFld-ContribAuthor ">Ozair  Alam</span>, <span class="hlFld-ContribAuthor ">Vrinda  Sharma</span>, <span class="hlFld-ContribAuthor ">Mohd.  Javed Naim</span>, <span class="hlFld-ContribAuthor ">Shruti  Mittal</span>, <span class="hlFld-ContribAuthor ">Imran A  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 104998. <a href="https://doi.org/10.1016/j.bioorg.2021.104998" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104998</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104998%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DGPR119%252Bagonists%25253A%252BNovel%252Btherapeutic%252Bagents%252Bfor%252Btype%252B2%252Bdiabetes%252Bmellitus%26aulast%3DManaithiya%26aufirst%3DAjay%26date%3D2021%26volume%3D113%26spage%3D104998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikita M.  Sotnikov</span>, <span class="hlFld-ContribAuthor ">Yurii А.  Kovygin</span>, <span class="hlFld-ContribAuthor ">Dmitrii Yu.  Vandyshev</span>, <span class="hlFld-ContribAuthor ">Irina V.  Ledenyova</span>, <span class="hlFld-ContribAuthor ">Yevgeniya А.  Kosheleva</span>, <span class="hlFld-ContribAuthor ">Oleg А.  Kozadyorov</span>, <span class="hlFld-ContribAuthor ">Khidmet S.  Shikhaliev</span>. </span><span class="cited-content_cbyCitation_article-title">Recyclization of N-arylitaconimides with carboximidamides – a novel efficient method for the synthesis of 2-(2-amino-6-oxo- 1,4,5,6-tetrahydropyrimidin-5-yl)acetanilides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2021,</strong> <em>57 </em>
                                    (2)
                                     , 154-158. <a href="https://doi.org/10.1007/s10593-021-02887-6" title="DOI URL">https://doi.org/10.1007/s10593-021-02887-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-021-02887-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-021-02887-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DRecyclization%252Bof%252BN-arylitaconimides%252Bwith%252Bcarboximidamides%252B%2525E2%252580%252593%252Ba%252Bnovel%252Befficient%252Bmethod%252Bfor%252Bthe%252Bsynthesis%252Bof%252B2-%2525282-amino-6-oxo-%252B1%25252C4%25252C5%25252C6-tetrahydropyrimidin-5-yl%252529acetanilides%26aulast%3DSotnikov%26aufirst%3DNikita%2BM.%26date%3D2021%26date%3D2021%26volume%3D57%26issue%3D2%26spage%3D154%26epage%3D158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Rik  Oost</span>, <span class="hlFld-ContribAuthor ">Boris  Maryasin</span>, <span class="hlFld-ContribAuthor ">Leticia  González</span>, <span class="hlFld-ContribAuthor ">Nuno  Maulide</span>. </span><span class="cited-content_cbyCitation_article-title">A redox-neutral synthesis of ketones by coupling of alkenes and amides. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-10151-x" title="DOI URL">https://doi.org/10.1038/s41467-019-10151-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-10151-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-10151-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DA%252Bredox-neutral%252Bsynthesis%252Bof%252Bketones%252Bby%252Bcoupling%252Bof%252Balkenes%252Band%252Bamides%26aulast%3DLi%26aufirst%3DJing%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhito  Harada</span>, <span class="hlFld-ContribAuthor ">Jun  Mizukami</span>, <span class="hlFld-ContribAuthor ">Takashi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Genki  Mori</span>, <span class="hlFld-ContribAuthor ">Minoru  Ubukata</span>, <span class="hlFld-ContribAuthor ">Katsunori  Suwa</span>, <span class="hlFld-ContribAuthor ">Sumiaki  Fukuda</span>, <span class="hlFld-ContribAuthor ">Tamotsu  Negoro</span>, <span class="hlFld-ContribAuthor ">Motohide  Sato</span>, <span class="hlFld-ContribAuthor ">Takashi  Inaba</span>. </span><span class="cited-content_cbyCitation_article-title">Lead generation and optimization of novel GPR119 agonists with a spirocyclic cyclohexane structure. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (3)
                                     , 373-379. <a href="https://doi.org/10.1016/j.bmcl.2018.12.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLead%252Bgeneration%252Band%252Boptimization%252Bof%252Bnovel%252BGPR119%252Bagonists%252Bwith%252Ba%252Bspirocyclic%252Bcyclohexane%252Bstructure%26aulast%3DHarada%26aufirst%3DKazuhito%26date%3D2019%26volume%3D29%26issue%3D3%26spage%3D373%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jin Won  Yang</span>, <span class="hlFld-ContribAuthor ">Hyo Seon  Kim</span>, <span class="hlFld-ContribAuthor ">Yong‐Won  Choi</span>, <span class="hlFld-ContribAuthor ">Young‐Mi  Kim</span>, <span class="hlFld-ContribAuthor ">Keon Wook  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic application of
              GPR119
              ligands in metabolic disorders. </span><span class="cited-content_cbyCitation_journal-name">Diabetes, Obesity and Metabolism</span><span> <strong>2018,</strong> <em>20 </em>
                                    (2)
                                     , 257-269. <a href="https://doi.org/10.1111/dom.13062" title="DOI URL">https://doi.org/10.1111/dom.13062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/dom.13062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fdom.13062%26sid%3Dliteratum%253Aachs%26jtitle%3DDiabetes%252C%2520Obesity%2520and%2520Metabolism%26atitle%3DTherapeutic%252Bapplication%252Bof%252BGPR119%252Bligands%252Bin%252Bmetabolic%252Bdisorders%26aulast%3DYang%26aufirst%3DJin%2BWon%26date%3D2018%26date%3D2017%26volume%3D20%26issue%3D2%26spage%3D257%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinying  Chen</span>, <span class="hlFld-ContribAuthor ">Zitai  Sang</span>, <span class="hlFld-ContribAuthor ">Lu  Li</span>, <span class="hlFld-ContribAuthor ">Linhong  He</span>, <span class="hlFld-ContribAuthor ">Liang  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 5-methyl-2-(4-((4-(methylsulfonyl)benzyl)oxy)phenyl)-4-(piperazin-1-yl)pyrimidine derivatives as novel GRP119 agonists for the treatment of diabetes and obesity. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2017,</strong> <em>21 </em>
                                    (3)
                                     , 637-654. <a href="https://doi.org/10.1007/s11030-017-9755-6" title="DOI URL">https://doi.org/10.1007/s11030-017-9755-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-017-9755-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-017-9755-6%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DDiscovery%252Bof%252B5-methyl-2-%2525284-%252528%2525284-%252528methylsulfonyl%252529benzyl%252529oxy%252529phenyl%252529-4-%252528piperazin-1-yl%252529pyrimidine%252Bderivatives%252Bas%252Bnovel%252BGRP119%252Bagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bdiabetes%252Band%252Bobesity%26aulast%3DChen%26aufirst%3DJinying%26date%3D2017%26date%3D2017%26volume%3D21%26issue%3D3%26spage%3D637%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Moon-Kook  Jeon</span>, <span class="hlFld-ContribAuthor ">Kyu Myung  Lee</span>, <span class="hlFld-ContribAuthor ">Il Hyang  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon Kyung  Jang</span>, <span class="hlFld-ContribAuthor ">Seung Kyu  Kang</span>, <span class="hlFld-ContribAuthor ">Jun Mi  Lee</span>, <span class="hlFld-ContribAuthor ">Kwan-Young  Jung</span>, <span class="hlFld-ContribAuthor ">Jaladi Ashok  Kumar</span>, <span class="hlFld-ContribAuthor ">Sang Dal  Rhee</span>, <span class="hlFld-ContribAuthor ">Won Hoon  Jung</span>, <span class="hlFld-ContribAuthor ">Jin Sook  Song</span>, <span class="hlFld-ContribAuthor ">Myung Ae  Bae</span>, <span class="hlFld-ContribAuthor ">Kwang Rok  Kim</span>, <span class="hlFld-ContribAuthor ">Jin Hee  Ahn</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of thienopyrimidine derivatives as GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (17)
                                     , 4281-4285. <a href="https://doi.org/10.1016/j.bmcl.2014.07.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.07.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.07.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bthienopyrimidine%252Bderivatives%252Bas%252BGPR119%252Bagonists%26aulast%3DJeon%26aufirst%3DMoon-Kook%26date%3D2014%26volume%3D24%26issue%3D17%26spage%3D4281%26epage%3D4285" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiang-Yang  Ye</span>, <span class="hlFld-ContribAuthor ">Christian L.  Morales</span>, <span class="hlFld-ContribAuthor ">Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Karen A.  Rossi</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Mojgan  Abousleiman</span>, <span class="hlFld-ContribAuthor ">Larisa  Sereda</span>, <span class="hlFld-ContribAuthor ">Atsu  Apedo</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Robl</span>, <span class="hlFld-ContribAuthor ">Keith J.  Miller</span>, <span class="hlFld-ContribAuthor ">John  Krupinski</span>, <span class="hlFld-ContribAuthor ">Dean A.  Wacker</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship of dihydrobenzofuran derivatives as novel human GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (11)
                                     , 2539-2545. <a href="https://doi.org/10.1016/j.bmcl.2014.03.096" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.03.096</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.03.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.03.096%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bof%252Bdihydrobenzofuran%252Bderivatives%252Bas%252Bnovel%252Bhuman%252BGPR119%252Bagonists%26aulast%3DYe%26aufirst%3DXiang-Yang%26date%3D2014%26volume%3D24%26issue%3D11%26spage%3D2539%26epage%3D2545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul  Gillespie</span>, <span class="hlFld-ContribAuthor ">Robert A.  Goodnow</span>, <span class="hlFld-ContribAuthor ">Goutam  Saha</span>, <span class="hlFld-ContribAuthor ">Gopal  Bose</span>, <span class="hlFld-ContribAuthor ">Kakali  Moulik</span>, <span class="hlFld-ContribAuthor ">Catherine  Zwingelstein</span>, <span class="hlFld-ContribAuthor ">Michael  Myers</span>, <span class="hlFld-ContribAuthor ">Karin  Conde-Knape</span>, <span class="hlFld-ContribAuthor ">Sherrie  Pietranico-Cole</span>, <span class="hlFld-ContribAuthor ">Sung-Sau  So</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazolo[3,4-d]pyrimidine derivatives as GPR119 agonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (3)
                                     , 949-953. <a href="https://doi.org/10.1016/j.bmcl.2013.12.063" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.12.063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.12.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.12.063%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bpyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252BGPR119%252Bagonists%26aulast%3DGillespie%26aufirst%3DPaul%26date%3D2014%26volume%3D24%26issue%3D3%26spage%3D949%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiu-Lei  Mo</span>, <span class="hlFld-ContribAuthor ">Zhao  Yang</span>, <span class="hlFld-ContribAuthor ">Ya-Xiong  Tao</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting GPR119 for the Potential Treatment of Type 2 Diabetes Mellitus. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 95-131. <a href="https://doi.org/10.1016/B978-0-12-800101-1.00004-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-800101-1.00004-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800101-1.00004-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800101-1.00004-1%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252BGPR119%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BType%252B2%252BDiabetes%252BMellitus%26aulast%3DMo%26aufirst%3DXiu-Lei%26date%3D2014%26spage%3D95%26epage%3D131%26pub%3DElsevier%26atitle%3DGlucose%252BHomeostatis%252Band%252Bthe%252BPathogenesis%252Bof%252BDiabetes%252BMellitus%26date%3D2014%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James S.  Scott</span>, <span class="hlFld-ContribAuthor ">Katy J.  Brocklehurst</span>, <span class="hlFld-ContribAuthor ">Hayley S.  Brown</span>, <span class="hlFld-ContribAuthor ">David S.  Clarke</span>, <span class="hlFld-ContribAuthor ">Helen  Coe</span>, <span class="hlFld-ContribAuthor ">Sam D.  Groombridge</span>, <span class="hlFld-ContribAuthor ">David  Laber</span>, <span class="hlFld-ContribAuthor ">Philip A.  MacFaul</span>, <span class="hlFld-ContribAuthor ">Darren  McKerrecher</span>, <span class="hlFld-ContribAuthor ">Paul  Schofield</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational restriction in a series of GPR119 agonists: Differences in pharmacology between mouse and human. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (11)
                                     , 3175-3179. <a href="https://doi.org/10.1016/j.bmcl.2013.04.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.04.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.04.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DConformational%252Brestriction%252Bin%252Ba%252Bseries%252Bof%252BGPR119%252Bagonists%25253A%252BDifferences%252Bin%252Bpharmacology%252Bbetween%252Bmouse%252Band%252Bhuman%26aulast%3DScott%26aufirst%3DJames%2BS.%26date%3D2013%26volume%3D23%26issue%3D11%26spage%3D3175%26epage%3D3179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative GPR119 agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Indolines <b>2</b>, <b>9</b>, and <b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ph<sub>3</sub>P, DIAD, THF, RT, 77%; (b) CuI, K<sub>3</sub>PO<sub>4</sub>, <i>trans</i>-1,2-cyclohexanediamine, toluene, reflux, 8%; (c) CuI, <span class="smallcaps smallerCapital">l</span>-proline, NaOH, CH<sub>3</sub>SO<sub>2</sub>Na, DMSO, 110 °C, 98% for <b>6</b>→<b>7</b>; (d) NaCNBH<sub>3</sub>, HOAc, RT, 71% for <b>7</b>→<b>9</b>; (e) (i) TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT, (ii) <i>i</i>-PrOCOCl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, RT, 54%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Attempted Preparation of DHPP Chemotype<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuI, K<sub>3</sub>PO<sub>4</sub>, toluene, reflux, 30%; (b) NaH, THF, reflux, 70%; (c) CuI, <span class="smallcaps smallerCapital">l</span>-proline, NaOH, CH<sub>3</sub>SO<sub>2</sub>Na, DMSO, 110 °C, 84%; (d) NaCNBH<sub>3</sub>, HOAc or NaCNBH<sub>3</sub>, BF<sub>3</sub>·OEt<sub>2</sub>, MeOH, reflux or NiCl<sub>2</sub>·6H<sub>2</sub>O, NaBH<sub>4</sub>, MeOH or 10% Pd/C, H<sub>2</sub>, MeOH.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of the DHPP Chemotype, Exemplifying <b>3</b> and <b>23</b>.<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a (i) 0.5M NaOMe in MeOH, (ii) POCl<sub>3</sub>, 86% yield from <b>16</b>; (b) NaH, THF, reflux; (c) (i) O<sub>3</sub>, −78 °C, CH<sub>2</sub>Cl<sub>2</sub>, (ii) NaBH<sub>4</sub>, MeOH; (d) Ms<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to RT, 46% overall yield from <b>17</b>; (e) NaH, THF, reflux, 71%.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Phenyl Ring Derivatives <b>25</b>–<b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CuCN, NMP, 150 °C, 85% for <b>25</b>, or PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, 2-(tributylstannanyl)-1,3-thiazole, THF, 78 °C, 61% for <b>26</b>, or PdCl<sub>2</sub>(Ph<sub>3</sub>P)<sub>2</sub>, 1-methyl-2-(tributylstannanyl)-1<i>H</i>-pyrrole, THF, 78 °C, 12% for <b>27</b>.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Piperidine Derivatives <b>29</b>–<b>44</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, THF, reflux, 71%; (b) (i) 20% TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT, (ii) RCO<sub>2</sub>Cl, Et<sub>3</sub>N (<b>29</b>–<b>36</b>); or RC(═O)SCl, Et<sub>3</sub>N (<b>37</b>, <b>38</b>); or 1,1′-carbonyldiimidazole; then MeI in CH<sub>3</sub>CN, then <i>i</i>-PrSH, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub> (<b>39</b>); RCS<sub>2</sub>Ph, Et<sub>3</sub>N (<b>40</b>); or RSO<sub>2</sub>Cl, Et<sub>3</sub>N (<b>41</b>–<b>43</b>); or ClCH<sub>2</sub>CONEt<sub>2</sub>, Et<sub>3</sub>N (<b>44</b>).</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Oxadiazole, Pyrimidine, and Guanidine Intermediates <b>47</b>, <b>50</b>, <b>51</b>, and <b>54</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) CNBr, aqueous NaHCO<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>; (b) (i) 1N ZnCl<sub>2</sub>, Et<sub>2</sub>O/EtOAc, (ii) 4N HCl, EtOH, ∼30% from <b>45</b>; (c) <i>i</i>-Pr<sub>2</sub>NEt, CH<sub>3</sub>CN, reflux, 83% for <b>50</b>, 50% for <b>51</b>, and 51% for <b>53</b>; (d) H<sub>2</sub>, 10% Pd/C, HOAc/aqueous HCl, 84%.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Oxadiazole, Pyrimidine, and Guanidine Derivatives <b>55</b>–<b>58</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaH, THF, reflux, 55% for <b>55</b>, 39% for <b>56</b>, 50% for <b>57</b>, and 6% for <b>58</b>.</p></p></figure><figure data-id="sch8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Preparation of C2-Methyl Analogues <b>60</b>–<b>62</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Preparation of C2-Amino Analogues <b>73</b> and <b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) CH<sub>3</sub>CN, 60 °C; (b) catalytic amount of concentrated H<sub>2</sub>SO<sub>4</sub>, MeOH, 43% for 2 steps; (c) P<sub>2</sub>S<sub>5</sub>, THF, 70 °C, 50%; (d) guanidine hydrochloride or <i>N</i>-methyl guanidine hydrochloride, 1M NaOMe, MeOH, 60 → 90 °C; (e) POCl<sub>3</sub>, Et<sub>3</sub>N, 70 °C; (f) NaH, THF, 60 °C, 2% from <b>61</b> and 15% from <b>62</b>.</p></p></figure><figure data-id="sch10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 10. Preparation of Analogues <b>77</b> and <b>78</b> Bearing a Nitrogen-Atom Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch10"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, DMF, μw, 200 → 220 °C, 12% for <b>77</b> and 9% for <b>78</b>.</p></p></figure><figure data-id="sch11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 11. Preparation of Analogues <b>80</b> and <b>81</b> Bearing a Sulfur-Atom Linker<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch11"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) K<sub>2</sub>CO<sub>3</sub>, acetone, 60 °C, 71%; (b) <i>m</i>-CPBA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C, 18%.</p></p></figure><figure data-id="sch12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 12. Preparation of C6-Methyl Analogues <b>86</b> and <b>87</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch12"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) Boc<sub>2</sub>O, cat. DMAP, CH<sub>2</sub>Cl<sub>2</sub>, RT, (ii) K<sub>2</sub>OsO<sub>4</sub>·2H<sub>2</sub>O, 3:2 acetone/H<sub>2</sub>O, NaIO<sub>4</sub>, RT; (b) 1.4M MeMgBr, THF, 39% from <b>19</b>; (c) 20% TFA, CH<sub>2</sub>Cl<sub>2</sub>, RT; (d) Ms<sub>2</sub>O, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, RT, 47% from <b>83</b>; (e) (i) NaH, THF, reflux; (ii) chiral separation, 82%.</p></p></figure><figure data-id="sch13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 13. Preparation of Pyridyl Analogues <b>97</b> and <b>98</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch13"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaCNBH<sub>3</sub>, HOAc, MeOH, −15 °C → RT; (b) KO-<i>t</i>-Bu, MeOH, 11% for <b>93</b>; (c) NaH, THF, reflux, 88% for <b>95</b>; (d) Oxone, MeOH/acetone/H<sub>2</sub>O, RT, 81% for <b>97</b> and 7% overall yield for <b>98</b> from <b>17</b>.</p></p></figure><figure data-id="fig2" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pyridyl (<b>99</b>–<b>101</b>) and substituted phenyl (<b>102</b>–<b>108</b>) analogues.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch14" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 14. Preparation of Sulfone Analogue <b>113</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=sch14"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaSMe, DMF, 85 °C, 88%; (b) SnCl<sub>2</sub>, conc HCl, EtOH, 80 °C, 81%; (c) (i) NaCNBH<sub>3</sub>, HOAc, MeOH, −15 °C → RT, (ii) 4% TFA, 1,2-DCE, MeOH, RT, 31%; (d) (i) NaH, THF, reflux, 72%, (ii) Oxone, MeOH/acetone/H<sub>2</sub>O, RT, 29%.</p></p></figure><figure data-id="fig3" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. GLP-1 release in GluTag cells with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. GLP-1 secretion in primary colonic crypt (PCC) cells with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Incretin secretion in WT and KO mice.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Glucose Infusion Rate with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Hyperglycemic clamp with <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Rat OGTT with <b>3</b> and a DPP-IV inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/large/jm-2012-01404a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301404a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i83">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16164" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16164" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 43 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>National Diabetes Fact Sheet, 2011; <span class="NLM_publisher-name">Centers for Disease Control and Prevention</span>: <span class="NLM_publisher-loc">Atlanta, GA</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf" class="extLink">http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf</a> (accessed November 7,<span class="NLM_x"> </span><span class="NLM_year">2012</span><span class="NLM_x">) </span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=National+Diabetes+Fact+Sheet%2C+2011%3B+Centers+for+Disease+Control+and+Prevention%3A+Atlanta%2C+GA%2C+2011%3B+http%3A%2F%2Fwww.cdc.gov%2Fdiabetes%2Fpubs%2Fpdf%2Fndfs_2011.pdf+%28accessed+November+7%2C+2012%29+."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DNational%2520Diabetes%2520Fact%2520Sheet%252C%25202011%26pub%3DCenters%2520for%2520Disease%2520Control%2520and%2520Prevention%26date%3D2011%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Wild, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roglic, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sicree, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, H.</span><span> </span><span class="NLM_article-title">Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1047</span><span class="NLM_x">–</span> <span class="NLM_lpage">1053</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.2337%2Fdiacare.27.5.1047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=15111519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=1047-1053&author=S.+Wildauthor=G.+Roglicauthor=A.+Greenauthor=R.+Sicreeauthor=H.+King&title=Global+prevalence+of+diabetes%3A+Estimates+for+the+year+2000+and+projections+for+2030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Global prevalence of diabetes: estimates for the year 2000 and projections for 2030</span></div><div class="casAuthors">Wild Sarah; Roglic Gojka; Green Anders; Sicree Richard; King Hilary</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes care</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1047-53</span>
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    </div><div class="casAbstract">OBJECTIVE:  The goal of this study was to estimate the prevalence of diabetes and the number of people of all ages with diabetes for years 2000 and 2030.  RESEARCH DESIGN AND METHODS:  Data on diabetes prevalence by age and sex from a limited number of countries were extrapolated to all 191 World Health Organization member states and applied to United Nations' population estimates for 2000 and 2030.  Urban and rural populations were considered separately for developing countries.  RESULTS:  The prevalence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030.  The total number of people with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.  The prevalence of diabetes is higher in men than women, but there are more women with diabetes than men.  The urban population in developing countries is projected to double between 2000 and 2030.  The most important demographic change to diabetes prevalence across the world appears to be the increase in the proportion of people >65 years of age.  CONCLUSIONS:  These findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant.  Given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRS1_5FBm4QLEbxh97K6Vt6fW6udTcc2eYkH8xS0wMB3bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itVymsw%253D%253D&md5=93096de002d513e4fdd49028be51d85d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2337%2Fdiacare.27.5.1047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiacare.27.5.1047%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DS.%26aulast%3DRoglic%26aufirst%3DG.%26aulast%3DGreen%26aufirst%3DA.%26aulast%3DSicree%26aufirst%3DR.%26aulast%3DKing%26aufirst%3DH.%26atitle%3DGlobal%2520prevalence%2520of%2520diabetes%253A%2520Estimates%2520for%2520the%2520year%25202000%2520and%2520projections%2520for%25202030%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D1047%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Koro, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowlin, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourgeois, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fedder, D. O.</span><span> </span><span class="NLM_article-title">Glycemic Control From 1988 to 2000 among U.S. Adults Diagnosed with Type 2 Diabetes</span> <span class="citation_source-journal">Diabetes Care</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2004&pages=17-20&author=C.+E.+Koroauthor=S.+J.+Bowlinauthor=N.+Bourgeoisauthor=D.+O.+Fedder&title=Glycemic+Control+From+1988+to+2000+among+U.S.+Adults+Diagnosed+with+Type+2+Diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKoro%26aufirst%3DC.%2BE.%26aulast%3DBowlin%26aufirst%3DS.%2BJ.%26aulast%3DBourgeois%26aufirst%3DN.%26aulast%3DFedder%26aufirst%3DD.%2BO.%26atitle%3DGlycemic%2520Control%2520From%25201988%2520to%25202000%2520among%2520U.S.%2520Adults%2520Diagnosed%2520with%2520Type%25202%2520Diabetes%26jtitle%3DDiabetes%2520Care%26date%3D2004%26volume%3D27%26spage%3D17%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Philippe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raccah, D.</span><span> </span><span class="NLM_article-title">Treating type 2 diabetes: how safe are current therapeutic agents?</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">332</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1111%2Fj.1742-1241.2008.01980.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=19196370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVKms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=321-332&author=J.+Philippeauthor=D.+Raccah&title=Treating+type+2+diabetes%3A+how+safe+are+current+therapeutic+agents%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Treating type 2 diabetes: how safe are current therapeutic agents?</span></div><div class="casAuthors">Philippe, J.; Raccah, D.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">321-332</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Sulfonylureas (SUs) and biguanides (metformin) are the current mainstays in the treatment of type 2 diabetes (T2DM) and represent the most commonly used oral hypoglycemic agents (OHAs).  In recent years, a variety of new OHAs have become available, including thiazolidinediones, glinides, α-glucosidase inhibitors, glucagon-like peptide-1 agonists, amylin analogs and dipeptidyl peptidase-IV inhibitors, providing physicians with a larger therapeutic catalog than ever before.  The traditional drugs metformin and SUs have an established safety profile through long-term use.  However, long-term clin. trials and routine use are lacking for many of the new agents, and some potentially serious side effects have been reported with several of these compds.  Until adequate data is obtained, it is difficult to assess the risk-benefit ratio of these agents in relation to the traditional drugs.  Until that becomes fully documented, it may be wise to start pharmacol. treatment of patients on an individual basis, weighing the benefits and costs of each medication.  Thus, there remains a place for well-established drugs that have a proven safety record and are supported by years of clin. use for the treatment of T2DM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpy-QJ6BKnjvrVg90H21EOLACvtfcHk0lgFXMv-hVUU9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVKms7w%253D&md5=097fdaf5f7b7e98c3f2b1b86914f0abe</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2008.01980.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2008.01980.x%26sid%3Dliteratum%253Aachs%26aulast%3DPhilippe%26aufirst%3DJ.%26aulast%3DRaccah%26aufirst%3DD.%26atitle%3DTreating%2520type%25202%2520diabetes%253A%2520how%2520safe%2520are%2520current%2520therapeutic%2520agents%253F%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2009%26volume%3D63%26spage%3D321%26epage%3D332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hansen, K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knop, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holst, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vilsbøll, T.</span><span> </span><span class="NLM_article-title">Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1160</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1111%2Fj.1742-1241.2009.02086.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=19624785" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksVeqsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2009&pages=1154-1160&author=K.+B.+Hansenauthor=F.+K.+Knopauthor=J.+J.+Holstauthor=T.+Vilsb%C3%B8ll&title=Treatment+of+type+2+diabetes+with+glucagon-like+peptide-1+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Treatment of type 2 diabetes with glucagon-like peptide-1 receptor agonists</span></div><div class="casAuthors">Hansen, K. B.; Knop, F. K.; Holst, J. J.; Vilsboell, T.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1154-1160</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The incretin system is an area of great interest for the development of new therapies for the management of type 2 diabetes.  Existing antidiabetic drugs are often insufficient at getting patients to glycemic goals.  Furthermore, current treatment modalities are not able to prevent the continued ongoing decline in pancreatic beta-cell function and, lastly, they have a no. of side effects including hypoglycemia and wt. gain.  Glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of pharmacol. agents, which improve glucose homeostasis in a multifaceted way.  Their effects include potentiation of glucose-stimulated insulin secretion, glucose-dependent inhibition of glucagon secretion and redn. in gastric emptying, appetite, food intake and body wt.  Addnl., preclin. data suggest that they may preserve beta-cell mass and function.  The incidence of hypoglycemia with GLP-1 receptor agonists is low, the compds. have clin. relevant effects on body wt., and data are suggesting beneficial effects on cardiovascular risk factors.  Exenatide was released in 2005 for the treatment of type 2 diabetes and liraglutide is expected to be approved by the Food and Drug Administration in US and the European Medical Agency in Europe for use in 2009.  In this review, the available data on the two drugs are presented and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCOv1S4HptubVg90H21EOLACvtfcHk0liFbungQwrPww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksVeqsbg%253D&md5=9a0bc77ce997e69140ecc6c81b46ced5</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-1241.2009.02086.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-1241.2009.02086.x%26sid%3Dliteratum%253Aachs%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DKnop%26aufirst%3DF.%2BK.%26aulast%3DHolst%26aufirst%3DJ.%2BJ.%26aulast%3DVilsb%25C3%25B8ll%26aufirst%3DT.%26atitle%3DTreatment%2520of%2520type%25202%2520diabetes%2520with%2520glucagon-like%2520peptide-1%2520receptor%2520agonists%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2009%26volume%3D63%26spage%3D1154%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mohler, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, D. D.</span><span> </span><span class="NLM_article-title">Recent and Emerging Anti-Diabetes Targets</span> <span class="citation_source-journal">Med. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1002%2Fmed.20142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=18855890" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Srtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=125-195&author=M.+L.+Mohlerauthor=Y.+Heauthor=Z.+Wuauthor=D.+J.+Hwangauthor=D.+D.+Miller&title=Recent+and+Emerging+Anti-Diabetes+Targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Recent and emerging anti-diabetes targets</span></div><div class="casAuthors">Mohler, Michael L.; He, Yali; Wu, Zhongzhi; Hwang, Dong Jin; Miller, Duane D.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">125-195</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  Diabetes is a disease that affects over 150 million people worldwide for which there are multiple oral and injectable medications.  Because of trends in obesity and sedentary lifestyles, diabetes rates in both developed and developing countries are increasing at an alarming rate.  Current medications are not adequately effective in maintaining long-term glycemic control in most patients, even when used in combination, leaving diabetics susceptible to developing life threatening and debilitating complications such as cardiovascular disease, blindness, kidney complications, and amputations.  Consequently, there is a crit. need for more potent pharmacotherapies with novel mechanisms of action.  A panel of 20 emerging diabetes targets is presented, and small mol. modulators for each target will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHxHdB-PSdtbVg90H21EOLACvtfcHk0liFbungQwrPww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Srtb4%253D&md5=78fd3b689994598729ad2f77c2030c75</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1002%2Fmed.20142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20142%26sid%3Dliteratum%253Aachs%26aulast%3DMohler%26aufirst%3DM.%2BL.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DHwang%26aufirst%3DD.%2BJ.%26aulast%3DMiller%26aufirst%3DD.%2BD.%26atitle%3DRecent%2520and%2520Emerging%2520Anti-Diabetes%2520Targets%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2009%26volume%3D29%26spage%3D125%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Ashiya, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, R. E.</span><span> </span><span class="NLM_article-title">Non-insulin therapies for type 2 diabetes</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">777</span><span class="NLM_x">–</span> <span class="NLM_lpage">778</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=777-778&author=M.+Ashiyaauthor=R.+E.+Smith&title=Non-insulin+therapies+for+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAshiya%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DR.%2BE.%26atitle%3DNon-insulin%2520therapies%2520for%2520type%25202%2520diabetes%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D777%26epage%3D778" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Soga, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohishi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsui, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takasaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamohara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Momose, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsushime, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobori, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuichi, K.</span><span> </span><span class="NLM_article-title">Lyophosphatidylcholine enhances glucose-dependent insulin secretion via orphan G-protein-coupled receptor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">326</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2005&pages=744-751&author=T.+Sogaauthor=T.+Ohishiauthor=T.+Matsuiauthor=T.+Saitoauthor=M.+Matsumotoauthor=J.+Takasakiauthor=S.+Matsumotoauthor=M.+Kamoharaauthor=H.+Hiyamaauthor=S.+Yoshidaauthor=K.+Momoseauthor=Y.+Uedaauthor=H.+Matsushimeauthor=M.+Koboriauthor=K.+Furuichi&title=Lyophosphatidylcholine+enhances+glucose-dependent+insulin+secretion+via+orphan+G-protein-coupled+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSoga%26aufirst%3DT.%26aulast%3DOhishi%26aufirst%3DT.%26aulast%3DMatsui%26aufirst%3DT.%26aulast%3DSaito%26aufirst%3DT.%26aulast%3DMatsumoto%26aufirst%3DM.%26aulast%3DTakasaki%26aufirst%3DJ.%26aulast%3DMatsumoto%26aufirst%3DS.%26aulast%3DKamohara%26aufirst%3DM.%26aulast%3DHiyama%26aufirst%3DH.%26aulast%3DYoshida%26aufirst%3DS.%26aulast%3DMomose%26aufirst%3DK.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DMatsushime%26aufirst%3DH.%26aulast%3DKobori%26aufirst%3DM.%26aulast%3DFuruichi%26aufirst%3DK.%26atitle%3DLyophosphatidylcholine%2520enhances%2520glucose-dependent%2520insulin%2520secretion%2520via%2520orphan%2520G-protein-coupled%2520receptor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D326%26spage%3D744%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fredriksson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höglund, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloriam, D. E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagerström, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiöth, H. B.</span><span> </span><span class="NLM_article-title">Seven evolutionary conserved human rhodopsin G protein-coupled receptors lacking close relatives</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">554</span><span class="NLM_x">, </span> <span class="NLM_fpage">381</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=554&publication_year=2003&pages=381-388&author=R.+Fredrikssonauthor=P.+J.+H%C3%B6glundauthor=D.+E.+I.+Gloriamauthor=M.+C.+Lagerstr%C3%B6mauthor=H.+B.+Schi%C3%B6th&title=Seven+evolutionary+conserved+human+rhodopsin+G+protein-coupled+receptors+lacking+close+relatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredriksson%26aufirst%3DR.%26aulast%3DH%25C3%25B6glund%26aufirst%3DP.%2BJ.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%2BI.%26aulast%3DLagerstr%25C3%25B6m%26aufirst%3DM.%2BC.%26aulast%3DSchi%25C3%25B6th%26aufirst%3DH.%2BB.%26atitle%3DSeven%2520evolutionary%2520conserved%2520human%2520rhodopsin%2520G%2520protein-coupled%2520receptors%2520lacking%2520close%2520relatives%26jtitle%3DFEBS%2520Lett.%26date%3D2003%26volume%3D554%26spage%3D381%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bonini, J. A.; Borowsky, B. E.; Adham, N.; Boyle, N.; Thompson, T. O.</span><span> </span><span class="NLM_article-title">DNA encoding SNORF25 receptor</span>. US Patent 6,221,660-B1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=J.+A.+Bonini&author=B.+E.+Borowsky&author=N.+Adham&author=N.+Boyle&author=T.+O.+Thompson&title=DNA+encoding+SNORF25+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonini%26aufirst%3DJ.%2BA.%26atitle%3DDNA%2520encoding%2520SNORF25%2520receptor%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Bonini, J. A.; Borowsky, B. E.; Adham, N.; Boyle, N.; Thompson, T. O.</span><span> </span><span class="NLM_article-title">Methods of identifying compounds that bind to SNORF25 receptors</span>. US Patent 6,468,756-B1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+A.+Bonini&author=B.+E.+Borowsky&author=N.+Adham&author=N.+Boyle&author=T.+O.+Thompson&title=Methods+of+identifying+compounds+that+bind+to+SNORF25+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBonini%26aufirst%3DJ.%2BA.%26atitle%3DMethods%2520of%2520identifying%2520compounds%2520that%2520bind%2520to%2520SNORF25%2520receptors%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sakamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyawaki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itakura, M.</span><span> </span><span class="NLM_article-title">Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting cells</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x">, </span> <span class="NLM_fpage">474</span><span class="NLM_x">–</span> <span class="NLM_lpage">480</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2006&pages=474-480&author=Y.+Sakamotoauthor=H.+Inoueauthor=S.+Kawakamiauthor=K.+Miyawakiauthor=T.+Miyamotoauthor=K.+Mizutaauthor=M.+Itakura&title=Expression+and+distribution+of+Gpr119+in+the+pancreatic+islets+of+mice+and+rats%3A+predominant+localization+in+pancreatic+polypeptide-secreting+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DKawakami%26aufirst%3DS.%26aulast%3DMiyawaki%26aufirst%3DK.%26aulast%3DMiyamoto%26aufirst%3DT.%26aulast%3DMizuta%26aufirst%3DK.%26aulast%3DItakura%26aufirst%3DM.%26atitle%3DExpression%2520and%2520distribution%2520of%2520Gpr119%2520in%2520the%2520pancreatic%2520islets%2520of%2520mice%2520and%2520rats%253A%2520predominant%2520localization%2520in%2520pancreatic%2520polypeptide-secreting%2520cells%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2006%26volume%3D351%26spage%3D474%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moloney, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mondala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span> </span><span class="NLM_article-title">A Role for β-Cell-Expressing G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucose-Dependent Insulin Release</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">2601</span><span class="NLM_x">–</span> <span class="NLM_lpage">2609</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2007&pages=2601-2609&author=Z.-L.+Chuauthor=R.+M.+Jonesauthor=H.+Heauthor=C.+Carrollauthor=V.+Gutierrezauthor=A.+Lucmanauthor=M.+Moloneyauthor=H.+Gaoauthor=H.+Mondalaauthor=D.+Bagnolauthor=D.+Unettauthor=Y.+Liangauthor=K.+Demarestauthor=G.+Sempleauthor=D.+P.+Behanauthor=J.+Leonard&title=A+Role+for+%CE%B2-Cell-Expressing+G+Protein-Coupled+Receptor+119+in+Glycemic+Control+by+Enhancing+Glucose-Dependent+Insulin+Release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DGutierrez%26aufirst%3DV.%26aulast%3DLucman%26aufirst%3DA.%26aulast%3DMoloney%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DMondala%26aufirst%3DH.%26aulast%3DBagnol%26aufirst%3DD.%26aulast%3DUnett%26aufirst%3DD.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DJ.%26atitle%3DA%2520Role%2520for%2520%25CE%25B2-Cell-Expressing%2520G%2520Protein-Coupled%2520Receptor%2520119%2520in%2520Glycemic%2520Control%2520by%2520Enhancing%2520Glucose-Dependent%2520Insulin%2520Release%26jtitle%3DEndocrinology%26date%3D2007%26volume%3D148%26spage%3D2601%26epage%3D2609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedraza, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mondala, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bagnol, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span> </span><span class="NLM_article-title">A Role for Intestinal Endocrine Cell-Expressing G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">2038</span><span class="NLM_x">–</span> <span class="NLM_lpage">2647</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=149&publication_year=2008&pages=2038-2647&author=Z.-L.+Chuauthor=C.+Carrollauthor=J.+Alfonsoauthor=V.+Gutierrezauthor=H.+Heauthor=A.+Lucmanauthor=M.+Pedrazaauthor=H.+Mondalaauthor=H.+Gaoauthor=D.+Bagnolauthor=R.+Chenauthor=R.+M.+Jonesauthor=D.+P.+Behanauthor=J.+Leonard&title=A+Role+for+Intestinal+Endocrine+Cell-Expressing+G+Protein-Coupled+Receptor+119+in+Glycemic+Control+by+Enhancing+Glucagon-Like+Peptide-1+and+Glucose-Dependent+Insulinotropic+Peptide+Release"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DAlfonso%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DV.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLucman%26aufirst%3DA.%26aulast%3DPedraza%26aufirst%3DM.%26aulast%3DMondala%26aufirst%3DH.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DBagnol%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DJ.%26atitle%3DA%2520Role%2520for%2520Intestinal%2520Endocrine%2520Cell-Expressing%2520G%2520Protein-Coupled%2520Receptor%2520119%2520in%2520Glycemic%2520Control%2520by%2520Enhancing%2520Glucagon-Like%2520Peptide-1%2520and%2520Glucose-Dependent%2520Insulinotropic%2520Peptide%2520Release%26jtitle%3DEndocrinology%26date%3D2008%26volume%3D149%26spage%3D2038%26epage%3D2647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parker, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, F.</span><span> </span><span class="NLM_article-title">Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=289-298&author=H.+E.+Parkerauthor=A.+M.+Habibauthor=G.+J.+Rogersauthor=F.+M.+Gribbleauthor=F.+Reimann&title=Nutrient-dependent+secretion+of+glucose-dependent+insulinotropic+polypeptide+from+primary+murine+K+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DH.%2BE.%26aulast%3DHabib%26aufirst%3DA.%2BM.%26aulast%3DRogers%26aufirst%3DG.%2BJ.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DReimann%26aufirst%3DF.%26atitle%3DNutrient-dependent%2520secretion%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520from%2520primary%2520murine%2520K%2520cells%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Jones, R. M.; Leonard, J. N.</span><span> </span><span class="NLM_article-title">The Emergence of GPR119 Agonists as Anti-Diabetic Agents</span>. In  <span class="citation_source-book">Annual Reports in Medicinal Chemistry</span>, Vol.  <span class="NLM_volume">44</span>; <span class="NLM_contrib-group">Macor, J. E.; Stamford, A. W.</span>, Eds.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">149</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&pages=149-170&author=R.+M.+Jones&author=J.+N.+Leonardauthor=J.+E.+Macor&author=A.+W.+Stamford&title=Annual+Reports+in+Medicinal+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DThe%2520Emergence%2520of%2520GPR119%2520Agonists%2520as%2520Anti-Diabetic%2520Agents%26btitle%3DAnnual%2520Reports%2520in%2520Medicinal%2520Chemistry%26volume%3D44%26aulast%3DMacor%26aufirst%3DJ.%2BE.%26pub%3DAcademic%2520Press%26date%3D2009%26spage%3D149%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babbs, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doel, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gardner, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasamison, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang-Christensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Widdowson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1016%2Fj.cmet.2006.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=16517404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=167-175&author=H.+A.+Overtonauthor=A.+J.+Babbsauthor=S.+M.+Doelauthor=M.+C.+T.+Fyfeauthor=L.+S.+Gardnerauthor=G.+Griffinauthor=H.+C.+Jacksonauthor=M.+J.+Procterauthor=C.+M.+Rasamisonauthor=M.+Tang-Christensenauthor=P.+S.+Widdowsonauthor=G.+M.+Williamsauthor=C.+Reynet&title=Deorphanization+of+a+G+protein-coupled+receptor+for+oleoylethanolamide+and+its+use+in+the+discovery+of+small-molecule+hypophagic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents</span></div><div class="casAuthors">Overton, Hilary A.; Babbs, Adam J.; Doel, Sheila M.; Fyfe, Matthew C. T.; Gardner, Lisa S.; Griffin, Graeme; Jackson, Helen C.; Procter, Martin J.; Rasamison, Chrystelle M.; Tang-Christensen, Mads; Widdowson, Peter S.; Williams, Geoffery M.; Reynet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-175</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The endogenous lipid signaling agent oleoylethanolamide (OEA) has recently been described as a peripherally acting agent that reduces food intake and body wt. gain in rat feeding models.  This paper presents evidence that OEA is an endogenous ligand of the orphan receptor GPR119, a G protein-coupled receptor (GPCR) expressed predominantly in the human and rodent pancreas and gastrointestinal tract and also in rodent brain, suggesting that the reported effects of OEA on food intake may be mediated, at least in part, via the GPR119 receptor.  Furthermore, we have used the recombinant receptor to discover novel selective small-mol. GPR119 agonists, typified by PSN632408, which suppress food intake in rats and reduce body wt. gain and white adipose tissue deposition upon subchronic oral administration to high-fat-fed rats.  GPR119 therefore represents a novel and attractive potential target for the therapy of obesity and related metabolic disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr8xt3VqDV07Vg90H21EOLACvtfcHk0ljCPRfcgoK-0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xislyhtr8%253D&md5=85c2756aa0809be0069ea515e2a1574d</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2006.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2006.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DBabbs%26aufirst%3DA.%2BJ.%26aulast%3DDoel%26aufirst%3DS.%2BM.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DGardner%26aufirst%3DL.%2BS.%26aulast%3DGriffin%26aufirst%3DG.%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DRasamison%26aufirst%3DC.%2BM.%26aulast%3DTang-Christensen%26aufirst%3DM.%26aulast%3DWiddowson%26aufirst%3DP.%2BS.%26aulast%3DWilliams%26aufirst%3DG.%2BM.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DDeorphanization%2520of%2520a%2520G%2520protein-coupled%2520receptor%2520for%2520oleoylethanolamide%2520and%2520its%2520use%2520in%2520the%2520discovery%2520of%2520small-molecule%2520hypophagic%2520agents%26jtitle%3DCell%2520Metab.%26date%3D2006%26volume%3D3%26spage%3D167%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Gillum, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erion, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamison, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanabrough, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duenas, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederick, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horvath, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lo, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tso, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span> </span><span class="NLM_article-title"><i>N</i>-Acylphosphatidylethanolamine, a Gut-Derived Circulating Factor Induced by Fat Ingestion, Inhibits Food Intake</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">813</span><span class="NLM_x">–</span> <span class="NLM_lpage">824</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2008&pages=813-824&author=M.+P.+Gillumauthor=D.+Zhangauthor=X.-M.+Zhangauthor=D.+M.+Erionauthor=R.+A.+Jamisonauthor=C.+Choiauthor=J.+Dongauthor=M.+Shanabroughauthor=H.+R.+Duenasauthor=D.+W.+Frederickauthor=J.+J.+Hsiaoauthor=T.+L.+Horvathauthor=C.+M.+Loauthor=P.+Tsoauthor=G.+W.+Clineauthor=G.+I.+Shulman&title=N-Acylphosphatidylethanolamine%2C+a+Gut-Derived+Circulating+Factor+Induced+by+Fat+Ingestion%2C+Inhibits+Food+Intake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillum%26aufirst%3DM.%2BP.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DX.-M.%26aulast%3DErion%26aufirst%3DD.%2BM.%26aulast%3DJamison%26aufirst%3DR.%2BA.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DJ.%26aulast%3DShanabrough%26aufirst%3DM.%26aulast%3DDuenas%26aufirst%3DH.%2BR.%26aulast%3DFrederick%26aufirst%3DD.%2BW.%26aulast%3DHsiao%26aufirst%3DJ.%2BJ.%26aulast%3DHorvath%26aufirst%3DT.%2BL.%26aulast%3DLo%26aufirst%3DC.%2BM.%26aulast%3DTso%26aufirst%3DP.%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26atitle%3DN-Acylphosphatidylethanolamine%252C%2520a%2520Gut-Derived%2520Circulating%2520Factor%2520Induced%2520by%2520Fat%2520Ingestion%252C%2520Inhibits%2520Food%2520Intake%26jtitle%3DCell%26date%3D2008%26volume%3D135%26spage%3D813%26epage%3D824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alfonso, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebring, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behan, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span> </span><span class="NLM_article-title"><i>N</i>-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119</span> <span class="citation_source-journal">Mol. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1210%2Fme.2009-0239" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=19901198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtVGhtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=161-170&author=Z.-L.+Chuauthor=C.+Carrollauthor=R.+Chenauthor=J.+Alfonsoauthor=V.+Gutierrezauthor=H.+Heauthor=A.+Lucmanauthor=C.+Xingauthor=K.+Sebringauthor=J.+Zhouauthor=B.+Wagnerauthor=D.+Unettauthor=R.+M.+Jonesauthor=D.+P.+Behanauthor=J.+Leonard&title=N-Oleoyldopamine+Enhances+Glucose+Homeostasis+through+the+Activation+of+GPR119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119</span></div><div class="casAuthors">Chu, Zhi-Liang; Carroll, Chris; Chen, Ruoping; Alfonso, Jean; Gutierrez, Veronica; He, Hongmei; Lucman, Annette; Xing, Charles; Sebring, Kristen; Zhou, Jinyao; Wagner, Brandee; Unett, David; Jones, Robert M.; Behan, Dominic P.; Leonard, James</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">161-170</span>CODEN:
                <span class="NLM_cas:coden">MOENEN</span>;
        ISSN:<span class="NLM_cas:issn">0888-8809</span>.
    
            (<span class="NLM_cas:orgname">Endocrine Society</span>)
        </div><div class="casAbstract">G protein-coupled receptor 119 (GPR119) is largely restricted to pancreatic insulin-producing β-cells and intestinal glucagon-like peptide-1-producing L-cells.  Synthetic agonists of this receptor elicit glucose-dependent release of these endocrine factors, thereby enhancing glycemic control.  Oleoylethanolamide also activates GPR119, but it remains unclear whether endogenous prodn. of this lipid modulates GPR119 activity under normal or dysglycemic conditions.  We show here that a relatively diverse set of lipid amides activate GPR119.  Among these, the endovallinoid N-oleoyldopamine (OLDA) stimulated cAMP accumulation in GPR119-transfected cells as effectively as oleoylethanolamide and the previously described synthetic agonist AR 231453.  None of these lipid amides increased cAMP in control-transfected cells or in cells transfected with a no. of other G protein-coupled receptors.  OLDA stimulated both cAMP accumulation and insulin release in HIT-T15 cells, which express GPR119 endogenously, and in GPR119-transfected RIN-5F cells.  Oral administration of OLDA to C57bl/6 mice elicited significant improvement in glucose tolerance, whereas GPR119-deficient mice were essentially unresponsive.  OLDA also acutely elevated plasma gastric inhibitory peptide levels, a known hallmark of GPR119 activation.  OLDA represents a possible paracrine modulator of GPR119 in pancreatic islets, where markers of dopamine synthesis correlated well with GPR119 expression.  However, no such correlation was seen in the colon.  Collectively, these studies indicate that multiple, distinct classes of lipid amides, acting via GPR119, may be important modulators of glucose homeostasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbj9QqAT_6VbVg90H21EOLACvtfcHk0lgIBhBsXMeRSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtVGhtg%253D%253D&md5=e5248ec2e73719f06dfd9256bab07916</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1210%2Fme.2009-0239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fme.2009-0239%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DR.%26aulast%3DAlfonso%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DV.%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLucman%26aufirst%3DA.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DSebring%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DUnett%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DLeonard%26aufirst%3DJ.%26atitle%3DN-Oleoyldopamine%2520Enhances%2520Glucose%2520Homeostasis%2520through%2520the%2520Activation%2520of%2520GPR119%26jtitle%3DMol.%2520Endocrinol.%26date%3D2010%26volume%3D24%26spage%3D161%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kogure, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiyamuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kojima, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeda, S.</span><span> </span><span class="NLM_article-title">5-Hydroxy-eicosapentaenoic acid is an endogenous GPR119 agonist and enhances glucose-dependent insulin secretion</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">416</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">63</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=416&publication_year=2011&pages=58-63&author=R.+Kogureauthor=K.+Toyamaauthor=S.+Hiyamutaauthor=I.+Kojimaauthor=S.+Takeda&title=5-Hydroxy-eicosapentaenoic+acid+is+an+endogenous+GPR119+agonist+and+enhances+glucose-dependent+insulin+secretion"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKogure%26aufirst%3DR.%26aulast%3DToyama%26aufirst%3DK.%26aulast%3DHiyamuta%26aufirst%3DS.%26aulast%3DKojima%26aufirst%3DI.%26aulast%3DTakeda%26aufirst%3DS.%26atitle%3D5-Hydroxy-eicosapentaenoic%2520acid%2520is%2520an%2520endogenous%2520GPR119%2520agonist%2520and%2520enhances%2520glucose-dependent%2520insulin%2520secretion%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D416%26spage%3D58%26epage%3D63" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Carpenter, A.; Ammala, C.; Briscoe, C.; Bullard, S.; Kashatus, J.; Katamreddy, S.; Mertz, R.; Ross, S.</span><span> </span><span class="NLM_article-title">The in vitro and in vivo effects of a GPR119 agonist</span>. <span class="NLM_conf-name">Keystone Symposium, Diabetes Mellitis, Insulin Action and Resistance</span>, <span class="NLM_conf-loc">Breckenridge, CO</span>, <span class="NLM_conf-date">January 22–27, 2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Carpenter%2C+A.%3B+Ammala%2C+C.%3B+Briscoe%2C+C.%3B+Bullard%2C+S.%3B+Kashatus%2C+J.%3B+Katamreddy%2C+S.%3B+Mertz%2C+R.%3B+Ross%2C+S.+The+in+vitro+and+in+vivo+effects+of+a+GPR119+agonist.+Keystone+Symposium%2C+Diabetes+Mellitis%2C+Insulin+Action+and+Resistance%2C+Breckenridge%2C+CO%2C+January+22%E2%80%9327%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DA.%26atitle%3DThe%2520in%2520vitro%2520and%2520in%2520vivo%2520effects%2520of%2520a%2520GPR119%2520agonist" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lauffer, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iakoubov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brubaker, P. L.</span><span> </span><span class="NLM_article-title">GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">1058</span><span class="NLM_x">–</span> <span class="NLM_lpage">1066</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2009&pages=1058-1066&author=L.+M.+Laufferauthor=R.+Iakoubovauthor=P.+L.+Brubaker&title=GPR119+Is+Essential+for+Oleoylethanolamide-Induced+Glucagon-Like+Peptide-1+Secretion+From+the+Intestinal+Enteroendocrine+L-Cell"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLauffer%26aufirst%3DL.%2BM.%26aulast%3DIakoubov%26aufirst%3DR.%26aulast%3DBrubaker%26aufirst%3DP.%2BL.%26atitle%3DGPR119%2520Is%2520Essential%2520for%2520Oleoylethanolamide-Induced%2520Glucagon-Like%2520Peptide-1%2520Secretion%2520From%2520the%2520Intestinal%2520Enteroendocrine%2520L-Cell%26jtitle%3DDiabetes%26date%3D2009%26volume%3D58%26spage%3D1058%26epage%3D1066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Flock, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">152</span><span class="NLM_x">, </span> <span class="NLM_fpage">374</span><span class="NLM_x">–</span> <span class="NLM_lpage">383</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2011&pages=374-383&author=G.+Flockauthor=D.+Hollandauthor=Y.+Seinoauthor=D.+J.+Drucker&title=GPR119+Regulates+Murine+Glucose+Homeostasis+Through+Incretin+Receptor-Dependent+and+Independent+Mechanisms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFlock%26aufirst%3DG.%26aulast%3DHolland%26aufirst%3DD.%26aulast%3DSeino%26aufirst%3DY.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DGPR119%2520Regulates%2520Murine%2520Glucose%2520Homeostasis%2520Through%2520Incretin%2520Receptor-Dependent%2520and%2520Independent%2520Mechanisms%26jtitle%3DEndocrinology%26date%3D2011%26volume%3D152%26spage%3D374%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Parker, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habib, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gribble, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reimann, F.</span><span> </span><span class="NLM_article-title">Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells</span> <span class="citation_source-journal">Diabetologia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">289</span><span class="NLM_x">–</span> <span class="NLM_lpage">298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=289-298&author=H.+E.+Parkerauthor=A.+M.+Habibauthor=G.+J.+Rogersauthor=F.+M.+Gribbleauthor=F.+Reimann&title=Nutrient-dependent+secretion+of+glucose-dependent+insulinotropic+polypeptide+from+primary+murine+K+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DParker%26aufirst%3DH.%2BE.%26aulast%3DHabib%26aufirst%3DA.%2BM.%26aulast%3DRogers%26aufirst%3DG.%2BJ.%26aulast%3DGribble%26aufirst%3DF.%2BM.%26aulast%3DReimann%26aufirst%3DF.%26atitle%3DNutrient-dependent%2520secretion%2520of%2520glucose-dependent%2520insulinotropic%2520polypeptide%2520from%2520primary%2520murine%2520K%2520cells%26jtitle%3DDiabetologia%26date%3D2009%26volume%3D52%26spage%3D289%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ammala, C.; Bullard, S.; Kashatus, J.; Katamreddy, S.; Way, J.; Carpenter, A.</span><span> </span><span class="NLM_article-title">GPR119 dependent hormone secretion: insulin, GLP-1 and more</span>. <span class="NLM_conf-name">Keystone Symposium, Islet and β-Cell Biology</span>, <span class="NLM_conf-loc">Snowbird, UT</span>, <span class="NLM_conf-date">April 6-11, 2008</span>,  <span class="NLM_fpage">Abstract 102</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Ammala%2C+C.%3B+Bullard%2C+S.%3B+Kashatus%2C+J.%3B+Katamreddy%2C+S.%3B+Way%2C+J.%3B+Carpenter%2C+A.+GPR119+dependent+hormone+secretion%3A+insulin%2C+GLP-1+and+more.+Keystone+Symposium%2C+Islet+and+%CE%B2-Cell+Biology%2C+Snowbird%2C+UT%2C+April+6-11%2C+2008%2C+Abstract+102."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DAmmala%26aufirst%3DC.%26atitle%3DGPR119%2520dependent%2520hormone%2520secretion%253A%2520insulin%252C%2520GLP-1%2520and%2520more%26spage%3DAbstract%2520102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Jones, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzard, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehmann, J.</span><span> </span><span class="NLM_article-title">GPR119 agonists for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1340</span><span class="NLM_x">–</span> <span class="NLM_lpage">1359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1517%2F13543770903153878" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1340-1359&issue=10&author=R.+M.+Jonesauthor=J.+N.+Leonardauthor=D.+J.+Buzardauthor=J.+Lehmann&title=GPR119+agonists+for+the+treatment+of+type+2+diabetes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1517%2F13543770903153878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903153878%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DLeonard%26aufirst%3DJ.%2BN.%26aulast%3DBuzard%26aufirst%3DD.%2BJ.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3DGPR119%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26issue%3D10%26spage%3D1340%26epage%3D1359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">GPR119, a novel G protein-coupled receptor target for the treatment of type 2 diabetes and obesity</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">153</span><span class="NLM_x">, </span> <span class="NLM_fpage">S76</span><span class="NLM_x">–</span> <span class="NLM_lpage">S81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2008&pages=S76-S81&author=H.+A.+Overtonauthor=M.+C.+T.+Fyfeauthor=C.+Reynet&title=GPR119%2C+a+novel+G+protein-coupled+receptor+target+for+the+treatment+of+type+2+diabetes+and+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DGPR119%252C%2520a%2520novel%2520G%2520protein-coupled%2520receptor%2520target%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520and%2520obesity%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D153%26spage%3DS76%26epage%3DS81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit16b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fyfe, M. C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormack, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overton, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Procter, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynet, C.</span><span> </span><span class="NLM_article-title">GPR119 agonists as potential new oral agents for the treatment of type 2 diabetes and obesity</span> <span class="citation_source-journal">Expert Opin. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">413</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=403-413&author=M.+C.+T.+Fyfeauthor=J.+G.+McCormackauthor=H.+A.+Overtonauthor=M.+J.+Procterauthor=C.+Reynet&title=GPR119+agonists+as+potential+new+oral+agents+for+the+treatment+of+type+2+diabetes+and+obesity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFyfe%26aufirst%3DM.%2BC.%2BT.%26aulast%3DMcCormack%26aufirst%3DJ.%2BG.%26aulast%3DOverton%26aufirst%3DH.%2BA.%26aulast%3DProcter%26aufirst%3DM.%2BJ.%26aulast%3DReynet%26aufirst%3DC.%26atitle%3DGPR119%2520agonists%2520as%2520potential%2520new%2520oral%2520agents%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520and%2520obesity%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2008%26volume%3D3%26spage%3D403%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jones, R. M.; Semple, G.; Xiong, Y.; Shin, Y.-J.; Ren, A. S.; Calderon, I.; Fioravanti, B.; Choi, J. S. K.; Sage, C. R.</span><span> </span><span class="NLM_article-title">Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto</span>. WO 2005/007658A2,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+M.+Jones&author=G.+Semple&author=Y.+Xiong&author=Y.-J.+Shin&author=A.+S.+Ren&author=I.+Calderon&author=B.+Fioravanti&author=J.+S.+K.+Choi&author=C.+R.+Sage&title=Fused-aryl+and+heteroaryl+derivatives+as+modulators+of+metabolism+and+the+prophylaxis+and+treatment+of+disorders+related+thereto"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DFused-aryl%2520and%2520heteroaryl%2520derivatives%2520as%2520modulators%2520of%2520metabolism%2520and%2520the%2520prophylaxis%2520and%2520treatment%2520of%2520disorders%2520related%2520thereto%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Semple, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fioravanti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pereira, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderon, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dave, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomsen, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unett, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xing, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, Z.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grottick, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R. M.</span><span> </span><span class="NLM_article-title">Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5172</span><span class="NLM_x">–</span> <span class="NLM_lpage">5175</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm8006867" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5172-5175&author=G.+Sempleauthor=B.+Fioravantiauthor=G.+Pereiraauthor=I.+Calderonauthor=J.+Uyauthor=K.+Choiauthor=Y.+Xiongauthor=A.+Renauthor=M.+Morganauthor=V.+Daveauthor=W.+Thomsenauthor=D.+J.+Unettauthor=C.+Xingauthor=S.+Bossieauthor=C.+Carrollauthor=Z.-L.+Chuauthor=A.+J.+Grottickauthor=E.+K.+Hauserauthor=J.+Leonardauthor=R.+M.+Jones&title=Discovery+of+the+First+Potent+and+Orally+Efficacious+Agonist+of+the+Orphan+G-Protein+Coupled+Receptor+119"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119</span></div><div class="casAuthors">Semple, Graeme; Fioravanti, Beatriz; Pereira, Guillherme; Calderon, Imelda; Uy, Jane; Choi, Karoline; Xiong, Yifeng; Ren, Albert; Morgan, Michael; Dave, Vibha; Thomsen, William; Unett, David J.; Xing, Charles; Bossie, Stuart; Carroll, Chris; Chu, Zhi-Liang; Grottick, Andrew J.; Hauser, Erin K.; Leonard, James; Jones, Robert M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">5172-5175</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">GPR119 is a rhodopsin-like GPCR expressed in pancreatic β-cells and incretin releasing cells in the GI tract.  As with incretins, GPR119 increases cAMP levels in these cell types, thus making it a highly attractive potential target for the treatment of diabetes.  The discovery of the first reported potent agonist of GPR119, (2-fluoro-4-methanesulfonylphenyl)-{6-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-5-nitro-pyrimidin-4-yl}-amine (8g, AR231453), is described starting from an initial inverse agonist screening hit.  Compd. 8g showed in vivo activity in rodents and was active in an oral glucose tolerance test in mice following oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhpbZwXhitc7Vg90H21EOLACvtfcHk0liZQ5QrLE2lhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslahuro%253D&md5=92b03eb4e221bb3956c59a486758016e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm8006867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8006867%26sid%3Dliteratum%253Aachs%26aulast%3DSemple%26aufirst%3DG.%26aulast%3DFioravanti%26aufirst%3DB.%26aulast%3DPereira%26aufirst%3DG.%26aulast%3DCalderon%26aufirst%3DI.%26aulast%3DUy%26aufirst%3DJ.%26aulast%3DChoi%26aufirst%3DK.%26aulast%3DXiong%26aufirst%3DY.%26aulast%3DRen%26aufirst%3DA.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DDave%26aufirst%3DV.%26aulast%3DThomsen%26aufirst%3DW.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DXing%26aufirst%3DC.%26aulast%3DBossie%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DChu%26aufirst%3DZ.-L.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DHauser%26aufirst%3DE.%2BK.%26aulast%3DLeonard%26aufirst%3DJ.%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3DDiscovery%2520of%2520the%2520First%2520Potent%2520and%2520Orally%2520Efficacious%2520Agonist%2520of%2520the%2520Orphan%2520G-Protein%2520Coupled%2520Receptor%2520119%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5172%26epage%3D5175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Katamreddy, S. R.; Caldwell, R. D.; Heyer, D.; Samano, V.; Thompson, J. B.; Carpenter, A. J.; Conlee, C. R.; Boros, E. E.; Thompson, B. D.</span><span> </span><span class="NLM_article-title">Preparation of pyrrolo[2,3-<i>d</i>]pyrimidine derivatives as GPR119 agonists</span>. WO 2008/008887A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=S.+R.+Katamreddy&author=R.+D.+Caldwell&author=D.+Heyer&author=V.+Samano&author=J.+B.+Thompson&author=A.+J.+Carpenter&author=C.+R.+Conlee&author=E.+E.+Boros&author=B.+D.+Thompson&title=Preparation+of+pyrrolo%5B2%2C3-d%5Dpyrimidine+derivatives+as+GPR119+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKatamreddy%26aufirst%3DS.%2BR.%26atitle%3DPreparation%2520of%2520pyrrolo%255B2%252C3-d%255Dpyrimidine%2520derivatives%2520as%2520GPR119%2520agonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ammala, C.; Briscoe, C.</span><span> </span><span class="NLM_article-title">GPR119 agonists for the treatment of diabetes and related disorders</span>. WO 2008/008895A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=C.+Ammala&author=C.+Briscoe&title=GPR119+agonists+for+the+treatment+of+diabetes+and+related+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAmmala%26aufirst%3DC.%26atitle%3DGPR119%2520agonists%2520for%2520the%2520treatment%2520of%2520diabetes%2520and%2520related%2520disorders%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">For a review, see:</p></div><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl halides and sulfonates</span> <span class="citation_source-journal">J. Organomet. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">576</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1016%2FS0022-328X%2898%2901054-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADyaK1MXivFOlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=576&publication_year=1999&pages=125-146&author=B.+H.+Yangauthor=S.+L.+Buchwald&title=Palladium-catalyzed+amination+of+aryl+halides+and+sulfonates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-catalyzed amination of aryl halides and sulfonates</span></div><div class="casAuthors">Yang, Bryant H.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organometallic Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">576</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">125-146</span>CODEN:
                <span class="NLM_cas:coden">JORCAI</span>;
        ISSN:<span class="NLM_cas:issn">0022-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">In this review, with 96 refs., the progress made in the Pd-catalyzed amination of aryl halides and sulfonates is described with particular attention given to applications in synthetic org. chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTmrEGXq9DOLVg90H21EOLACvtfcHk0ljxvNp9dCr15g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXivFOlsrw%253D&md5=ca681694d1700bbd4e02135465dc29e0</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0022-328X%2898%2901054-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0022-328X%252898%252901054-7%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520halides%2520and%2520sulfonates%26jtitle%3DJ.%2520Organomet.%2520Chem.%26date%3D1999%26volume%3D576%26spage%3D125%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span> </span><span class="NLM_article-title">Synthesis of aryl sulfones via <span class="smallcaps smallerCapital">l</span>-proline-promoted CuI-catalyzed coupling reaction of aryl halides with sulfinic acid salts</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">2696</span><span class="NLM_x">–</span> <span class="NLM_lpage">2700</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo047758b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=2696-2700&author=W.+Zhuauthor=D.+Ma&title=Synthesis+of+aryl+sulfones+via+l-proline-promoted+CuI-catalyzed+coupling+reaction+of+aryl+halides+with+sulfinic+acid+salts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjo047758b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo047758b%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DW.%26aulast%3DMa%26aufirst%3DD.%26atitle%3DSynthesis%2520of%2520aryl%2520sulfones%2520via%2520l-proline-promoted%2520CuI-catalyzed%2520coupling%2520reaction%2520of%2520aryl%2520halides%2520with%2520sulfinic%2520acid%2520salts%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D2696%26epage%3D2700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gribble, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffman, J. H.</span><span> </span><span class="NLM_article-title">Reactions of sodium borohydride in acidic media; VI. Reduction of indoles with cyanoborohydride in acetic acid</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1977</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">859</span><span class="NLM_x">–</span> <span class="NLM_lpage">860</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1055%2Fs-1977-24606" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1977&pages=859-860&author=G.+W.+Gribbleauthor=J.+H.+Hoffman&title=Reactions+of+sodium+borohydride+in+acidic+media%3B+VI.+Reduction+of+indoles+with+cyanoborohydride+in+acetic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1055%2Fs-1977-24606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1977-24606%26sid%3Dliteratum%253Aachs%26aulast%3DGribble%26aufirst%3DG.%2BW.%26aulast%3DHoffman%26aufirst%3DJ.%2BH.%26atitle%3DReactions%2520of%2520sodium%2520borohydride%2520in%2520acidic%2520media%253B%2520VI.%2520Reduction%2520of%2520indoles%2520with%2520cyanoborohydride%2520in%2520acetic%2520acid%26jtitle%3DSynthesis%26date%3D1977%26volume%3D12%26spage%3D859%26epage%3D860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><div class="note"><p class="first last">For a previously reported synthesis of 6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines, see: </p></div><span class="NLM_contrib-group">Di Fabio, R.; Marchionni, C.; Micheli, F.; Pasquarello, A.; Perini, B.; St.-Denis, Y.</span><span> </span><span class="NLM_article-title">Preparation of substituted 6,7-dihydro-5<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidines as corticotropin releasing factor antagonists</span>. WO 2002/100863A1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=R.+Di+Fabio&author=C.+Marchionni&author=F.+Micheli&author=A.+Pasquarello&author=B.+Perini&author=Y.+St.-Denis&title=Preparation+of+substituted+6%2C7-dihydro-5H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+corticotropin+releasing+factor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFabio%26aufirst%3DR.%26atitle%3DPreparation%2520of%2520substituted%25206%252C7-dihydro-5H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520corticotropin%2520releasing%2520factor%2520antagonists%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Boros, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katamreddy, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, A. J.</span><span> </span><span class="NLM_article-title">Facile Reductive Amination of Aldehydes with Electron-Deficient Anilines by Acyloxyborohydrides in TFA: Application to a Diazaindoline Scale-Up</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">3587</span><span class="NLM_x">–</span> <span class="NLM_lpage">3590</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo900157z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktFemtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2009&pages=3587-3590&author=E.+Borosauthor=J.+B.+Thompsonauthor=S.+R.+Katamreddyauthor=A.+J.+Carpenter&title=Facile+Reductive+Amination+of+Aldehydes+with+Electron-Deficient+Anilines+by+Acyloxyborohydrides+in+TFA%3A+Application+to+a+Diazaindoline+Scale-Up"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Facile Reductive Amination of Aldehydes with Electron-Deficient Anilines by Acyloxyborohydrides in TFA: Application to a Diazaindoline Scale-Up</span></div><div class="casAuthors">Boros, Eric E.; Thompson, James B.; Katamreddy, Subba R.; Carpenter, Andrew J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3587-3590</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A scale-up of diazaindoline I was achieved in four stages and 32% overall yield.  The key step involved rapid reductive amination of (4,6-dichloro-5-pyrimidinyl)acetaldehyde with 2-fluoro-4-(methylsulfonyl)aniline by sodium triacetoxyborohydride (STAB-H) and TFA followed by ring closure of an intermediate amine to I in the same pot.  These reaction conditions were also applied to facile reductive aminations with anilines known to have little reactivity under STAB-H/AcOH conditions.  Spectral data supported the tris(trifluoroacetoxy)borohydride anion as the active reducing agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps8239xRckeLVg90H21EOLACvtfcHk0ljxvNp9dCr15g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktFemtLY%253D&md5=48cadd9073736b14543b1e37d4021d04</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo900157z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo900157z%26sid%3Dliteratum%253Aachs%26aulast%3DBoros%26aufirst%3DE.%26aulast%3DThompson%26aufirst%3DJ.%2BB.%26aulast%3DKatamreddy%26aufirst%3DS.%2BR.%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26atitle%3DFacile%2520Reductive%2520Amination%2520of%2520Aldehydes%2520with%2520Electron-Deficient%2520Anilines%2520by%2520Acyloxyborohydrides%2520in%2520TFA%253A%2520Application%2520to%2520a%2520Diazaindoline%2520Scale-Up%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2009%26volume%3D74%26spage%3D3587%26epage%3D3590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Friedman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shechter, H.</span><span> </span><span class="NLM_article-title">Dimethylformamide as a useful solvent in preparing nitriles from aryl halides and cuprous cyanide; improved isolation techniques</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1961</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">2522</span><span class="NLM_x">–</span> <span class="NLM_lpage">2524</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo01351a092" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1961&pages=2522-2524&author=L.+Friedmanauthor=H.+Shechter&title=Dimethylformamide+as+a+useful+solvent+in+preparing+nitriles+from+aryl+halides+and+cuprous+cyanide%3B+improved+isolation+techniques"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjo01351a092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01351a092%26sid%3Dliteratum%253Aachs%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DShechter%26aufirst%3DH.%26atitle%3DDimethylformamide%2520as%2520a%2520useful%2520solvent%2520in%2520preparing%2520nitriles%2520from%2520aryl%2520halides%2520and%2520cuprous%2520cyanide%253B%2520improved%2520isolation%2520techniques%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1961%26volume%3D26%26spage%3D2522%26epage%3D2524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hermann, W.</span><span> </span><span class="NLM_article-title">The Suzuki Cross-Coupling</span>. In  <span class="citation_source-book">From Applied Homogeneous Catalysis with Organometallic Compounds</span>, <span class="NLM_edition">2nd</span> ed.; <span class="NLM_contrib-group">Cornils, B.; Herrmann, W. A.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2002</span><span class="NLM_x">, </span>pp  <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">598</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1002%2F9783527618231.ch2k" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&pages=591-598&author=W.+Hermannauthor=B.+Cornils&author=W.+A.+Herrmann&title=From+Applied+Homogeneous+Catalysis+with+Organometallic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F9783527618231.ch2k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527618231.ch2k%26sid%3Dliteratum%253Aachs%26aulast%3DHermann%26aufirst%3DW.%26atitle%3DThe%2520Suzuki%2520Cross-Coupling%26btitle%3DFrom%2520Applied%2520Homogeneous%2520Catalysis%2520with%2520Organometallic%2520Compounds%26aulast%3DCornils%26aufirst%3DB.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%26date%3D2002%26spage%3D591%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Preparation of the thiocarbamates was accomplished by two different methods.</p></div><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">An example of a secondary, cyclic amine with <i>S</i>-methyl chlorothioformate in the presence of triethylamine:</p></div><span class="NLM_contrib-group">Fishbein, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, H.</span><span> </span><span class="NLM_article-title">Synthesis and Antineoplastic Activity of 1a-Formyl and 1a-Thioformyl Derivatives of Mitomycin C and 2-Methylaziridine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1767</span><span class="NLM_x">–</span> <span class="NLM_lpage">1773</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00393a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=1767-1773&author=P.+L.+Fishbeinauthor=H.+Kohn&title=Synthesis+and+Antineoplastic+Activity+of+1a-Formyl+and+1a-Thioformyl+Derivatives+of+Mitomycin+C+and+2-Methylaziridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjm00393a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00393a015%26sid%3Dliteratum%253Aachs%26aulast%3DFishbein%26aufirst%3DP.%2BL.%26aulast%3DKohn%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520Antineoplastic%2520Activity%2520of%25201a-Formyl%2520and%25201a-Thioformyl%2520Derivatives%2520of%2520Mitomycin%2520C%2520and%25202-Methylaziridine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D1767%26epage%3D1773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grzyb, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batey, R. A.</span><span> </span><span class="NLM_article-title">Carbamoylimidazolium salts as diversification reagents: an application to the synthesis of tertiary amides from carboxylic acids</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">7485</span><span class="NLM_x">–</span> <span class="NLM_lpage">7488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=7485-7488&author=J.+A.+Grzybauthor=R.+A.+Batey&title=Carbamoylimidazolium+salts+as+diversification+reagents%3A+an+application+to+the+synthesis+of+tertiary+amides+from+carboxylic+acids"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrzyb%26aufirst%3DJ.%2BA.%26aulast%3DBatey%26aufirst%3DR.%2BA.%26atitle%3DCarbamoylimidazolium%2520salts%2520as%2520diversification%2520reagents%253A%2520an%2520application%2520to%2520the%2520synthesis%2520of%2520tertiary%2520amides%2520from%2520carboxylic%2520acids%26jtitle%3DTetrahedron%2520Lett.%26date%3D2003%26volume%3D44%26spage%3D7485%26epage%3D7488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Danishefsky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, R. K.</span><span> </span><span class="NLM_article-title">A Highly Activated Cyclopropane for Homoconjugate Reactions</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">3239</span><span class="NLM_x">–</span> <span class="NLM_lpage">3241</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00844a065" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=1975&pages=3239-3241&author=S.+Danishefskyauthor=R.+K.+Singh&title=A+Highly+Activated+Cyclopropane+for+Homoconjugate+Reactions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja00844a065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00844a065%26sid%3Dliteratum%253Aachs%26aulast%3DDanishefsky%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DR.%2BK.%26atitle%3DA%2520Highly%2520Activated%2520Cyclopropane%2520for%2520Homoconjugate%2520Reactions%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1975%26volume%3D97%26spage%3D3239%26epage%3D3241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Ravikumar, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bégué, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet-Delpon, D.</span><span> </span><span class="NLM_article-title">A Selective Conversion of Sulfide to Sulfoxide in Hexafluoro-2-propanol</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">3141</span><span class="NLM_x">–</span> <span class="NLM_lpage">3144</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1998&pages=3141-3144&author=K.+S.+Ravikumarauthor=J.-P.+B%C3%A9gu%C3%A9author=D.+Bonnet-Delpon&title=A+Selective+Conversion+of+Sulfide+to+Sulfoxide+in+Hexafluoro-2-propanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRavikumar%26aufirst%3DK.%2BS.%26aulast%3DB%25C3%25A9gu%25C3%25A9%26aufirst%3DJ.-P.%26aulast%3DBonnet-Delpon%26aufirst%3DD.%26atitle%3DA%2520Selective%2520Conversion%2520of%2520Sulfide%2520to%2520Sulfoxide%2520in%2520Hexafluoro-2-propanol%26jtitle%3DTetrahedron%2520Lett.%26date%3D1998%26volume%3D39%26spage%3D3141%26epage%3D3144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Stephens, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devlin, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.-J.</span><span> </span><span class="NLM_article-title">The Determination of the Absolute Configurations of Chiral Molecules Using Vibrational Circular Dichroism (VCD) Spectroscopy</span> <span class="citation_source-journal">Chirality</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">643</span><span class="NLM_x">–</span> <span class="NLM_lpage">663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1002%2Fchir.20477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=17955495" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltlCjsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2008&pages=643-663&author=P.+J.+Stephensauthor=F.+J.+Devlinauthor=J.-J.+Pan&title=The+Determination+of+the+Absolute+Configurations+of+Chiral+Molecules+Using+Vibrational+Circular+Dichroism+%28VCD%29+Spectroscopy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The determination of the absolute configurations of chiral molecules using vibrational circular dichroism (VCD) spectroscopy</span></div><div class="casAuthors">Stephens, Philip J.; Devlin, Frank J.; Pan, Jian-Jung</div><div class="citationInfo"><span class="NLM_cas:title">Chirality</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-663</span>CODEN:
                <span class="NLM_cas:coden">CHRLEP</span>;
        ISSN:<span class="NLM_cas:issn">0899-0042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The vibrational CD (VCD) spectra of the two enantiomers of a chiral mol. are of equal magnitude and opposite sign: i.e. mirror-image enantiomers give mirror-image VCD spectra.  In principle, the abs. configuration (AC) of a chiral mol. can therefore be detd. from its VCD spectrum.  In practice, the detn. of the AC of a chiral mol. from its exptl. VCD spectrum requires a methodol. which reliably predicts the VCD spectra of its enantiomers.  The only reliable methodol. developed to date uses the Stephens quantum-mech. theory of the rotational strengths of fundamental vibrational transitions, developed in the early 1980s, implemented using ab initio d. functional theory in the GAUSSIAN program in the mid 1990s.  This methodol. has by now been widely used in detg. ACs from exptl. VCD spectra.  In this article we discuss the protocol for detg. the ACs of chiral mols. with optimum reliability and its implementation for a variety of mols., including the D3 symmetry perhydrotriphenylene, a thiazino-oxadiazolone recently shown to be a highly active calcium entry channel blocker, the alkaloid natural products schizozygine, iso-schizogaline, and iso-schizogamine, and the iridoid natural products plumericin, iso-plumericin, and prismatomerin.  The power of VCD spectroscopy in detg. ACs, even for large org. mols. and for substantially conformationally-flexible org. mols. is clearly documented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphb2yuC19HTLVg90H21EOLACvtfcHk0lg-K-JzYUy5-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltlCjsb0%253D&md5=21c2c1bb7fafdd188978333ac828c860</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fchir.20477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchir.20477%26sid%3Dliteratum%253Aachs%26aulast%3DStephens%26aufirst%3DP.%2BJ.%26aulast%3DDevlin%26aufirst%3DF.%2BJ.%26aulast%3DPan%26aufirst%3DJ.-J.%26atitle%3DThe%2520Determination%2520of%2520the%2520Absolute%2520Configurations%2520of%2520Chiral%2520Molecules%2520Using%2520Vibrational%2520Circular%2520Dichroism%2520%2528VCD%2529%2520Spectroscopy%26jtitle%3DChirality%26date%3D2008%26volume%3D20%26spage%3D643%26epage%3D663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="note"><p class="first last">The assay consists of CHO-K1 6CRE-luciferase cells that stably express human GPR119 receptor plated at 15000 cells/well in Dulbecco’s Modified Eagle Medium: Nutrient Mixture F12 (DMEM/F12), 5% fetal bovine serum (FBS), and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine in black 384-well assay plates. On the following day, the media is removed by aspiration and replaced with 20 μL of DMEM/F12, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (no FBS) utilizing a Matrix Multidrop. Test compounds (20 μL) are then pipetted into the assay plate using a Packard Minitrak. The plates are then incubated for 5 h at 37 °C. Under subdued light conditions, 15 μL of a 1:1 solution containing SteadyLite and Dulbecco’s Phosphate Biffered Saline with 1 mM CaCl<sub>2</sub> and 1 mM MgCl<sub>2</sub> is added to the plates using a Matrix Multidrop Plates are then sealed with self-adhesive clear plate seals and the amount of luciferase generated is quantified in a Wallac Viewlux. Compounds are also tested in the same manner against cells without the GPR119 receptor so as to check for false positives.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">All compounds are referenced to a small molecule GPR119 agonist for evaluation of intrinsic efficacy (%max response) because this reporter assay is not sensitive enough to demonstrate robust activity of putative endogenous ligands (OEA, LPC, etc.). Our experience with the ∼3000 compounds made for the program is that compounds with ∼80–200% max response are likely full agonists. Compounds with consistent levels of receptor activation below 80% may be partial agonists. The degree of variability in the assay accounts for the large range considered as full agonists. The structure of our standard compound <b>114</b>, with an EC<sub>50</sub> = 0.2 μM (max response = 100%), is shown below. This compound is reported<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> to have an EC<sub>50</sub> = 0.13 μM in a cAMP assay.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-24/jm301404a/production/images/medium/jm-2012-01404a_0023.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Jones, R. M.; Semple, G.; Fioravanti, B.; Pereira, G.; Calderon, I.; Uy, J.; Duvvuri, K.; Choi, J. S. K.; Xiong, Y.; Dave, V.</span><span> </span><span class="NLM_article-title">1,2,3-Trisubstituted Aryl and Heteroaryl Derivatives as Modulators of Metabolism and the Prophylaxis and Treatment of Disorders Related Thereto Such as Diabetes and Hyperglycemia</span>. WO 2004/065380 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+M.+Jones&author=G.+Semple&author=B.+Fioravanti&author=G.+Pereira&author=I.+Calderon&author=J.+Uy&author=K.+Duvvuri&author=J.+S.+K.+Choi&author=Y.+Xiong&author=V.+Dave&title=1%2C2%2C3-Trisubstituted+Aryl+and+Heteroaryl+Derivatives+as+Modulators+of+Metabolism+and+the+Prophylaxis+and+Treatment+of+Disorders+Related+Thereto+Such+as+Diabetes+and+Hyperglycemia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BM.%26atitle%3D1%252C2%252C3-Trisubstituted%2520Aryl%2520and%2520Heteroaryl%2520Derivatives%2520as%2520Modulators%2520of%2520Metabolism%2520and%2520the%2520Prophylaxis%2520and%2520Treatment%2520of%2520Disorders%2520Related%2520Thereto%2520Such%2520as%2520Diabetes%2520and%2520Hyperglycemia%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="note"><p class="first last">All studies were conducted after review by the GSK Institutional Animal Care and Use Committee and in accordance with the GSK Policy on the Care, Welfare and Treatment of Laboratory Animals.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lee, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asa, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drucker, D. J.</span><span> </span><span class="NLM_article-title">Glucagon Gene 5′-Flanking Sequences Direct Expression of Simian Virus 40 Large T Antigen to the Intestine, Producing Carcinoma of the Large Bowel in Transgenic Mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">10705</span><span class="NLM_x">–</span> <span class="NLM_lpage">10709</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=10705-10709&author=Y.+C.+Leeauthor=S.+L.+Asaauthor=D.+J.+Drucker&title=Glucagon+Gene+5%E2%80%B2-Flanking+Sequences+Direct+Expression+of+Simian+Virus+40+Large+T+Antigen+to+the+Intestine%2C+Producing+Carcinoma+of+the+Large+Bowel+in+Transgenic+Mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DY.%2BC.%26aulast%3DAsa%26aufirst%3DS.%2BL.%26aulast%3DDrucker%26aufirst%3DD.%2BJ.%26atitle%3DGlucagon%2520Gene%25205%25E2%2580%25B2-Flanking%2520Sequences%2520Direct%2520Expression%2520of%2520Simian%2520Virus%252040%2520Large%2520T%2520Antigen%2520to%2520the%2520Intestine%252C%2520Producing%2520Carcinoma%2520of%2520the%2520Large%2520Bowel%2520in%2520Transgenic%2520Mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D10705%26epage%3D10709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kaneko, T.; Kaneto, A.; Yanaihara, N.; Yasuda, H.; Suzuki, S.; Oka, H.; Oda, T.</span><span> </span><span class="NLM_article-title">Insulin and C-peptide secretion in animals</span>.  <span class="citation_source-book">Int. Congr. Ser.</span>,<span class="NLM_x"> </span><span class="NLM_year">1979</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">468</span>, <div class="note"><p class="first last">Proinsulin, Insulin, C-Pept.</p></div>, pp  <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1979&pages=138-147&author=T.+Kaneko&author=A.+Kaneto&author=N.+Yanaihara&author=H.+Yasuda&author=S.+Suzuki&author=H.+Oka&author=T.+Oda&title=Int.+Congr.+Ser."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DKaneko%26aufirst%3DT.%26atitle%3DInsulin%2520and%2520C-peptide%2520secretion%2520in%2520animals%26btitle%3DInt.%2520Congr.%2520Ser.%26date%3D1979%26volume%3D468%26spage%3D138%26epage%3D147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Barlocco, D.</span><span> </span><span class="NLM_article-title">LAF-237 Novartis</span> <span class="citation_source-journal">Curr. Opin. Investig. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1094</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=1094-1100&author=D.+Barlocco&title=LAF-237+Novartis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarlocco%26aufirst%3DD.%26atitle%3DLAF-237%2520Novartis%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1094%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Hatanaka, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondoh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawarabayashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuhama, K.</span><span> </span><span class="NLM_article-title">The Measurement of Gastric Emptying in Conscious Rats by Monitoring Serial Changes in Serum Acetaminophen Level</span> <span class="citation_source-journal">J. Pharmacol. Toxicol. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">161</span><span class="NLM_x">–</span> <span class="NLM_lpage">165</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1016%2F1056-8719%2894%2990079-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=8068978" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADyaK2cXlsVyhsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1994&pages=161-165&author=S.+Hatanakaauthor=M.+Kondohauthor=K.+Kawarabayashiauthor=K.+Furuhama&title=The+Measurement+of+Gastric+Emptying+in+Conscious+Rats+by+Monitoring+Serial+Changes+in+Serum+Acetaminophen+Level"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">The measurement of gastric emptying in conscious rats by monitoring serial changes in serum acetaminophen level</span></div><div class="casAuthors">Hatanaka, Satoshi; Kondoh, Masaki; Kawarabayashi, Keiko; Furuhama, Kazuhisa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">161-5</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    </div><div class="casAbstract">A method for evaluation of gastric emptying via monitoring serial serum levels of acetaminophen (APAP) as an indicator, without involving animal sacrifice, has been developed in conscious rats.  The authors administered orally suspended test meals of 0.5, 1,2, or 4 mL/rat each, contg. 20 mg APAP.  The animals were repeatedly bleed at 15, 30, 45, 60, or 90 min after APAP treatment.  Serum APAP level was detd. by a high-performance liq. chromatog.  As a result, a 2-mL meal was found optimal to attain continuous levels of APAP in serum.  The APAP method showed a close correlation (r = 0.77) with the phenol red method, a std. procedure for quant. detection of gastric emptying entailing rat sacrifice.  The blood loss (approx. 2 mL) resulting from the APAP method did not significantly modify the rate of gastric emptying.  In addn., data was presented to substantiate the validity of the APAP method in demonstrating enhancement and inhibition of gastric emptying using cisapride and cholecystokinin-octapeptide (CCK), resp.  These results suggest that the APAP method is easy, versatile, and reliable, and requires only a minimal no. of animals for the evaluation of sequential changes in gastric emptying.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_0zwZSDfXFbVg90H21EOLACvtfcHk0lj_zfglc6gQSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXlsVyhsrc%253D&md5=7fd0cfe8014594a451f7244e644070fa</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F1056-8719%2894%2990079-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1056-8719%252894%252990079-5%26sid%3Dliteratum%253Aachs%26aulast%3DHatanaka%26aufirst%3DS.%26aulast%3DKondoh%26aufirst%3DM.%26aulast%3DKawarabayashi%26aufirst%3DK.%26aulast%3DFuruhama%26aufirst%3DK.%26atitle%3DThe%2520Measurement%2520of%2520Gastric%2520Emptying%2520in%2520Conscious%2520Rats%2520by%2520Monitoring%2520Serial%2520Changes%2520in%2520Serum%2520Acetaminophen%2520Level%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D1994%26volume%3D31%26spage%3D161%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Roberts, B.; Gregoire, F. M.; Karpe, D. B.; Clemens, E.; Lavan, B.; Johnson, J.; McWherter, C. A.; Martin, R.; Wilson, M.</span><span> </span><span class="NLM_article-title">MBX-2982, a Novel Oral GPR119 Agonist for the Treatment of Type 2 Diabetes: Results of Single & Multiple Dose Studies</span>. <span class="NLM_conf-name">American Diabetes Association Meeting</span>, <span class="NLM_conf-loc">New Orleans, LA</span>, <span class="NLM_conf-date">2009</span>,  <span class="NLM_fpage">164-OR</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Roberts%2C+B.%3B+Gregoire%2C+F.+M.%3B+Karpe%2C+D.+B.%3B+Clemens%2C+E.%3B+Lavan%2C+B.%3B+Johnson%2C+J.%3B+McWherter%2C+C.+A.%3B+Martin%2C+R.%3B+Wilson%2C+M.+MBX-2982%2C+a+Novel+Oral+GPR119+Agonist+for+the+Treatment+of+Type+2+Diabetes%3A+Results+of+Single+%26+Multiple+Dose+Studies.+American+Diabetes+Association+Meeting%2C+New+Orleans%2C+LA%2C+2009%2C+164-OR."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DRoberts%26aufirst%3DB.%26atitle%3DMBX-2982%252C%2520a%2520Novel%2520Oral%2520GPR119%2520Agonist%2520for%2520the%2520Treatment%2520of%2520Type%25202%2520Diabetes%253A%2520Results%2520of%2520Single%2520%2526%2520Multiple%2520Dose%2520Studies%26spage%3D164-OR" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Katz, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambale, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rothenberg, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanapalli, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polidori, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vets, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarich, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, P. P.</span><span> </span><span class="NLM_article-title">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span> <span class="citation_source-journal">Clin. Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">685</span><span class="NLM_x">–</span> <span class="NLM_lpage">692</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm301404a&amp;key=10.1038%2Fclpt.2011.169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm301404a&amp;key=21975348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm301404a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2011&pages=685-692&issue=5&author=L.+B.+Katzauthor=J.+J.+Gambaleauthor=P.+L.+Rothenbergauthor=S.+R.+Vanapalliauthor=N.+Vaccaroauthor=L.+Xiauthor=D.+C.+Polidoriauthor=E.+Vetsauthor=T.+C.+Sarichauthor=P.+P.+Stein&title=Pharmacokinetics%2C+Pharmacodynamics%2C+Safety%2C+and+Tolerability+of+JNJ-38431055%2C+a+Novel+GPR119+Receptor+Agonist+and+Potential+Antidiabetes+Agent%2C+in+Healthy+Male+Subjects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male Subjects</span></div><div class="casAuthors">Katz, L. B.; Gambale, J. J.; Rothenberg, P. L.; Vanapalli, S. R.; Vaccaro, N.; Xi, L.; Polidori, D. C.; Vets, E.; Sarich, T. C.; Stein, P. P.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">90</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">685-692</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The incidence of type 2 diabetes mellitus is increasing worldwide.  Several G-protein-coupled receptor agonists are being studied for their efficacy as antidiabetes agents.  JNJ-38431055 is a novel, potent, and orally available selective agonist of the glucose-dependent insulinotropic (GPR119) receptor.  Double-blind, randomized, placebo-controlled studies were conducted to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single oral doses of JNJ-38431055 (2.5-800 mg) in healthy male volunteers.  The systemic exposure of JNJ-38431055 in plasma increased in proportion to the dose and was not influenced by coadministration of food.  The terminal elimination half-life was ∼13 h when administered as an oral suspension formulation.  JNJ-38431055 was well tolerated and was not assocd. with hypoglycemia.  As compared with placebo, single-dose oral JNJ-38431055 increased postmeal plasma glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and peptide YY (PYY) concns. but did not significantly decrease glucose excursion or increase insulin secretion.  However, in a graded glucose infusion study, JNJ-38431055 was shown to induce a higher insulin secretion rate (ISR) relative to placebo at elevated plasma glucose levels.  These studies provide evidence for the potential efficacy of JNJ-38431055 as an antidiabetes agent in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu9J3wfDOF_LVg90H21EOLACvtfcHk0lj_zfglc6gQSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlGlsLnP&md5=a9345cd8b438a8568505c0ff327f522f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.169%26sid%3Dliteratum%253Aachs%26aulast%3DKatz%26aufirst%3DL.%2BB.%26aulast%3DGambale%26aufirst%3DJ.%2BJ.%26aulast%3DRothenberg%26aufirst%3DP.%2BL.%26aulast%3DVanapalli%26aufirst%3DS.%2BR.%26aulast%3DVaccaro%26aufirst%3DN.%26aulast%3DXi%26aufirst%3DL.%26aulast%3DPolidori%26aufirst%3DD.%2BC.%26aulast%3DVets%26aufirst%3DE.%26aulast%3DSarich%26aufirst%3DT.%2BC.%26aulast%3DStein%26aufirst%3DP.%2BP.%26atitle%3DPharmacokinetics%252C%2520Pharmacodynamics%252C%2520Safety%252C%2520and%2520Tolerability%2520of%2520JNJ-38431055%252C%2520a%2520Novel%2520GPR119%2520Receptor%2520Agonist%2520and%2520Potential%2520Antidiabetes%2520Agent%252C%2520in%2520Healthy%2520Male%2520Subjects%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D90%26issue%3D5%26spage%3D685%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Carpenter, A. J.</span><span> </span><span class="NLM_article-title">Discovery of GSK1292263A, a GPR119 Agonist for the Treatment of T2D</span>. <span class="NLM_conf-name">National Medicinal Chemistry Symposium</span>, <span class="NLM_conf-loc">Minneapolis, MN</span>, <span class="NLM_conf-date">2010</span>,  <span class="NLM_fpage">OS2–2</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Carpenter%2C+A.+J.+Discovery+of+GSK1292263A%2C+a+GPR119+Agonist+for+the+Treatment+of+T2D.+National+Medicinal+Chemistry+Symposium%2C+Minneapolis%2C+MN%2C+2010%2C+OS2%E2%80%932."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DCarpenter%26aufirst%3DA.%2BJ.%26atitle%3DDiscovery%2520of%2520GSK1292263A%252C%2520a%2520GPR119%2520Agonist%2520for%2520the%2520Treatment%2520of%2520T2D%26spage%3DOS2%25E2%2580%25932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Nuñez, D. J.; Bush, M. A.; Collins, D. A.; McMullen, S. L.; Feldman, P. L.; Jackson, T. D.; Ross, S. A.</span><span> </span><span class="NLM_article-title">Evaluation of GSK1292263, a Novel GPR119 Agonist, in Type 2 Diabetes Mellitus (T2DM): Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Multiple Doses</span>. <span class="NLM_conf-name">American Diabetes Association Meeting</span>, <span class="NLM_conf-loc">San Diego, CA</span>, <span class="NLM_conf-date">2011</span>,  <span class="NLM_fpage">996-P</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Nu%C3%B1ez%2C+D.+J.%3B+Bush%2C+M.+A.%3B+Collins%2C+D.+A.%3B+McMullen%2C+S.+L.%3B+Feldman%2C+P.+L.%3B+Jackson%2C+T.+D.%3B+Ross%2C+S.+A.+Evaluation+of+GSK1292263%2C+a+Novel+GPR119+Agonist%2C+in+Type+2+Diabetes+Mellitus+%28T2DM%29%3A+Safety%2C+Tolerability%2C+Pharmacokinetics+%28PK%29+and+Pharmacodynamics+%28PD%29+of+Single+and+Multiple+Doses.+American+Diabetes+Association+Meeting%2C+San+Diego%2C+CA%2C+2011%2C+996-P."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DNu%25C3%25B1ez%26aufirst%3DD.%2BJ.%26atitle%3DEvaluation%2520of%2520GSK1292263%252C%2520a%2520Novel%2520GPR119%2520Agonist%252C%2520in%2520Type%25202%2520Diabetes%2520Mellitus%2520%2528T2DM%2529%253A%2520Safety%252C%2520Tolerability%252C%2520Pharmacokinetics%2520%2528PK%2529%2520and%2520Pharmacodynamics%2520%2528PD%2529%2520of%2520Single%2520and%2520Multiple%2520Doses%26spage%3D996-P" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301404a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm301404a%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301404a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799756b3829238c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
